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The development of the lung is a highly regulated and complex process that is not
fully characterised. Although there have been many studies into the development
of the lung many of the mechanisms regulating lung organogenesis are still unclear.
In recent years, the importance of epigenetic regulators in embryogenesis has been
established but epigenetic control of lung morphogenesis is largely underexplored.
I have developed a novel in vitro assay to grow embryonic lung stem cells. These
cells, called pneumospheres express the early lung progenitor factor Sox9 and re-
capitulate the E11.5 lung throughout their time in culture. Pneumospheres can be
genetically and chemically manipulated to assess the role of signalling pathways
and genes-of-interest on lung progenitor cell self-renewal or differentiation. Using
pneumospheres I performed a shRNA knockdown screen, targeting 130 genes in-
volved in epigenetic regulation. Nineteen genes were identified in the screen and
validated using in vitro and ex vivo culture systems to determine their role lung
stem cells and branching morphogenesis. These experiments identified Aurora ki-
nase B (Aurkb) as an interesting candidate gene. Aurkb exerts a dual role as a
regulator of cell cycle and epigenetic control through phosphorylation of histones.
Disruption of Aurkb either by short-hairpin RNA or by chemical inhibition in
vitro abrogates growth of lung epithelial progenitor cells and causes defects in cell
cycle, leading to an accumulation of cells in G2/M of the cell cycle. Conditional
deletion of Aurkb in the embryonic lung, leads to a complete lack of lung tissue
at birth and severe epithelial growth retardation can be seen as early as midges-
tation. Understanding the regulation of lung development will provide a better
understanding of the lung organogenesis and how disruptions in normal biology
can cause early lung diseases such as bronchopulmonary dysplasia or can have an
impact on lung disorders later in life such as COPD or lung cancer.
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"No organ in the body has been the object of a greater number of erroneous
descriptions and interpretations of normal and abnormal processes than has the
lung." Edith L. Potter, MD (1901-1993)
We take air from our environment into our bodies through our lungs. It is this
complex organ that extracts the oxygen from the environment and absorbs it into
the bloodstream and simultaneously extracts carbon dioxide from our blood and
returns it to the atmosphere. The lungs also provide us with the necessary airflow
to produce sounds and speech which has been a crucial part of our evolution.
The lung is an important organ for all land-based animals and mammals in par-
ticular share many common features in their gas-exchange organs. This thesis will
focus on the mouse lung as it is a tractable model for lung development. However,
it is still important to note that there are differences between the mouse and hu-
man which are important to continually assess to ensure experiments performed
in mice are relevant. The differences between the murine lung and human lung
that will be described as necessary throughout this review.
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Figure 1.1: Schematic comparison of the human and mouse lung
Human lung is composed of three right lobes and two left lobes in comparison with the mouse
lung which has four right lobes and only one left lobe. Submucosal glands (green), cartilage
(pink) and pseudostratified epithelium (yellow) is present further into the human lung than the
mouse lung. The trachea is connected to the primary bronchi which eventually become the
bronchioles in the distal parts of the lung. At the end of the bronchioles are the alveoli which
are closely associated with the vasculature (red) to facilitate gas exchange.
The human lung is comprised of three lobes on the right side and two lobes on
the left, while the mouse lung has four lobes on the right and one on the left
(Figure 1.1). Rings of cartilage surround the human trachea and intrapulmonary
airways, but in the mouse only surrounds the trachea. The left and right sides of
the lung are connected by the primary bronchi which connect to the trachea. The
bronchi are further subdivided into smaller bronchi which are divided further into
the bronchioles (less than 1mm diameter) and at the end of the bronchioles are
the alveoli which is the gas exchange region of the lung. Surrounding each lobe
of the lungs is the pleural sac which minimises friction as the lungs move during
breathing. The mechanical act of breathing is controlled by the diaphragm.
1.1.1 Adult lung epithelial cells
In the trachea and large airways there is a layer of pseudostratified epithelium. The
epithelium sits on the basement membrane which separates it from the blood and
lymphatic system, smooth muscle, fibroblasts and other supporting cell types. In
2
Introduction
the human this organisation persists much further into the airway branch system
than in the mouse which adopts the simple columnar epithelium just after the
tracheal branch point into the conducting airway [Rock and Hogan, 2011, Hogan
et al., 2014]. The proximal conducting airway consists of basal, secretory (goblet
and club cells) and ciliated cell types and their main role is to produce particle
trapping mucous and remove any debris from the lung. The distal airways contain
more club cells and less basal, ciliated, and mucous cells compared with proximal
airways [Pack et al., 1981]. At the end of the bronchioles are the alveolar sacs,
composed of flat alveolar type 1 (AT1) cells and cuboidal type 2 (AT2) cells. AT1
cells are responsible for exchanging oxygen and carbon dioxide with the blood
stream and atmosphere, while AT2 cells secrete surfactant protein C (SPC) to
prevent collapsing of the alveoli [Rawlins and Hogan, 2006]. Differences exist
between the mouse and human lung, with the mouse lung recapitulating the more
distal human lung and the mouse trachea representing the pseudostratified regions
of the upper airways of the of the human lung. However, most of the cell types
found in the human lung can be identified in the mouse lung, making the mouse
a good model for studying lung epithelial cells [Rock and Hogan, 2011].
1.1.2 Adult stem lung cells
The lung is a relatively quiescent organ and turnover of cells is slow, with the
epithelium turning over roughly every 100 days. This is in juxtaposition to the
intestines which is a highly proliferative organ, where cells are replaced every
2-4 days. Due to the continual exposure to environmental pollutants through
inhalation, the lung is very susceptible to injury. It is in response to injury that
the lung has an amazing capacity to repair and replace damaged cells through
its many different resident stem cells [Hogan et al., 2014]. Traditionally tissue
specific stem cells are long lived cells that can self-renew and differentiate into all
cell types that make up that organ. Similar to the stem cells are progenitor cells,
their ability to self-renew is usually more limited and their differentiation potential
is limited to a few cell types [Wagers and Weissman, 2004]. Stem and progenitor
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cells in the adult maintain tissue homeostasis and repair the organ after damage.
In the lung a significant amount of research has been conducted into finding the
stem and progenitor cells. Many studies have been conducted in the mouse using
lineage tracing experiments where specific cell types are tagged with a reporter and
cell progeny are traced throughout the lifespan of the mouse and after response
to injury [Grompe, 2012]. Because the lung is such a quiescent organ, injury
models have been necessary to tease apart the cells with stem and progenitor
activity. There are many different types of lung injury models which can target
specific subsets of cells [Asselin-Labat and Filby, 2012]. By using these models, it
has been discovered that ablation of different cell types can elicit different repair
responses, revealing many different stem cells of the adult lung. The existence of
a single lung stem cell that can repopulate all of different lung cell types is still
highly controversial [Hogan et al., 2014]. Two recent studies reported that after
an extreme injury event in the mouse lung, a very rare population of basal cells
in the distal lung could repopulate the airway and alveolar cells [Vaughan et al.,
2014, Zuo et al., 2014].
Adult epithelial lung stem cells differ from the traditional stem cell in three ways.
The first is that the stem cell may not be an undifferentiated cell, but rather
a mature cell that could de-differentiate after injury to act as a stem cell. The
second is that a cell expressing certain differentiated cell markers can change its
phenotype to produce cells that expresses markers of a different cell type. The
third difference between traditional stem cells and lung stem cells is that each
region of the lung likely has a different stem cell(s). Some of the identified lung
stem cells only display stem/progenitor activity in response to injury while others
are involved in homeostasis as well as injury [Hogan et al., 2014]. Lung epithelial
cell types and their stem/progenitor activity is described below. It is important
to note that while all the cell types below have been identified in the human and
mouse there are cells such as the rare bronchoalveolar stem cells found in the
bronchoalveolar duct junction that have only been identified so far in the mouse




Basal cells are the progenitor cells of the adult lung and can self-renew as well
as differentiate into secretory and ciliated cells [Evans et al., 2001, Hong et al.,
2004, Rock et al., 2009, Teixeira et al., 2013, Watson et al., 2015]. They are
identified by expression of keratin 5 (Krt5), keratin 14, and p63 [Asselin-Labat and
Filby, 2012, Watson et al., 2015] as well as T1α (podoplanin) expression [Atsumi
et al., 2008, Shimada et al., 2009, Weeden et al., 2017]. An important difference
between mouse and human is that basal cells are only found in the trachea and
primary bronchi in mice whereas they are found in all the conducting airways of
the human lung [Boers et al., 1998, Nakajima et al., 1998].
1.1.4 Club cells
Club cells are a secretory cell type found throughout the airways and can be
identified from the expression of a secreted protein known as club cell secretory
protein (CC10/CCSP). Through the release of CC10, club cells are thought to
regulate airway inflammation [Johnston et al., 1997]. They act as progenitor
cells but to different capacities depending on their location. In the bronchioles
there is evidence in mouse models that the club cells are progenitor cells for both
maintenance and repair of the airways following injury but do not contribute to
the alveolar lineages [Giangreco et al., 2002, Giangreco et al., 2009, Hong et al.,
2001, Rawlins et al., 2009b]. Interestingly, lineage tracing experiments in the
mouse trachea show that club cells have a limited capacity for renewal but this
increases in response to injury. This limited self-renewal capacity is likely due to
the presence of the known tracheal basal stem cell which would eliminate the need
for a club cell progenitor as basal cells can differentiate into the club cell lineage.
The increase in club cell self-renewal capacity upon a model injury in which basal
cells are depleted, highlights the complexity and necessary overlapping functions
to repopulate all of the cell types in the lung to repair and maintain a healthy




Ciliated cells, as their name suggest have long thin cilia protrusions on their surface
protruding into the lumen that beat to move mucous out of the airways. They are
identified by forkhead box J1 (Foxj1) and acetylated-tubulin (ac-tub) expression
[Kotton and Fine, 2008]. Ciliated cells are terminally differentiated and cannot
self-renew [Pardo-Saganta et al., 2013, Rawlins and Hogan, 2008, Rawlins et al.,
2007].
1.1.6 Goblet cells
Goblet cells contain a large vacuole filled with mucin that distorts the cell shape
giving the cell a goblet appearance. The cells function in collaboration with ciliated
cells to keep the lung free of debris. The number of goblet cells in the adult human
lung varies depending on the mucin-releasing cycle and response to environmental
stimuli such as toxins and pathogens [Jeffery and Li, 1997, Jeffery and Reid, 1975,
Whitsett et al., 2019, Chen et al., 2009]. The main marker of a goblet cells is the
production of mucin 5AC (MUC5AC) [Hovenberg et al., 1996].
1.1.7 Alveolar type 1 cells
Alveolar type 1 (AT1) cells are the gas exchange cells in the lung. They are long
flat cells that make up 95% of the alveolar surface area. AT1 cells are identified by
the expression of T1α and aquaporin 5 (AQP5) [Ramirez et al., 2003, Williams,
2003]. AT1 cells have limited self-renewal ability in vivo but in vitro they have
some potential to de-differentiate into ATII cells [Danto et al., 1995, Evans et al.,
1973, Hogan et al., 2014].
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1.1.8 Alveolar type 2 cells
Alveolar type 2 (AT2) cells are cuboidal cells that produce surfactant proteins
to prevent the collapse of the alveoli. Despite covering only 7% of the alveolar
surface, AT2 cells are twice as abundant as AT1 cells. AT2 cells are identified
by the secretion of surfactant proteins including surfactant protein C (SPC) and
B (SPB) [Rawlins and Hogan, 2006]. The surfactant produced by AT2 cells is a
mixture of proteins and phospholipids that decrease the surface tension [Hogan
et al., 2014, Weibel, 2013, Williams, 2003]. AT2 cells are progenitor cells of the
alveolar region, able to self-renew and differentiate into AT1 cells to maintain
tissue homeostasis and after injury to the alveoli [Barkauskas et al., 2013, Rock
and Hogan, 2011, Desai et al., 2014].
1.2 Congenital lung disease
Respiratory disease includes any illness that affects the lungs or respiratory tract.
In Australia from 2014-2015 approximately 7.1 million Australians were estimated
to have a chronic respiratory condition (NIH). Respiratory diseases can be acute,
such as pneumonia or chronic, such as asthma and COPD. Acute respiratory
diseases are usually a one-off infection and can be cured, whereas chronic disease
is long-term, often persisting for the lifetime of the individual. As the lungs
are not required until after birth, lung malformations are typically not diagnosed
until after birth. Infants suffering for abnormal lungs usually display respiratory
struggle or failure and in severe cases will lead to death shortly after.
Many of the chronic lung diseases have a developmental basis and can be the result
of either a genetic condition or improper development of the embryonic or neonatal
lung. In 1986, Barker et al. hypothesised that early prenatal and childhood events
can influence disease later in life [Barker and Osmond, 1986]. There are many
causes for the disruption of the developing lung including, preterm birth, expo-
sure to infection and heritable genetic causes. Defects associated with mutations
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in important developmental pathways regulating lung development are associated
with lung disorders. Table 1.1 lists some examples of transcription factors that
have been associated with lung disorders (adapted from [Whitsett et al., 2019]).
These disruptions can result in damage of the lungs leading to inflammation and
apoptosis. Insufficient repair of tissue damages can lead to a remodelling of the
lung resulting in aberrant tissue features such as fibrosis and emphysema which
are common characteristics of chronic respiratory disease [Carraro et al., 2014].
Additionally, excessive or insufficient production of important growth factors and
cytokines regulating lung development can lead to lung disease. For example,
transforming growth factor beta (TGF-B) is necessary for normal lung develop-
ment, but overexpression of TGF-B has been shown to promote fibrosis in the
adult lung [Sime et al., 1997, Morty et al., 2009].
Table 1.1: Examples of mutations in genes leading to lung disease
Gene Expression pattern Phenotype Reference
Egfr Epi; mes IB; deficient alveolarization [Miettinen et al., 1997]
Fgf9 Epithelium IB; reduced mesenchyme [Colvin et al., 2001]
Fgf10 Mesenchyme No lung [Sekine et al., 1999]
Fgfr1/2 Epithelium No lung [De Moerlooze et al., 2000]
Fgfr3/4 Epi; mes Deficient alveolarization [Weinstein et al., 1998]
Shh Epithelium IB; TEF [Litingtung et al., 1998]
Hip1 Mesenchyme IB [Chuang et al., 2003]
Gli2/3 Mesenchyme LO lung; impaired sacculation [Motoyama et al., 1998]
Catnnb1 Epithelium IB; p-d patterning [Mucenski et al., 2003]
Cebpa Epithelium Hyperproliferation of AT2 cells [Sugahara et al., 2001]
Foxa1/2 Epithelium IB [Wan et al., 2005]
Foxf1a Mesenchyme IB; lung lobe defect [Lim et al., 2002]
Foxj1 Epithelium L-R asymmetry; LO ciliated cells [Brody et al., 2000]
Hoxa5 Mesenchyme IB; tracheal defect [Aubin et al., 1997]
Nkx2.1 Epithelium LO distal lung fate; IB; TEF [Kimura et al., 1996]
Gata6 Epithelium Impaired sacculation [Yang et al., 2002]
Bmpr1a Epithelium Ectopic primary bronchi; tracheal defect [Domyan and Sun, 2011]
Raldh2 (RA) Mesenchyme No lung [Wang et al., 2006]
Yap Epithelium Lung cyst [Lin et al., 2017]
Yy1 Epithelium Lung cyst [Boucherat et al., 2015]
Elf5 Epithelium Distal lung cysts [Metzger et al., 2008a]
Grhl2 Epithelium Impaired sacculation [Kersbergen et al., 2018]
Pofut1/Rbpjk Epithelium No club, increased ciliated & neuroendocrine [Tsao et al., 2016]
IB = impaired branching, TEF = trachealoesoghageal fistula, LO = loss of
While some genetic causes are known, many of the developmental causes of lung
diseases are still being elucidated. Some lung diseases are characterised by which
stage lung development was arrested in.
Lung diseases that result from defects in lung development earlier than the pseu-
doglandular stage are severe 1.2. Two related diseases occur when there is an
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incorrect separation of the trachea and the oesophagus in the initial stages of lung
development, tracheal-oesophageal fistula (TEF) and oesophageal atresia (OA).
TEF is the fusion of the trachea and oesophagus. The most severe form of OA is
the complete absence of the oesophagus but the disease varies in severity with the
mildest resulting in only a narrowing of the oesophagus. For the most severe cases
surgical intervention is required however complications from surgery are common,
such as leakage or constriction from one of the tubes [Lee, 2018]. Overall, by fur-
thering our understanding of even the earliest stages of lung development we can
understand the causes of severe disease such as TEF and OA.
Acinar dysplasia is the result of lung development arrest at the pseudoglandular to
canalicular phase and at birth infants usually have no alveoli. Often this diagnosis
is made during autopsy as these children, even with intensive medical intervention,
do not survive. Congenital alveolar capillary dysplasia is due to arrested lung
development during the late canalicular to saccular phases of lung development.
This disease is characterised by pulmonary hypertension and development of severe
lung disease. Multiple incidents of congenital alveolar capillary dysplasia have been
reported within families, suggesting a genetic cause, however to date no causative
genes have been identified [Nogee, 2017]. A suggested candidate for familial cases
of congenital capillary alveolar dysplasia is FOXF1. FOXF1 is a transcription
factor important for vascular development and deletions and mutations have been
found in many patients with the disorder [Stankiewicz et al., 2009]. Another
common form of lung distress in the new born infant is from insufficient surfactant
production. Mutations in SFTPB, SFTPC, ABCA3 and NKX2.1 have all been
identified in patients suffering from surfactant dysfunction disorders [Nogee et al.,
1994, Shulenin et al., 2004, Bullard et al., 2005, Wert et al., 2009, Whitsett et al.,
2010, Tredano et al., 2004].
While many of the above developmental diseases described are rare, there are
a number of common chronic lung diseases present in the population including:
bronchopulmonary dysplasia (BPD) and asthma. BPD is one of the most common
disorders found in neonatal care units and are associated with defects in late lung
development [Collins et al., 2017, Donahoe et al., 2016].
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1.2.1 Bronchopulmonary dysplasia (BPD)
Bronchopulmonary dysplasia is characterised by incomplete alveolar development
and increased inflammation in the lung [Merritt et al., 1981, Munshi et al., 1997].
Infants suffering from BPD have immature respiratory systems characterised by
simplified alveoli, arrested alveolar-capillary development and increased fibrosis
[Voynow, 2017]. BPD is commonly associated with premature birth due to oxy-
gen toxicity (hyperoxia) and mechanical stress on immature lungs [Northway et al.,
1967, Philip, 1975]. BPD can arise due to an arrest in the late stages of lung devel-
opment. Additionally, risk factors such as genetic susceptibility, maternal smoking
and postnatal infection have been correlated with BPD
[Kalikkot Thekkeveedu et al., 2017]. Recent research suggests a role for resi-
dent alveolar macrophages (AMs) in BPD and depletion of AMs results in im-
proved alveolarization [Kalymbetova et al., 2018]. Anti-inflammatories are given
to preterm babies to help prevent damaged caused by increased inflammation how-
ever these only moderately reduce the impact of defective lung structure [Rudloff
et al., 2017].
1.2.2 Asthma
Asthma is a common inflammatory disease of the airways which leads to hyper
constriction of the airways. Symptoms of asthma including wheezing, breathless-
ness and chest tightness. Asthma can be triggered by many external influences
such as allergens, tobacco smoke, exercise and viral infections, however the under-
lying causes are not well understood [Herriges and Morrisey, 2014]. Recent studies
to address the underlying genetic mechanisms have identified several genes such as
IL33, IL1RL1/IL18R1, IL2RB and SMAD3 in genome-wide associations studies
in children and adults suffering from asthma. These genes implicate the immune
system in contributing to asthma, corroborating observations of large number of
infiltrating immune cells, such as eosinophils in the asthmatic lungs as well as the
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extensive inflammation [Moffatt et al., 2010, Papi et al., 2018]. Airway remod-
elling can also be a side effect of the disease, and usually leads to a thickening
of the airway walls thus limiting airflow. Therefore, it is necessary to understand
normal lung development and the interaction and role that the immune system
plays to further our understanding of asthma development and progression [Papi
et al., 2018].
By furthering our understanding of normal development, we will be able to deci-
pher how disordered lung development pathologies arise. In addition, by studying
the development of the lung we can reveal new pharmacologically suitable targets
that could provide more effective treatments and managements of lung disorders,
with the ultimate outcome of research being to protect the lung from damage
caused by lifesaving treatment or to promote repair and regeneration leading to
better quality of life [Hütten et al., 2016, Stabler and Morrisey, 2017].
1.3 Lung Development
Studying lung development in humans is a difficult and often impossible task
therefore we must rely on models, including animal models, cells lines, iPSCs and
many others to fully understand the development of the lung. Although there
are important cellular and physiological differences between mouse and human
lungs the majority of the cell lineages are shared and there is increasing evidence
in human studies showing important transcriptional and signalling pathways are
conserved across the two species. Throughout this review, the majority of the
information presented will be on the mouse lung.
1.3.1 Stages of lung development
Mouse lung development first starts at embryonic day (E) 9, with the localised
expression of NK2 homeobox 1 (Nkx2.1; or thyroid transcription factor 1 TTF-
1) in endodermal cells found on the ventral side of the anterior foregut [Kimura
11
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Figure 1.2: Stages of lung development
Lung development can be categorised into 5 main stages including: embryonic, pseudoglandular,
canalicular, saccular and alveolar. At each of these stages major morphological changes occur
that lead to the formation of the lung.
et al., 1996]. The expression of Nkx2.1 causes the foregut to split into two parallel
tubes, the dorsally situated oesophagus and the more ventral trachea by E9.5
[Cardoso and Lu, 2006]. During this time the formation of two lung buds will
begin. From here lung development can be broken down into five overlapping
stages: the embryonic stage, the pseudoglandular stage, the canalicular stage, the
saccular stage and finally the alveolar stage (Figure 1.2) [Burri, 1984].
1.3.1.1 Embryonic stage
Starting from the appearance of the two lung buds, the embryonic stage of lung
development happens from E9.5 to E12.5 (human 4-7 weeks). During this time,
elongation of the trachea and lung buds takes place and the separation of trachea
and oesophagus completes. The lung buds consist of an endodermal epithelium
12
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tube covered by a mesoderm layer and intercalated vasculature. Surrounding all
of these tissues is a thin layer of mesothelium [Dixit et al., 2013].
1.3.1.2 Pseudoglandular stage
The pseudoglandular stage happens between E12.5 and E16.5 (human 5-17 weeks).
The pseudoglandular name arose because the first observations of lung develop-
ment noted that a similar branched structure to other glands, such as the mam-
mary gland [Hannezo et al., 2017]. During this stage, the left and right lung buds
will branch, four buds will emerge from the right side and one on the left (in
mice) which will demarcate the five lobes found in the adult lung [Yang and Chen,
2014]. During these initial branching events, cells expressing the transcription
factors Sox9 and Sox2 will emerge and the start of the proximal-distal patterning
of differentiation will begin. Very recent work by Frank et al. has suggested that
alveolar linage specification starts to occur during this stage at around E13.5 al-
though additional studies will be needed to verify this observation [Frank et al.,
2019]. More branches will emerge from these initial points to create the complex
tree-like structure [Alanis et al., 2014].
Branching morphogenesis is controlled by proximal-distal patterning, epithelium-
mesenchyme interactions, and growth factor signalling. There are three types of
branching observed during this time, domain branching, planar bifurcation and
orthogonal bifurcation. Domain branching describes the formation of a branch
laterally to the parental branch. Bifurcation is the splitting of a branch tip into
two separate branches and this may happen in a planar way (each daughter branch
splits in a similar orientation to their parent) or in an orthogonal way (each daugh-
ter branch rotates 90◦C) [Metzger et al., 2008b]. The timing and positions of these
branching mechanisms has been extensively studied and although highly regulated
and stereotypical or perhaps because of, the branching program is able to continue




By the beginning of the canalicular stage at E16.5 most of the branching mor-
phogenesis has been completed and the basic tube structure has been laid down.
Between E16.5 and E17.5 (human 16-26 weeks) the most distal airways will be-
come narrower and capillary networks will move closer to the distal epithelial air
spaces [deMello and Reid, 2000]. The first differentiated cell types will appear
and the distinction between bronchiolar regions and alveolar regions will become
more defined. Cells in the distal region of the developing lung will begin to express
markers of surfactant production and secretion, associated with AT2 cells while
other cells will express markers such as Hopx, podoplanin (Pdpn/T1α) and Ager,
associated with AT1 cells [Treutlein et al., 2014]. During the canalicular stage
mechanical forces interact with signalling pathways to promote normal structure
and differentiation of the airways. Amniotic fluid will reach the distal airways by
E17.5 which will cause mechanical tension on the cells helping to induce flattening
of future AT1 cells. During flattening, the expression of Fgf10/Fgfr2 signalling
prevents too much protrusion of these cells into the surrounding mesenchyme. A
subset of these cells will respond to the signalling of Fgf10/Fgfr2 and will retain
their shape, committing to the AT2 cell type [Li et al., 2018a]. It is at the end of
this stage that human pre-term babies are able to survive if given intensive care.
1.3.1.4 Saccular stage
Branching morphogenesis is now completely finished. As the name suggests, during
the saccular stage (E17.5-P5, human 24 weeks-term) clusters of tiny sacs separated
by primary septa will develop at the end of the distal airways. As this process
continues these sacs will be divided by a second septa increasing the surface area
for gas exchange. At this stage in the distal epithelium there are still bipotent





The final stage of mouse lung development happens postnatally at P0-P21 (human
36 weeks- 21 years). Alveoli rapidly increase in surface area as the sacs are further
divided by septa. Over this period in mice, the number of the alveoli greatly
increases and does not reach peak density until P39 [Pozarska et al., 2017]. This
alveolar production will continue for several months in mice and for many years
in human. Recent research suggests that this process can continue into the early
20’s in humans [Narayanan et al., 2012, Herring et al., 2014]. As the number of
alveoli is increasing, the capillary network is also being remodelled and increasing
in size in a process known as intussusceptive microvascular growth [Burri et al.,
2004]. As maturation occurs a thin basal lamina is all that separate the AT1 gas
exchange cells and the capillary endothelial cells. Other cell types also differentiate
and migrate into this area during alveologenesis such as pericytes, lipofibroblasts,
myofibroblasts and other less defined cells. All of these cells help keep the alveolar
ducts open and provide elastic and flexible network that is necessary for a normal
functioning lung [Weibel, 2013].
1.3.2 Proximal-distal patterning and the master regulators
Sox2 and Sox9
Differentiation of the respiratory system happens proximally to distally. The prox-
imal region is classified as the trachea and large airways and the distal region refers
to the smaller bronchioles and gas-exchange regions. The proximal region, also
referred to as the airway or bronchiolar region consists of basal, ciliated, neuroen-
docrine and secretory cell types. The distal area, or alveolar region, is made up
of two epithelial cell types, AT1 and AT2 cells which are the gas exchange and
surfactant producing cells respectively.
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Figure 1.3: Proximal Sox2+ and distal Sox9+ cells in the E11.5 lung
will give rise to all of the epithelial cells of the mature lung
The E11.5 lung is composed of the epithelial progenitor cells (yellow and orange), surrounded
by a layer of mesenchyme and mesothelium. Fgf10 secreted from the mesenchyme signals to
the receptor, Fgfr2 in the epithelium promoting outgrowth of the lung. Sox2+ cells found in
the proximal, stalk regions of the developing lung will give rise to all of the cell types of the
bronchiolar regions. Sox9+ cells found in the distal, tip regions will give rise to the alveolar cell
types.
1.3.2.1 Airway cell specification
The earliest lung stem cells present at the tip of the lung embryonic bud are Sox9-
positive and drive epithelial growth during branching morphogenesis. As growth
continues distally, proximal cells in the large airways will down-regulate Sox9 and
upregulate Sox2, specifying them towards the airway lineage. The appearance of
Sox2 is the first factor indicating cell fate as all bronchiolar lineages will be derived
from Sox2+ cells (Figure 1.3) [Chang et al., 2013, Rockich et al., 2013, Que et al.,
2009, Tompkins et al., 2011].
In addition to being an important transcription factor expressed in lung epithelial
cells, Sox2+ cells in the oesophagus can contribute to the normal development of
the epithelium of the lung. Two compound mutant mouse models of Sox2, where
expression of Sox2 is less than 50% show that decreased levels in the oesophagus
lead to a disorganisation of the stratified epithelium in the lung and an increase
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in mucins. In one of the two Sox2 mutant models in which Sox2 could not be
detected, embryos had tracheoesophageal fistula (TEF), a failure to separate the
trachea from the oesophagus. In contrast the other model in which Sox2 levels
were approximately 18% of WT, they did not observe TEF but did observe an
irregular oesophagus, which display cells common to the stomach and intestines
and expression of Nkx2.1. This study was the first to identify Sox2 and Nkx2.1
repress each others expression, spatially limiting the factors to a correct ventral-
dorsal pattern [Que et al., 2007].
Sox2+ epithelial cells in the proximal airways, give rise to all the bronchiolar cells
types including ciliated, secretory and neuroendocrine cells. Knockout studies of
Sox2 have shown that loss of Sox2 expression results in no differentiation of secre-
tory or ciliated lineages in the lung epithelium [Que et al., 2009, Tompkins et al.,
2009]. Conditional knockout of Sox2 using the Nkx2.5-Cre deleted Sox2 expres-
sion from the ventral foregut epithelium from E9.5. This resulted in post-natal
death due to respiratory distress. Lungs of Nkx2.5; Sox2 mutant mice had similar
size and shaped lungs compared to heterozygote controls but displayed shorter
tracheas and longer main stem bronchi. Que et al. also observed a reduction of
the number of basal, ciliated and club cells and an increase in Muc5ac+ mucus-
producing cells [Que et al., 2009]. Deletion of Sox2 post-natally in club cells using
the CC10-Cre coincided with a decreased number of club, ciliated and goblet cells
in the large airways of mutant mice [Tompkins et al., 2009]. These knockout stud-
ies show the importance of Sox2 in the specification and differentiation of airways
cells and highlights the role of Sox2 during different lung development stages.
The first evidence of differentiated Sox2+ cells in the upper airways appears at
E14.5 with the emergence of Dll1 positive neuroendocrine cells [Post et al., 2000].
Very shortly after, Foxj1+ ciliated cell precursors appear from the Sox2+ lineage
to become mature ciliated cells of the airways [Rawlins et al., 2007]. Expression
of Foxj1 is necessary for the differentiation into ciliated cells and its loss results
in an absence of ciliated cells in the airways. Conversely, an overexpression of
Foxj1 in alveolar progenitor cells using the Sftpc-Cre resulted in ectopic formation
of ciliated cells in the distal lung indicating that Foxj1 is a master regulator of
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ciliated cell specification [Chen et al., 1998, Tichelaar et al., 1999]. Sox2+ cells
also give rise to the Trp63+/Krt5+ basal cells found in the main stem bronchi.
These cells act as the resident stem cell population for the large airways of the
mouse adult lung [Hong et al., 2004, Rock et al., 2009, Morrisey and Hogan, 2010].
Notch signalling plays a vital role during differentiation of the airway lung epithe-
lial cell types. An increase in Notch signalling is associated with differentiation
into the secretory cell lineage while a decreased level of Notch is associated with
ciliated and NE lineage. A necessary balance of Notch signalling is required to
ensure a proportional number of cells are present in the lung. As evident by the
conditional knockout of Notch pathway members Pofut1 and Rbpjk using the Shh-
Cre leads to an expansion of ciliated and NE cells and decrease of secretory cells
[Tsao et al., 2009]. Knockout of Notch using the Sftpc-Cre results in distal cysts
which expressed Nkx2.1 but not markers of differentiated alveolar lung cells such as
SPC. Guseh et al. noticed a small subset of cells in these cysts that co-expressed
CC10 and Sox2, suggesting that Notch regulates alveolar differentiation [Guseh
et al., 2009].
It has been proposed that smooth muscle cells (SMCs) also play a role in branching
morphogenesis. In fixed human foetal lungs airway SMCs were found surrounding
the cleft between two daughter branches. It is suggested that these SMCs restrict
Sox9 expression to distal tips allowing an expansion of Sox2 proximally thus driving
branching morphogenesis [Danopoulos et al., 2017]. In support of this, another
study pharmacologically removed SMCs from the cleft in mouse developing lungs
at E12.5 in an ex vivo model, which led to a relaxing and flattening of the two
demarcated daughter branches [Kim et al., 2015].
1.3.2.2 Alveolar cell specification
Once elongation of the branches ends, Sox9+ cells will eventually form the alveo-
lar cells of the mature lung (Figure 1.3). Sox9+ progenitor cells also express the
transcription factor Id2, an important marker of the early lung progenitor cells.
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Examination of Id2+ cells in the developing lung has shown that these cells re-
main multipotent up to E13.5, being able to give rise to both bronchiolar and
alveolar lineages. However, Id2+ cells lose their stemness over time to generate
only alveolar lineages post E13.5 [Rawlins et al., 2009a].
Sox9 is expressed in the distal developing lung epithelium from E11.5. Conditional
deletion of Sox9 using the Shh-Cre leads to a defect in lung branching and death
at birth due to breathing difficulties [Rockich et al., 2013, Chang et al., 2013]. It
is well known that the distal epithelium during branching morphogenesis is signif-
icantly more proliferative than proximal epithelium [Okubo, 2005]. Conditional
knockout of Sox9 in the Shh-Cre model leads to a significant decrease in epithe-
lial cell proliferation [Rockich et al., 2013]. Lungs of Sox9 deficient mice have
significantly fewer branches, which end in large cysts. Interestingly though, Sox9
gain-of-function (GOF) experiments using the Shh-Cre model show that proximal
cells expressing ectopic Sox9 have no increase in proliferation. Lungs of Sox9 GOF
mice have reduced air spaces likely a result of reduced proliferation. It was also
noted that loss of Sox9 does not affect Sox2 expression or proximal-distal pattern-
ing. Overall, these GOF and LOF studies of Sox9 reveal a fine balance of Sox9
expression is needed to regulate proliferation but not proximal distal patterning
[Rockich et al., 2013].
Like many of the models discussed above, Sox9 has been implicated in Fgf10
regulation. Loss of Fgfr2 leads to large cysts in place of the lungs, consistent
with Fgf10 inhibition [De Moerlooze et al., 2000, Sekine et al., 1999]. These
Fgfr2 -null lungs also do not express Sox9 and the entire epithelium cyst was
Sox2+. Under normal conditions, Fgfr2 activates Kras, therefore to examine if
Sox9 functionally regulates Fgf/Kras, Chang et al. expressed a hyperactive form
of Kras driven from the Shh promoter in early lung epithelium. They found that
upon hyperactive Kras expression, Sox9 expression expanded resulting in a larger
lung, ectopic branches observed from the tracheal epithelium and distal epithelium
branches were much larger. This suggests that Sox9 is a positive regulator of the
branching morphogenesis via Fgf signalling [Chang et al., 2013].
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The downregulation of Sox9 expression around E16.5 marks the beginning of dif-
ferentiation of the distal epithelium [Rawlins et al., 2009a, Okubo, 2005, Perl et al.,
2005, Herriges et al., 2012, Rawlins et al., 2007]. In the knockout models of Sox9,
loss of Sox9 resulted in early increased expression of Sftpc at E14.5, comparable to
E17.5 levels when differentiation of AT2 cells begins [Rockich et al., 2013, Chang
et al., 2013]. Chang et al. also observed upregulation of Sftpb, Lamp3, Napsa
and Ctsh which are also markers of alveolar cells from E13.5 after Sox9 deletion.
Conversely, in Sox9 -GOF lungs there was evidence of decreased differentiation.
These results reveal that Sox9 suppresses premature differentiation into the alve-
olar lineage [Rockich et al., 2013, Chang et al., 2013]
Two recent studies found important differences between the mouse and human
developing lung. As discussed above, mouse epithelial tip progenitors are Sox2-
/Sox9+ but in the human developing tip cells are double positive for these two
markers. In human lung organoid cultures, these double positive cells will form
bronchiolar descendants and cells that downregulate Sox2 will form the alveolar
lineage [Nikolić et al., 2017, Danopoulos et al., 2017]. Though this is an important
difference between mouse and human development Nikolic et al. also found that
96% of genes expressed in the embryonic human tip cells are also found in the
mouse lung. Additionally, culture conditions used for outgrowth of the human
organoids were the same as those used for mouse organoids, indicating a high level
of conservation between mouse and human. These studies highlight the power of
using mouse models but also the necessity to study them alongside the human
[Nikolić et al., 2017, Danopoulos et al., 2017].
1.3.3 Signalling pathways participating in development of
the primary lung buds
Outgrowth of the initial lung cells is induced by signalling factors from surround-
ing tissues such as the notochord and splanchnic mesoderm which induce the
expression of Nkx2.1 in the anterior foregut of the E9.5 embryo [Kimura et al.,
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1996]. Wnt signalling is a key regulator of the embryonic stage of lung develop-
ment. Wnt signalling promotes the expression of Nkx2.1 ventrally through the
expression of Wnt2 and Wnt2b in the ventral mesoderm. Loss of Wnt signalling
at E9 completely abrogates Nkx2.1 expression and results in the absence of the
trachea and lung, demonstrating the importance of Wnt signalling in the devel-
opment of the embryonic lung primordia [Goss et al., 2009, Harris-Johnson et al.,
2009]. β-catenin (CTNNB1), an effector of the Wnt canonical signalling pathway,
maintains the lung fate by suppressing the intestinal signals also derived from the
foregut. In addition, by regulating Nkx2.1, β-catenin restricts Sox2 expression to
the distal side where the oesophagus will develop [De Langhe et al., 2005, Okubo
and Hogan, 2004, Ostrin et al., 2018]. When β-catenin is deleted in the epithelium
using Sftpc-Cre mice, the lung architecture was composed mostly of proximal air-
ways. Interestingly when β-catenin is deleted using the CC10-Cre they observed
no lung phenotype [Mucenski et al., 2003]. This highlights the role of β-catenin in
regulation of the Sox9+ derived proximal progenitors and cell types. It is further
supported by conditional knockout of β-catenin using the Sox9-CreER, which did
not lead to loss of Sox9+ cells, as was suggested in other organs such as the intes-
tine, but lead to an increase of Sox9+ cells in the proximal airways. This confirms
that Wnt/β-catenin signalling is an important regulator of Sox9+ progenitor cells
[Rockich et al., 2013].
Two Bmp receptors Bmpr1a and Bmpr1b are also found in the foregut endoderm
during the embryonic stage and signal to Bmp4, found in the surrounding mes-
enchyme. Conditional knockout of Bmpr1a and b resulted in ectopic primary
bronchi and failure of the formation of the trachea due to a reduction in Nkx2.1
expression and an increase in Sox2 expression. Indicating that Bmpr1a/b is neces-
sary to restrict Sox2 expression and is necessary for formation of the trachea and
for the organisation and branching of future lung buds [Domyan et al., 2011].
Retinoic acid (RA), is a derivative of vitamin A and is a known regulator of differ-
entiation and patterning in many organs. RA is found in the mesenchyme at E8 in
the foregut area that will become the lung. Conditional knockout of retinaldehyde
dehydrogenase 2 (Raldh2 ), an enzyme responsible for RA synthesis resulted in
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embryonic lethality at E10.5 due to heart malformations and no evidence of lung
budding was observed. Lack of RA resulted in a decrease in Fgf10 expression.
By maternally supplementing exogenous RA Wang et al. were able to examine
stage-dependent RA deficiency and found that short term RA treatment (E7.5-
E8.5) could not rescue Fgf10 expression and led to absence of lung development.
The supplemented RA at later stages was able to partial rescue the phenotype,
leading to the development of the right lung with reduced branching this was also
found to be due to a reduction in Fgf10 expression. This result led Wang et al. to
suggest that RA acts upstream of Fgf10 and supplemented RA is not enough to
fully restore Fgf10-mediated lung growth [Wang et al., 2006].
1.3.4 Mesenchyme-epithelial cross talk in lung
development
The mesenchyme of the lung and its development is important for the functional
organ. Cartilage, blood vessels, mesothelium, interstitial fibroblasts, myofibrob-
lasts, vascular smooth muscle, pericytes and endothelial cells are all derived from
the developing lung mesenchyme. It also provides the necessary scaffolding for the
epithelium to ensure efficient gas-exchange.
Cross talk between the epithelium and mesenchyme is essential at all stages of
lung development as well as maintaining adult lung homeostasis. Early studies
in lung development found that culture of E12.5 lung epithelium die shortly after
plating but when put in close proximity to lung mesenchyme the epithelial cells
grew normally. The opposite was described in the absence of epithelium, where
no development of mesenchymal vasculature or smooth muscle cell growth was
observed when mesoderm cells were cultured without epithelial cells [Taderera,
1967]. It has since been established that a gradient of growth factors excreted by
the mesenchyme and epithelium is necessary to promote outgrowth during lung
development. Factors that have been implicated in this process are fibroblast
growth factors (Fgfs), wingless/intergrated (Wnts) signaling, bone morphogenetic
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proteins (Bmps) and sonic hedgehog (Shh) [Volckaert and De Langhe, 2014]. Pos-
itive and negative feedback loops between the signalling pathways are essential in
normal branching morphogenesis to stimulate growth but also preventing ectopic
budding and overgrowth. The plethora of research around the signalling pathways
that regulate lung outgrowth and branching morphogenesis show that there is no
one master regulator of lung development. Rather, it is a complex interplay of sig-
nalling cascades, positive and negative feedback and factor gradients that perform
to a strict special and temporal pattern to develop the lung.
Interactions between Fgfs and Shh signalling pathways are critical mediators of
the cellular communication between the mesenchyme and the epithelium. Shh is
found in the endoderm, at the ventral wall of the foregut before lung development
commences. Shh regulates the differentiation and proliferation of the mesenchyme
which shape the epithelium of the developing lung. In Shh-null mice the trachea
and oesophagus do not separate into separate tubes and at the end of the tubes
which should be the developing lungs and stomach, there is just a rudimentary
sac and the surrounding mesenchyme displays more cell death and decreased pro-
liferation compared to WT controls. Additionally, Shh target genes, Ptch and Gli
family members are located in the mesenchyme and are downregulated in the Shh
null mutants. This indicates that Shh expressed in the endoderm is necessary for
the separation of the trachea and oesophagus, lung mesenchyme development and
correct branching morphogenesis. [Litingtung et al., 1998, Pepicelli et al., 1998].
Fgf10 is located in the mesenchyme in the early developing lung and is an im-
portant regulator of endoderm proliferation and lung bud outgrowth. Fgf10 is a
chemoattractant, it acts to attract epithelial cells towards its expression in the
mesenchyme thus promoting outgrowth of the lung buds [Park et al., 1998]. Over-
expression expression of Fgf10 in E11.5 mouse lungs resulted in ectopic lung bud
growth and an increase in epithelial cell proliferation [Bellusci et al., 1997b, Park
et al., 1998]. Conditional deletion of Fgf10 led to death shortly after birth due to
serve lung defects. In E10.5 Fgf10 -null lungs, there is evidence of a trachea but no
lung buds are observed [Sekine et al., 1999]. Fgf10 in the mesenchyme stimulates
its receptor Fgfr1/2 on the epithelial cells and Fgfr1/2 conditional knockout mice
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show similar phenotypes to Fgf10 knockouts [De Moerlooze et al., 2000]. Another
Fgf, Fgf9, found in the distal epithelium during pseudoglandular stage of lung de-
velopment also contributes to normal lung development. In Fgf9 knockout mouse
lungs, Fgf10 expression is decreased indicating that Fgf9 regulates Fgf10 expres-
sion. Fgf9 also directly activates Gli3 in the Shh signalling pathway [del Moral
et al., 2006].
As mentioned, Shh is expressed in the distal epithelium and activates patched
(Ptch1) and smoothened (Smo) expression in the mesenchyme [Bellusci et al.,
1997a, Lebeche et al., 1999]. Ptch1 and Smo activate the transcription factors
Gli1, 2, and 3 also in the mesenchyme, resulting in the downregulation of Fgf10
[Li et al., 2004, Motoyama et al., 1998]. Simultaneously, high Shh expression in the
distal tip of the branch activates mesenchymal hedgehog-interacting protein (Hhip)
which negatively regulates Shh by sequestering the Shh ligand and inhibiting Shh
expression resulting in de-repression of Fgf10 and promoting outgrowth [Chuang
et al., 2003]. Bmp4 expression in epithelial cells also has a restrictive effect on
Fgf10, mediating the formation of buds [Lebeche et al., 1999, Weaver et al., 2000].
When exogenous Bmp4 is added to E11.5 lungs it inhibits Fgf-induced outgrowth,
and the opposite is observed when Bmp4 is inhibited it promotes budding and
lung outgrowth [Weaver et al., 2000].
This description is by no means a detailed look at outgrowth and branching of the
early lung. Many reviews ([Herriges and Morrisey, 2014, Volckaert and De Langhe,
2014, Stabler and Morrisey, 2017, Schittny, 2017]) exist covering the extensive sig-
nalling pathways observed. These negative feedback loops tightly control the con-
tinued growth of the lung. Overall, these results show the importance of timing,
dosages and positive and negative feedback between the epithelial and mesenchy-
mal signals to ensure correct development of the lung.
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1.3.5 Individual genes in lung development
As well as signalling pathways, there are individual factors that also play roles in
regulating lung morphogenesis. There have been many different genes implicated
in regulating lung development, mostly identified through knockout mouse models.
Many of these factors have other roles outside of the lung both in embryogenesis
and in the adult.
For example, early epithelial deletion of the protein (YAP) using the Shh-Cre
resulted in defective branching morphogenesis. This model is embryonic lethal
and displays defects in branching morphogenesis which leads to large cysts that
are composed of Sox9+ cells. Yap is a protein involved in the HIPPO signalling
pathway that controls the size of many organs and Yap directly controls actin
cytoskeleton remodelling in the mammalian heart. The authors suggest that me-
chanical force regulated by Yap is necessary in Sox9+ cells to which produce new
buds. Loss of mechanical force regulated by Yap leads to an inability to branch
and subsequently insufficient numbers of cells to become Sox2+ and form proximal
airways. Overall these results demonstrate an additional regulation of branching
morphogenesis that will need to be investigated further to expand our understand-
ing of lung development [Lin et al., 2017].
A similar lung-cyst phenotype was observed when the transcription factor Yy1
was deleted using the Shh-Cre model in developing lung epithelium. Loss of Yy1
also results in embryonic lethality, formation of large cysts and downregulation of
Sox2+ cells. The mechanism by which the defect occurs is completely different
from the loss of Yap. Knockout of Yy1 leads to an increase in Fgf10 and a de-
crease in Shh, and chromatin immuno-precipitation (ChIP) experiments revealed
that Shh is a direct target of Yy1. It is likely through direct interaction with
Shh that loss of Yy1 results in a severe lung phenotype due to aberrant Fgf10
expression as also seen in Fgf10 overexpression models [Boucherat et al., 2015].




Another transcription factor, Elf5 has also been implicated in regulating early lung
development. Elf5 is exclusively found in epithelial cells in the early developing
distal lung cells and becoming restricted to the proximal airways. Overexpression
of Elf5 using the Sftpc-Cre mouse model led to lung cyst formation at the distal
ends of branches, though to a much lesser extent than Yy1 or Yap disruption.
Metzger et al. also observed a lack of differentiated cell types in these cysts with
no expression of AT2 markers such as SPC at E16.5. Metzger et al. had previously
identified that Elf5 acts downstream of Fgf10. They suggest that overexpression
of Elf5 leads to mis-expression of Fgf10 which in turn results in distal lung cysts
[Metzger et al., 2008b, Metzger et al., 2008a]. Recently, it was identified that
Grhl2 transcription factor binds to Elf5. Grhl2 knockout using the Shh-Cre mouse
model resulted in a disorganised lung structure, decreased number of saccules and
impaired ciliated differentiation. A retained expression of Sox9+ cells was observed
compared to WT controls which led to a decrease in the number of pro-SPC+ AT2
cells, but no change in T1α+ AT1 cells was observed. ChIP experiments revealed
Elf5 to be a direct target of Grhl2 and highlights the extensive interconnected
regulators of lung development [Kersbergen et al., 2018].
These experiments accentuate the many mechanisms that regulate Fgf10 expres-
sion which can drastically affect lung outgrowth. They highlight the importance
of correct dosing and spatial timing for various morphogens to regulate lung de-
velopment. Although only three lung specific morphogens were mentioned here,
there are many more examples as seen in table 1.1. As we discover more about
embryogenesis and organogenesis and as we become more familiar with how the
epigenome, proteome, metabolome and environment impact development there




1.3.6 Proliferation, polarity and orientation in lung
development
Proliferation is an important part of lung development and necessary to form
the tree-like architecture. Polarity and orientation of cells during proliferation is
known to play important roles in body axis elongation and during gastrulation in
the early embryo as well as regulating cell size and shape during organogenesis,
however it is only just beginning to be explored in lung development [Xiong et al.,
2014, Minc et al., 2011, Mao et al., 2013, LeGoff and Lecuit, 2015].
In the first stages of lung development when the trachea is forming and the distal
tubes are changing shape, the length of the tubes increases more than the circum-
ference and lung epithelial cells divide in parallel to the longitudinal axis of the
airway. This development is due to the spindle orientation in dividing cells which
is regulated by Erk1/2 signalling. Disruption to the Erk1/2 pathway by hyperac-
tive expression of Kras, which signals to Erk through the Fgf pathway, randomises
the spindle pole orientation leading to an abnormal tracheal and primary bronchi
shape. Interestingly, no change in cell size or shape is associated with normal
branch elongation [Tang et al., 2011].
A recent study by Tan et al. showed that there are two types of spindle orienta-
tions during cell division in the E11.5 developing lung epithelium, a fixed spindle
and a rotating spindle. A fixed spindle was defined as a cell that fixes its spin-
dle within the first six minutes of metaphase while rotating spindles do not stop
rotating throughout cell division. These orientations are maintained from E10.5
to E11.5 and possibly throughout branching morphogenesis. A ratio of fixed to
rotating spindles appears necessary for the development of normal airway shape.
When BRAF epithelial lung cells were examined they were found to all be rotat-
ing spindles, therefore Tan et al. used an inducible Braf-Shh-Cre mouse model to
examine the effect of only rotating spindles on lung formation. Interestingly, they
found a compensatory mechanism that fixed the spindle orientation in 40% of the
cells. How this ratio of the two spindle orientations is maintained is yet unknown
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but these results suggest that orientation is essential for normal tube development
[Tang et al., 2018].
Cell shape and cell-to-cell interactions play important roles in the formation from
the initial cluster of epithelial cells to the first tubular structures and then on to the
many shape changes as more branches are added to the respiratory tree. There are
many factors such as Yy1, Yap, and Fzd2 that upon their deletion in the early lung
epithelium, no branching morphogenesis occurs and large cyst structures are found
in place of a functional lung. Fzd2 is a member of the Wnt signalling pathway and
is involved in cell shape and apical constriction. Conditional deletion of Fzd2 using
the Shh-Cre resulted in loss of apical-basal lengthening in epithelial cells and an
inability to form the pseudostratified epithelium. Loss of Fzd2 in epithelial cells
prevented the cells from taking on a bottle shape and thus sculpting and creating
bends to accommodate new branches leading to large distal cysts [Kadzik et al.,
2014]. Yap is important in mechanical force production through its control of
actin polymerisation and Yap loss results in an inability of cells to contract and
to branch without cell tension, as discussed above [Lin et al., 2017]. These studies
highlight how cell shape regulate branching morphogenesis.
The planar cell polarity (PCP) refers to the orientation of a group of cells along
a plane of cells by regulating cytoskeletal dynamics. The PCP core proteins are
made up of Vangl, Celsr, Frizzled, Dishevelled and Prickle and are responsible
for the PCP pathway’s role in organ development. In the lung, loss of the PCP
pathway members Scribble results in defects in branching morphogenesis, display-
ing fewer branches that were narrower and some branches lacking a visibly open
lumen at all. The organisation of the epithelium was disrupted, resulting in a
multilayered, pseudostratified epithelium rather than the single layer columnar
epithelium. Yates et al. show that Scribble acts through the PCP to regulate
epithelial cohesion and loss of Scribble disrupts adherens in the tight junctions
between cells [Yates et al., 2013]. A similar phenotype is seen in Vangl and Celsr
knockouts [Yates et al., 2010].
The PCP is also important in ciliated cells to ensure coordinated beating. Within
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the lung, ciliated cells play an important role in sweeping out mucus and particles
out of the lung and not further into the lung, indicating an important role for
coordinated cilia movement. Cell cultures from Vangl2 and Prickle2 knockout
mutants have misaligned cilia and defective barrier function consistent with PCP
disruption to motile cilia [Vladar et al., 2016]. Overall these experiments uncover
another layer of regulation of lung development.
1.3.7 Mechanical force and lung development
Much of the work in lung development has aimed to identify and understand the
role of growth factors and morphogens. However, there is significant clinical evi-
dence that pressure, provided by fluid in the airways prior to birth, is necessary
for the normal development of the lung [Warburton et al., 2010]. When fluid
is lost from the developing lungs, due to a loss of amniotic fluid in the womb,
then the lungs will develop abnormally. Pressure within the airway epithelium
has been shown to regulate branching morphogenesis and smooth muscle con-
tractions. Increased pressure has also been linked to an increased rate of lung
maturation suggesting possible treatments for premature birth with underdevel-
oped lungs [Nelson et al., 2017, Unbekandt et al., 2008]. Pressure in the epithelium
is also necessary for proper development of the AT1 and AT2 cells in preparation
for the first breath.
Brigid Hogan recently wrote a preview article for Developmental Cell in which
she expertly provided a fitting analogy to mechanical force on the developing
lung. She suggests that the ends of the developing lung during sacculation and
alveolarization are like ". . . deflated balloons in which patches of the latex [AT2]
are stiffened so that they cannot expand. When water is pumped into the balloon,
the regions that are flexible [AT1] expand, while the stiff patches remain small
[AT2]" [Hogan, 2018]. To address the role of mechanical force on the developing
lung is difficult but as will be reviewed in section 1.6 recent advances in technology
are starting to unveil the importance of mechanical force.
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Overall there is a great deal of knowledge known about lung development. Through
knockout studies we have uncovered many of the important regulatory factors
that govern the complex machinery needed to develop a functioning organ. How-
ever, there is still much that isn’t known and further investigation into how the
epigenome participates in the development of the lung will be crucial in providing
a fuller picture of proper lung development.
1.4 Epigenetics and lung development
The study of genetic alterations has been the focus of much of the research on lung
development but it is known that disruption to the epigenome can cause similarly
devastating effects to the lung. Epigenetic changes can cause disruptions to struc-
ture, cell function and cell to cell interactions. Changes in the epigenome at sen-
sitive time points can also lead to a "resetting" of transcriptional programs upon
which more changes will be built. Additionally, these changes in the epigenome
can affect the response of lung cells to injury and repair later in life [Joss-Moore
et al., 2015].
Over time, natural changes and alterations occur in the epigenome, due to de-
velopment and ageing. Exposure to the external environment can also affect our
epigenome. It is of particular importance to the lung as the act of breathing ex-
poses the lung to the environment. Additionally, changes to the epigenome have
the potential to be transmitted through generations. These changes may alter
phenotypes and potentially increase disease susceptibility.
Much of the research around epigenetics and the early lung has been conducted
in relation to early respiratory disease. Many genome and epigenome studies have
aimed to identify aberrations involved in asthma development, implicating DNA
methylation, histone modifications and miRNAs as regulators and modulators of
the disease. In the adult, lung disease such as COPD and idiopathic pulmonary
fibrosis have been the subject of epigenetic studies and links have been found with
30
Introduction
many modifications in the epigenome compared to age matched normal controls
(reviewed in [Gruzieva et al., 2014]).
However, to truly understand how disease develops and what epigenetic factors
contribute we must further our knowledge into the normal epigenetic regulation of
lung development. So far, research regarding epigenetics and lung development is
still limited. More knowledge on how these factors are regulating lung development
is vital to our overall understanding of the lung and lung disease.
Epigenetic control refers to mitotically heritable changes that can modify gene
expression without altering the DNA sequence. All tissues for their normal de-
velopment, homeostasis and response to injury require a coordination of many
cellular events such as gene activation or repression to activate proliferation or
migration. Each cell contains the genetic material to perform these tasks but it
is the coordination of gene silencing and activation in response to developmental
signals or environmental cues and the subsequent inheritance of this information
by daughter cells that ensure normal response. This process is mediated by the
epigenome [Hagood, 2014]. Epigenetic modifications include methylation of the
DNA, post-translational histone modifications, chromatin higher-order structure
and remodelling and noncoding RNAs (Figure 1.4). Broadly, these modifications
control gene expression by organising the chromatin into euchromatin (open) or
heterochromatin (closed) states, allowing transcriptional machinery to assess the
DNA [Paluch et al., 2016]. Most epigenetic marks are inherently flexible, with
the cell containing machinery to both lay down marks but also to remove them.
This adaptive nature makes them attractive to targeting therapeutically [Allis and
Jenuwein, 2016]. These modifications and their relation to lung development will
be introduced below.
1.4.1 DNA methylation
DNA methylation is a highly conserved, dynamic process, in which methylation
marks can be added, maintained and removed. Traditionally DNA methylation
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Figure 1.4: Schematic of epigenetic modifications
Epigenetic modifications control the state of DNA to either an open (euchromatin) state which
allows transciption or a closed (heterochromatin) state preventing transciption. Epigenetic mod-
ifications include chromatin binding proteins and remodellers, post transciptional histone modi-
fications, non-coding RNAs and direct methylation of the DNA.
is the addition of a methyl group to the 5’ position of a cytosine followed by a
guanine (CpG), however there is increasing evidence to show methylation is not
just restricted to the CpG positions but can be found in other sites in the DNA
[Ziller et al., 2011, Arand et al., 2012]. The addition of a methyl group, is medi-
ated by the de novo DNA methyltransferases (DNMTs) 3a, 3b or 3c [Okano et al.,
1999, Barau et al., 2016]. During cell replication the DNMT1 is localised to the
replication fork where it copies CpG methylation patterns onto the newly repli-
cated DNA [Li et al., 1992]. DNA methylation has traditionally been associated
with gene silencing as around many gene promoters are "CpG islands" or areas
of high CpG content which when methylated are associated with gene repression
[Meissner et al., 2008]. DNA methylation is also observed at transposable elements
and is thought to be responsible for silencing these elements to maintain genome
stability [Berdasco and Esteller, 2010]. Additionally, in tissue-restricted genes, the
inactive X chromosome and imprinted genes these areas are typically methylated
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[BIRD et al., 1985, Li et al., 1992]. However, the vast majority of CpG islands
remain unmethylated, independent of their transcriptional activity. This suggests
that DNA methylation alone is not always enough for transcriptional silencing
[Weber et al., 2007, Jones, 2012].
The enzymatic addition or removal of a methyl (CH3) group onto the cytosine
ring of DNA is mediated by the DNA methyltransferases (DNMTs) and the DNA
demethylases. DNMT3a, 3b, and 3c, the de novo methyltransferases, are pre-
dominantly active during embryogenesis. The initial DNA methylation pattern
is established by DNMT3a and DNMT3b, which if expressed can also maintain
DNA methylation after cell division [Okano et al., 1999, Barau et al., 2016]. Main-
tenance of DNA methylation after cell replication or damage repair is controlled
by DNMT1. DNMT1 copies the methylation pattern from methylated parental
strand to the newly synthesised, hemimethylated, DNA strand [Hermann et al.,
2004]. Faithfully copying the DNA methylation pattern to the new daughter cells
by DNMT1 also requires the ubiquitin-like plant homeodomain and RING finger
domain1 (UHRF1). UHRF1 recognises and binds to hemimethylated DNA and
recruits DNMT1 which binds to UHRF1 to form a complex which adds a methyl
group [Sharif et al., 2007, Bostick et al., 2007].
Although methylation is often thought of as a stable epigenetic mark due to abun-
dance of DNMT1 in cells, there are pathways mediating demethylation. The
removal of a methyl group from the DNA can be achieved in either an active way
or a passive way. Through successive cycles of cell division, a methyl group can
be lost due to the absence of DNMT1/UHRF1 i.e. passive loss of methylation
[Wu and Zhang, 2014]. This process is best demonstrated in the preimplantation
embryo when global loss of methylation of the maternal genome is observed [Guo
et al., 2014]. Active DNA demethylation is mediated by the ten-eleven transloca-
tion methylcytosinedioxygenase (TET) proteins. TETs oxidise the methyl group
(5mC) to become 5-hydroxymethl cytosine (5hmC) which is further oxidised to
5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) [Ito et al., 2011]. These ox-




During embryogenesis DNA methylation has been shown to be essential to normal
development. Knockout mouse models of the DNMT proteins lead to embryonic
lethality and a global loss of methylation throughout the genome [Okano et al.,
1999, Li et al., 1992]. In early embryonic stem cells, genes important for pluripo-
tency such as Nanog and Oct4, have hypomethylated promoters however in differ-
entiated cells these promoters are methylated and silenced [Hattori et al., 2007].
Much of the study into DNA methylation and development has been conducted in
the early post-implantation embryo to address maternal and paternal contribution
and X inactivation. However as more studies have emerged, there has been in-
creasing evidence for the role of DNA methylation in the development of the bone,
prostate, brain and hematopoietic system (reviewed [Smith and Meissner, 2013].
It is now most likely that DNA methylation plays less of a role in establishing si-
lencing, and instead plays a role in maintaining the silent state. In developmental
terms, this equates to DNA methylation being less involved in directing the em-
bryogenesis program but instead reinforcing lineage commitment decisions [Zhang
et al., 2018].
In lung development the role of methylation has increasingly been studied at all
stages of lung development. There is particular interest in determining the dif-
ferential methylation patterns of normal development versus lung developmental
diseases such as bronchopulmonary dysplasia (BPD). In a recent study, Cuna et
al. found 95 genes in mice and 25 genes in humans that were differentially methy-
lated and led to gene expression changes in BPD versus normal lung. Twenty of
these genes were overlapping and many were already identified as important reg-
ulators of lung development. This study identifies potential candidates that are
regulated by DNA methylation which will provide insight into normal lung devel-
opment. Additionally, validation of these genes and their regulatory mechanism
will further our understanding of how aberrant DNA methylation contributes to
developmental lung disorders and potentially offer new treatments to diseases such
as BPD if we can target the reversible epigenetic modifications [Cuna et al., 2015].
It is known that ventilation of premature babies can lead to lung development
issues. In neonatal rats, prolonged exposure to oxygen reduces alveolar septation
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and leads to fibrosis of the lung, similar to human BPD. In a study by Chen et
al. they looked at the methylation profiles of rat lungs that had been exposed to
hypoxic conditions versus wildtype controls and found several genes involved in
actin cytoskeleton and focal adhesion were differentially methylated. These genes
are important in cell spreading, migration and proliferation during alveolariza-
tion. Overall the hypoxia induced methylation led to arrested alveolarization and
a higher mortality rate. As DNA methylation is quite stable due to the infrequent
expression of TET enzymes and common expression of DNMT1, it could lock in
the early alveolar development gene expression state, leading to an arrest in alve-
olarization. This study reflects the real-life consequences of medical intervention
and highlights our lack of understanding of the processes that are regulating lung
development [Chen et al., 2017a].
Overall the research involving DNA methylation in lung development has been
restricted to later lung developmental stages with a particular focus on how ex-
ternal factors such as smoking or ventilation affect DNA methylation during late
lung development. It will be necessary and interesting to identify what role DNA
methylation is playing in earlier stages of lung development.
1.4.2 Histone modifications
Packaging of the DNA in the nucleus requires it to be wrapped around the nucle-
osome. Nucleosomes are made up of two copies of four histones (H2A, H2B, H3
and H4) making a histone octamer. Histones are positively charged and have a
lysine and arginine rich, N-terminal tail which can bind tightly to DNA restrict-
ing access of transcriptional machinery [Black and Whetstine, 2011, Karlic et al.,
2010, Kornberg, 1974, Luger et al., 1997]. It is the post translational modifica-
tion (PTMs) of these tails that correlates with open or closed states of chromatin
thus controlling gene expression. Histones can be modified in many ways includ-
ing but not limited to: methylated, acetylated, phosphorylated, ubiquitylated and
SUMOylated [Rivera and Ren, 2013]. PTM of histones controls gene expression
in two main ways: one by altering chromatin structure and conformation; and
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two by signalling to recruit activators/suppressors of transcription [Workman and
Kingston, 1998, Chen et al., 2017b].
One of the defining characteristics of epigenetic modifications is their ability to
be removed. In the case of histone PTMs, there are enzymes that can "write"
and also those that "erase" the PTMs. Writers include histone acetyltransferases
(HATs), histone methyltransferases (HMTs) and protein arginine methyltrans-
ferases (PRMT) which add marks to histones while erasers include histone deacety-
lases (HDACs) and lysine demethylases (KDMs) that can remove marks. Certain
histone marks are always associated with active transcription such as trimethy-
lation of histone 3 at lysine position 4 (H3K4me3) as well as histone acetyla-
tion. Repressive transcription is associated with marks such as H3K27me3 and
H3K4me2/3 [Workman and Kingston, 1998, Black and Whetstine, 2011, Ernst
et al., 2011]. Although histone PTMs are labelled as epigenetic modifications due
to their involvement in transcription, evidence for their mitotic inheritance is lim-
ited. Methylation is the most stable of the PTMs, displaying a half-life of several
hours to days, an important feature necessary for a mark to be transmitted during
cell division. In contrast, histone acetylation and phosphorylation have half-lives
of only minutes. For a mark to be mitotically heritable the information should be
duplicated during cell division to the new daughter cell, currently the mechanisms
for this process are unknown for most histone modification, with the exception
being for polycomb repressive complex 2 which imparts H3K27me3 [Di Croce and
Helin, 2013]. However, histone PTMs are re-established indicating some epigenetic
memory however in most cases the exact processes remain to be elucidated [Huang
et al., 2013].
Much of the work around PTMs in embryo development has been conducted us-
ing knockout mouse models. Knockout models of the methyltransferase EZH2, the
predominant enzymatic component of polycomb repressive complex 2, responsible
for di and tri-methylation of H3K27 and the methyltransferase EHMT2, which
adds a mono or di-methyl group to H3K9, lead to lethality shortly after gastru-
lation and developmental abnormalities [O’Carroll et al., 2001, Tachibana et al.,
2007]. Therefore, to investigate the effect of PTMs on organs that form later in
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development or to specifically address their role in tissues of interest it is necessary
to use mouse models in which recombination of the gene occurs in a tissue-specific
manner, such as the Cre-LoxP system.
Loss of Histone deacetylases 1/2 (Hdac1/2) in the lung endoderm abrogates Sox2-
positive cell differentiation resulting in a lung comprised only of Sox9+ cells. The
knockout mouse model in which Hdac1/2 were specifically deleted in the early
lung endoderm using the Shh-Cre showed that Sox2 is a direct target of Hdac1/2.
The researchers also showed that loss of Hdac1/2 was not required for homeostasis
in the adult lung when they conditionally deleted Hdac1/2 using the CC10-Cre
and saw no adverse effects. However, after injury of the lung in this model they
observed a decreased capacity for regeneration [Wang et al., 2013]. This is par-
ticularly interesting as severe COPD patients are associated with reduced HDAC
expression, suggesting a role for HDACs in repair and regeneration and the pro-
gression of the disease [Ito et al., 2002, Ito et al., 2005].
Loss of another histone deacetylase, Hdac3, also causes disruption to late stage
developing lung epithelium wherein the ATI cells cannot expand and remodelling
of the lung after birth is restricted. Interestingly, when Hdac3 was conditionally
deleted in the lung endoderm using the same Shh-Cre as the Hdac1/2 model,
there was no evidence or early lung defects and the lung developed normally until
E17.5 [Wang et al., 2016b]. In a separate study where Hdac3 was deleted in the
lung mesenchyme from E10.5, alveolar differentiation defects were also observed.
Deletion of Hdac3 prevented mesenchymal proliferation which caused a defect
in AT1 cell proliferation and differentiation [Wang et al., 2016a]. These studies
show the complexity involved in epigenetic regulation of the developing lung and
how different histone modifiers, despite having similar roles can act on different
developmental pathways.
Akin to the defects observed in the endodermal deletion of Hdac1/2, deletion of
the scaffolding protein Sin3a using Shh-Cre also showed a similar yet more severe
phenotype [Yao et al., 2017]. Sin3a forms a complex with many different histone
modifiers including Hdac1 and 2 and Kdm5 which facilitates deacetylation and
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demethylation of histones respectively [Hassig et al., 1997, Silverstein and Ekwall,
2005]. Loss of Sin3a in foregut endoderm resulted in postnatal mortality due to
the insufficient formation of the lung. The early trachea and left and right lung
buds formed but did not progress into branching morphogenesis and after E11.5
regression of early lung tissue was observed. No defects were seen when Sin3a was
deleted in the developing lung mesenchyme, but the endoderm-specific deletion
affected mesenchyme development with a decrease in regulating signals such as
Shh secreted by the mesenchyme. A permanent arrest of the cell cycle in Sin3a-
deficient epithelial cells prevented any further development of the lung. Sin3a was
found to interact with the cell cycle checkpoint inhibitors Cdkn1a and Cdkn2a and
loss of Sin3a caused these checkpoint proteins to activate and prevent cell cycle
progression stalling cells in G1. Yao et al. suggest that Sin3a plays an important
role in preventing cellular senescence which is important in the context of diseases
such as COPD and idiopathic pulmonary fibrosis in which senescence is a common
event. This also highlights a common theme among epigenetic regulators; their
multiple functionalities. Demonstrated by the evidence that Sin3a is not solely an
epigenetic protein but a regulator of cell cycle [Yao et al., 2017].
Global loss of the histone demethylase, Jumonji domain containing-3
(Jmjd3/Kdm6b), which removes di- and tri-methylation of H3K27, results in peri-
natal lethality due to an inability to breathe. Interestingly examination of these
dead pups revealed no lung defect. Further examination found that global dele-
tion of Jmjd3 resulted in a defect in the respiratory rhythm generation (RRG)
which controls the mechanical act of breathing [Burgold et al., 2012]. Intriguingly
though, in another study by Li et al., when Jmjd3 was also deleted globally they
did find defects in the development of the lung [Li et al., 2014]. Homozygote mice
showed arrested lung development at the canalicular stage, displaying immature
alveolar sacs and stall vascular development. To further probe Jmjd3’s role in
lung development the researchers conditionally deleted Jmjd3 using the SPC-cre
and the CC10-cre models upon which they found there was no evidence of lung
defects. They then used the Wnt1-Cre which is expressed much earlier, E7.5 in
embryogenesis. This cross resulted in severe lung development defects including
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fewer air spaces. This led them to the conclusion that Jmjd3 is not important in
epithelial cells after the lung development is initiated [Li et al., 2014]. These two
studies highlight how the method of generation for a knockout mouse can impact
on our understanding of how a process works. In the first study by Burgold et al.,
the model was generated using a gene trap ESC line in which the neo-cassette was
inserted between exons 1 and 2. In contrast, in the second study by Li et al., Jmjd3
was deleted by homologous recombination technology. The differences observed
could be due to leaky expression or gene region-specific deletions where partial
deletion of the gene still resulted in a functional or semi-functional protein, and
suggest that there may be more than one mechanism responsible for phenotypes
observed.
Two studies in 2015 found a role for the polycomb repressive complex (PRC)
2 member, EZH2 in normal lung development. The PRC is responsible for di-
and tri-methylation of lysine 27 on histone 3 (H3K27) [Hansen et al., 2008].
The PRC proteins have been implicated in the development of many tissues,
through targeting developmentally important genes and repressing cell cycle in-
hibitors thereby regulating proliferation (reviewed in [Holoch and Margueron,
2017],
[Moritz and Trievel, 2018]). Conditional deletion of Ezh2 in the lung endoderm
using the Shh-Cre led to perinatal lethality with Ezh2 null lungs displaying smaller
lung size, reduced number of branches and fewer alveolar sacs. Further cellular
analysis showed a decrease in secretory club cells while also resulting in an increase
in basal cells providing evidence for Ezh2 regulatory role in basal cell development
and differentiation [Galvis et al., 2015, Snitow et al., 2015]. Furthermore, when
Ezh2 is deleted in the developing lung mesoderm, mutant mice die perinatally
due to immature epithelium, lack of alveolar differentiation, reduced mesenchy-
mal development and ectopic smooth muscle formation. It was found that Ezh2
suppresses smooth muscle differentiation in the multipotent lung mesothelium in
early lung development [Snitow et al., 2016]. These studies provide further evi-
dence of the plethora of roles that these histone modifiers play and the complex
relationship between gene expression and regulation and epigenetic control.
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1.4.3 Chromatin higher-order structure and remodelling
Chromatin has two forms, the tight non-transcribed heterochromatin or the loose
transcriptionally active, euchromatin. Nucleosome positioning contributes to these
forms and thus influences if an area of DNA will be transcribed [Pugh, 2010, Zhang
et al., 2011, Struhl and Segal, 2013]. Nucleosome remodelers alter the structure
and position of the nucleosome. For example, the ATP-dependent chromatin re-
modeler family ISWI (imitation switch) which slides histones along DNA to ensure
all the nucleosomes are spaced evenly to be folded into a higher order structure
[Vincent et al., 2008]. Other chromatin remodelers use different mechanisms.
Folding and looping of the chromatin also regulates chromatin structure. An
example of such a chromatin remodeler is CCCTC-binding factor (CTCF) which
brings distal enhancers closer to the target promoter [Bell et al., 1999, Nora et al.,
2017]. CTCF itself doesn’t have enzymatic capacity, but rather it works with the
cohesin complex, made up of core subunits: Smc1, Smc3, Rad21 and Scc3/SA.
This complex stabilises topological loops to create multidimensional organisation
of the chromatin (reviewed in [Zhu and Wang, 2018]).
The regulation of chromatin architecture has been an area of intense research in
recent years, particularly considering the relationship between architecture and
gene transcription. Just after fertilisation, the zygote has a very relaxed chro-
matin state. As preimplantation development proceeds this chromatin state be-
comes more organised finally resulting in a more mature higher-order chromatin
structure just before implantation [Ke et al., 2017, Du et al., 2017, Flyamer et al.,
2017]. The techniques needed to investigate these higher order chromatin struc-
tures have only been developed in recent years and are still being refined, as such
there is limited knowledge about how the chromatin structure regulates lung de-
velopment. However, as the technology improves so will our understanding and




One example of a higher order chromatin modifier identified in lung development
are the structural maintenance of chromosome (SMC) subunits, SMC2 and SMC4.
SMC2 and SMC4 are part of the condensin complex which act to condense chro-
mosomes and aid in segregation during mitosis [Hirano, 1998]. In addition to their
role in mitosis they have been implicated in maintenance of silent gene expression,
DNA repair and heterochromatin organisation [Hirano, 2012].
Recently SMC4 was identified as exhibiting constant expression change during
human lung development in a gene expression profile that analysed four different
lung development stages. In this profile they looked for genes that were consis-
tently upregulated or downregulated in lung development and did the opposite
in lung adenocarcinoma samples. SMC4 was identified as gradually decreasing
during lung development while showing increased levels in lung adenocarcinoma
compared to normal lung. Using this data, they theorised that SMC4 could also
play a similar developmental role in the development of lung cancer as it has al-
ready been implicated in liver and colon tumorigenesis [Feng et al., 2014, Zhou
et al., 2014]. They found that SMC4 upregulation acts as a poor prognosis in-
dicator and suggest that SMC4 plays a similar role in disease progression and
during lung development. As SMC2 forms a heterodimer with SMC4 it would be
valuable to assess SMC2 role in lung development and cancer progression [Zhang
et al., 2016].
1.4.4 Noncoding RNA and lung development
Noncoding RNAs (ncRNAs) are transcribed lengths of RNA that are not trans-
lated into proteins. They include but are not limited to: microRNA (miRNA),
short interfering RNA (siRNA) and long noncoding RNA (lncRNA) [Costa, 2010].
ncRNAs are thought to regulate most of genome as there are many and they have
high binding affinity for most regulatory machinery. They have been described
in the regulation of proliferation, migration, differentiation and apoptosis [Ameis
et al., 2017]. Some ncRNAs are described as epigenetic modifiers as they have
the ability to influences where epigenetic regulators bind. For example, enhancer
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RNAs (eRNAs) are ncRNAs that are transcribed from enhancers regions in the
DNA. Although their molecular mechanism is not fully understood, it is clear that
they play a role in gene transcriptional regulation [Ding et al., 2018].
There are thousands of ncRNAs, the best characterised are small (miRNA, 20-
30 nucleotides), they are involved in gene regulation, chromatin structure, RNA
stability and processing and translation to proteins. To date there have been over
1000 miRNAs validated in the human genome [Ameis et al., 2017]. LncRNAs have
more than 200bp and are rather less understood but like their shorter counterparts
have many different functions [Salamon et al., 2018].
miRNAs and their machinery are known to play important roles throughout devel-
opment. Dicer, an important RNA processing protein, cleaves miRNA into siRNA
which regulate gene expression [Hutvágner et al., 2001, Knight and Bass, 2001].
Dicer has been implicated in the development of many tissues and global knockout
models results in embryonic lethality at E7.5 also characterised by a decrease in
the stem cell marker Oct4 expression [Bernstein et al., 2003]. Knockout of Dicer
in lung endoderm using the Shh-Cre results in large fluid-filled sacs that displayed
no evidence of branching and embryos died just after birth due to respiratory
failure [Harris et al., 2006]. Further examination of the embryonic lung showed
that branching arrested just after E12.5 but the epithelium continued to grow.
Interestingly, increased cell death was observed in the distal lung epithelium as
development proceeded which the authors suggested was independent of its role
in regulating lung epithelial morphogenesis. However, as cell death is rare in the
developing lung it is possible that this is just a side effect of abnormal develop-
ment due to knockout of an important regulator [Harris et al., 2006]. Notably,
in humans suffering from pleuropulmonary blastoma, mutations have been found
in DICER1 indicating an important role in regulating disease [Messinger et al.,
2015].
Far less is known about lncRNAs and their role in lung development. Most of
the defined lncRNAs have been identified from large sequencing experiments. A
study from Herriges et al. performed RNA sequencing on E12.5 and adult mouse
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lung to look for lncRNAs in the developing and adult lung. They identified 363
candidate lncRNAs of which 163 were novel, that were located near important
lung development transcription factors such as Nkx2.1, Foxa2, Foxf1 and Gata6.
They characterised one of the lncRNAs near Nkx2.1, near transcription factor
loci (NANCI ). NANCI regulates lung epithelial gene expression, functioning up-
stream of Nkx2.1 and downstream of Wnt signalling [Herriges et al., 2014]. In-
ducible NANCI knockout mouse models have shown that loss of NANCI results
in decreased Nkx2.1 expression but this did not lead to any major defects in the
lung. However, knockout of NANCI combined with loss of one Nkx2.1 allele led
to developmental delay in the lung and at 6 months mutants displayed pulmonary
degeneration due to an immature alveolar epithelium, indicating that while one
allele Nkx2.1 is sufficient to progress through embryogenesis, it is insufficient to
support long term lung health in combination with loss of NANCI [Herriges et al.,
2017]. Importantly, a patient was identified with a chromosomal deletion elimi-
nating most of the NANCI locus but maintaining the Nkx2.1 locus. This patient
showed signs of Nkx2.1 haploinsufficiency such as respiratory distress, indicating
an important role of NANCI in disease and further evidence that more research
into lncRNAs is necessary [Herriges et al., 2014].
Another recent paper used human iPSCs to create proximal and distal lung cells
that expressed all the markers of developing lung progenitors. They then used
next generation sequencing to look for lncRNAs that were close to genes involved
in lung development. Through this process they identified a novel lncRNA, RP11-
380D23.2 which is associated with the WNT signalling pathway. Knockdown
of this lncRNA in their human iPSCs resulted in an enrichment for markers of
proximal airway progenitors such as Sox2, P63, Muc5AC and Foxj1 while also
resulting in a decreased expression of alveolar markers, Sox9 and Aqp5 [Banerjee
et al., 2018]. It will be necessary to continue this work in vivo to really elucidate
RP11-380D23.2 ’s role in lung development but it highlights how much there is




The external environmental impact is often brought up with the topic of epige-
netics. Due to the broad epigenetic reprogramming in early development, envi-
ronmental impact can have long reaching consequences that could affect postnatal
health. Furthermore, many researchers have shown how an event impacting an
ancestor can have long reaching implications for generations to come. Addition-
ally, although there have been many studies addressing environmental impact and
changes in the epigenome and thus phenotype, it is still unclear how the environ-
ment leads to epigenetic changes.
Smoking has been known for a long time to be one of the major risk factors in the
development of lung diseases including COPD and lung cancer. Additionally, ma-
ternal tobacco smoke, maternal environmental tobacco smoke and environmental
tobacco smoke exposure leads to abnormal lung development as well as a predispo-
sition to lung diseases such as asthma [Zakarya et al., 2019]. Exposure to cigarette
smoke has shown to have effects on methylation in lung epithelial cells in culture
and in rat embryonic lung cells [Izzotti et al., 2009, Cuna et al., 2015, Liu et al.,
2010]. Cigarette smoke has also been documented as effecting histone modifiers
such as HDACS and HATs [Glass et al., 2018].
A specific example, examining methylation, pregnant mice exposed to cigarette
smoke had offspring with lower mRNA levels of Igf1 in lung cells and a loss of
methylation was found in Igf1r promoter regions [Meyer et al., 2017]. Insulin-like
growth factor (Igf1 ) and its receptor (Igf1r) are important in lung development and
loss of Igf1r leads to lung hypoplasia and growth retardation of lung, highlighting
the importance of deregulation of the methylation of these genes due to exposure
to cigarette smoke [Epaud et al., 2012].
More recently the study of e-vapour exposure on the developing lung epigenome
is emerging. Reduction in alveolar cell proliferation and changes in postnatal lung
growth was observed in mice exposed to e-cigarette emission containing nicotine in
the first 10 days of life [McGrath-Morrow et al., 2015]. In another study looking at
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maternal e-vapour exposure on cognitive function Nguyen et al. found an increase
in global DNA methylation in the maternally exposed offspring. Additionally, the
authors found 13 genes that were differentially altered in exposed brains. These
genes included Dnmt3a/b, Kdm5c, Kdm6b, Aurka, Aurkb, and Aurkc [Nguyen
et al., 2018]. As many of these genes have been implicated in lung development it
potentially means exposure to e-cigarette smoke either from maternal inhalation
or postnatal exposure would have similar effects.
Topically the effect of pollution on the developing lung is being explored. Many
studies have found links between both gestational and early life exposure to air
pollution and disrupted lung development and respiratory conditions. Several
epigenome wide association studies have looked at changes in global methylation
between offspring of mothers who were exposed to different levels of pollution.
One study conducted in New York City found that there was an overall reduction
in global methylation [Herbstman et al., 2012]. While another study in the Czech
Republic found a link between air pollution and asthma and a global hypomethy-
lation pattern [Rossnerova et al., 2013]. Further molecular probing has identified
many epigenetic alterations which have the capacity to have long reaching gener-
ational effects [Veras et al., 2017].
Diet has long been implicated in epigenetic changes that can persist over many
generations. Folic acid has been given to pregnant women worldwide to prevent
neural tube defects for many years. Folic acid is a methyl donor, and it has been
hypothesised that a diet rich in methyl donors could contribute to hypermethyla-
tion and is the clearest example of how the external environment can affect the
epigenome. However, research providing causality is still limited. In studies in
humans, looking at the link between folic acid supplement and respiratory disease,
there has been some evidence to suggest that there is a link between an increased
risk of contracting a lung disease such as asthma. However there has been studies
also showing no link between folic acid and development of lung disease. Fur-
ther studies in animal models as well as large long-term cohorts are necessary to
truly evaluate the role of a methyl-rich diet in respiratory disease [Håberg et al.,
2011, Magdelijns et al., 2011, Gruzieva et al., 2014].
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Research involving other dietary supplements such as vitamin D have shown to
convey some protective effect of vitamin D against wheezing in young children
[Baïz et al., 2014]. It is suggested that an active metabolite of vitamin D con-
tributes to H4 acetylation which has been implicated in the expression of inflam-
matory genes [Sundar and Rahman, 2011].
It is clear that the epigenome can not be ignored when studying lung develop-
ment. The role of epigenetics in normal patterning, growth, cell specification,
maintenance and disease have been well established. While we are starting to
understand how the epigenome regulates these processes much more is left to be
uncovered. Further research is needed in conjunction with more traditional genome
studies to develop a clearer understanding of how the lung develops.
1.5 Models of lung development
The mouse remains the primary model to study lung development and disease. It
allows for not only genetic modification studies but a range of physiological studies
(eg. smoking, pollution effects on lungs) as well pharmacological studies and are
the necessary precursor to clinical trials for developing lung disease treatments
[Mercer et al., 2015]. However, there are essential differences in human and mouse
lung as well as disease presentation and manifestation that cannot be robustly
modelled in mouse models, requiring the development of other model systems
such as cell lines, organs on a chip and organoid systems.
1.5.1 In vivo models
Due to their relatively short lives, fast embryonic development, workable size and
because they are mammalian, the laboratory mouse is an invaluable tool for study-
ing human disease and healthy development.
Knockout mouse models have only been around since the late 80’s [Capecchi,
1989], and the technology since has revolutionised the way we conduct science
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and shaped our understanding of human and mammalian biology. So much so
that the initial creators were awarded the Nobel Prize in Physiology or Medicine
in 2007. A knockout mouse refers to a mouse strain in which a gene has been
inactivated or "knocked out". These knockout mice allow researchers to observe
differences between normal and loss-of-function models and thereby determining
the role of that gene. Although knockout mice have been a useful resource they
have their limitations, the primary being that a significant proportion of gene
inactivations result in embryonic lethality. This hampers the analysis of gene
function in specific organs or in adulthood. To circumvent this issue, conditional
knockout mouse models were created. The conditional knockout enables gene
deletion or activation in specific cell types and has quickly become one of the most
valuable tools for studying mouse genetics.
1.5.1.1 Cre-LoxP recombination
As opposed to global mutation of a gene which will affect every cell in which that
gene is expressed, the Cre-LoxP system is a more controlled method of studying
gene mutations in areas of interest. By driving Cre expression from tissue or cell
specific promoters this tool allows examination of activation or inactivation of
specific genes in specific organs and cells. During embryogenesis important genes
may play numerous and diverse roles in many different processes and knocking
them out globally makes it difficult to elucidate their functions.
Cre-loxP recombination involves introducing specific gene alterations in a selected
population of cells in mice. A mammalian-codon-containing bacteriophage P1-
derived Cre recombinase (Cre) is able to direct DNA recombination between two
LoxP sites [Sauer and Henderson, 1988]. This system allows for genes-of-interest to
be permanently inactivated or activated [Rawlins and Perl, 2012, Shimshek et al.,
2002]. Using the Cre-lox system usually requires a mating between the Cre mouse
strain and a mouse strain with a segment of gene flanked by LoxP sites. The Cre
mouse will drive Cre expression from a tissue-specific promoter. This system can
induce deletions, inversions and translocations of the floxed region [Nagy, 2000].
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With the addition of inducible Cre models controlled for example by tamoxifen
or tetracycline, timing-specific inactivation/activation can be investigated [Indra
et al., 1999, Feil et al., 1996, Feil et al., 1997]. In the tamoxifen-inducible Cre
model the binding domain of the estrogen receptor (ER) is mutated (ERT2) and
a fusion with Cre is made. Upon treatment with tamoxifen, Cre recombinase is
moved from the cytoplasm into the nucleus thereby inducing Cre activity. Ta-
moxifen binds strongly to ERT2 while endogenous estrogens have a much weaker
binding affinity, mitigating the leaky effect of first generation CreER fusions that
were affected by endogenous estrogens [Feil et al., 1997, Indra et al., 1999]. An-
other important use of the Cre recombinase is for lineage-tracing experiments. By
crossing a Cre mouse with a reporter mouse line it allows for the expression of a
reporter specifically in Cre-expressing cells. Induction of expression of a reporter
at different developmental stages or in different progenitor cells allows tracking of
cells and their progeny can be tracked throughout development and the life of the
organism to define stem cell function [Rawlins and Perl, 2012].
There are many different Cre models used to study lung development, lung home-
ostasis and lung repair. A summary of the transgenic mouse models that are used
and discussed in this thesis are briefly described below.
1.5.1.2 Shh-Cre
Sonic Hedgehog (Shh) is an important regulator of lung development. It is also
expressed in other organs such as the notochord and the limb buds [Riddle et al.,
1993, Litingtung and Chiang, 2000]. Shh is expressed in the ventral foregut endo-
derm at E9.5 just before the lung buds and the trachea and oesophagus separates
[Harris et al., 2006, Harfe et al., 2004]. Shh-Cre mice have been extensively used to
study early lung development. Many models that have used the Shh-Cre demon-
strate its high specificity to the early lung epithelial cells, rarely observing off
unwanted effects in the limb or notochord. It is the most common lung develop-
ment Cre, due to its early lung specific embryonic expression at around E9.5 and
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is commonly used to address the role of specific genes in the development of the
first epithelial lung cells [Rawlins and Perl, 2012].
1.5.1.3 Sox9-CreER
Sox9 is a marker of stem cells in the developing lung. It is also expressed in
the developing skeleton, brain, kidney, intestines and limbs [Soeda et al., 2010].
The Sox-CreER is an inducible mouse model, providing an important mechanism
for assessing the role of a gene of interest timing in Sox9+ cells. Within lung
development, the Sox9-CreER has been used to identify the stem cell capacity of
the Sox9+ cell in the lung as well as in lineage tracing experiments to show that
the alveolar differentiation is dependent on proper Sox9 signalling in the distal
branches [Chang et al., 2013, Rockich et al., 2013].
1.5.1.4 SPC-Cre (Sftpc-Cre)
There are many transgenic Cre models utilising the Sftpc promoter to target res-
piratory epithelium. It is commonly used as it is highly specific to the lung epithe-
lium, with Sftpc expression observed from E14.5 in the developing lung. Using one
of the Sftpc-Cre lines, the AT2 cells were discovered to be the stem cell of the alveo-
lar region of the adult lung [Barkauskas et al., 2013]. In the adult, Sftpc expression
is mainly found in AT2 cells and a small subset of bronchiolar cells. The use of
tamoxifen-inducible or dox-inducible models of Sftpc-Cre are particularly useful
to temporally induce excision of genes on interest in Sftpc-expressing cells. For
example, if Cre-recombination is induced early (E6.5-E10.5) only the progenitor
pool of the distal epithelium is targeted, by contrast, late induction (E14.5-E18.5)
only targets the AT2 Sftpc-expressing cells [Rawlins and Perl, 2012].
1.5.1.5 CC10-Cre (Scgb1a1-Cre)
Expression of secretoglobin1a1 or CC10, is found in all club cells in the lung
epithelium. Like the Sftpc-Cre there are many strains available. Often these
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utilise the transgenic rat Scgb1a1 promoter that is active in AT2 cells as well as
club cells, whereas the mouse knock-in construct is specifically active in club cells
[Rawlins et al., 2009b]. This model is commonly used for adult lung studies or late
lung development as CC10 expression does not appear until just after birth. Our
laboratory uses the Scgb1a1-CreERT2 mouse, which drives expression of Cre from
the mouse promoter. This knock-in estrogen-responsive mouse only expresses Cre
in bronchiolar and tracheal club cells after exposure to tamoxifen. Lineage tracing
experiments using this model crossed with the Rosa-26R-eYFP mouse showed that
Scgb1a1+ club cells are long-term progenitors in the bronchiolar region during
postnatal growth and adult homeostasis [Rawlins et al., 2009b].
1.5.1.6 Reporter lines
As mentioned, the ability to lineage trace cells stemming from a specific subset
can reveal a lot about the origins of cell types and the stem cells that make
up an organism. In order to utilise the Cre systems above for lineage tracing
experiments they must be paired with a specific reporter system. Many exist, one
already mentioned is one of the most common, the Rosa26R-eYFP [Srinivas et al.,
2001]. Other systems include the ROSA-mT/mG in which cells constitutively
express dTomato until exposure to Cre where recombined cells turn off tomato
and express GFP [Muzumdar et al., 2007]. Even more powerful are the brainbow
and R26R-Confetti strains [Livet et al., 2007, Snippert et al., 2010]. These systems
use three to four, different fluorophores and mutated loxP sites they are able to
create stochastic recombination and randomly assign a different colour to each cell
expressing Cre. This technique not only allows for in depth lineage tracing but
also for clonal and spatial tracing of cells [Livet et al., 2007, Snippert et al., 2010].
1.5.2 In vitro models
Although mouse models are the gold standard for investigating lung development,
sometimes it is necessary to use alternative methods. As technology improves
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and our understanding of developmental processes grows better techniques for
culturing and recapitulating in vivo systems are emerging in vitro.
1.5.2.1 Ex vivo models
One of the most common ways to study branching morphogenesis is to culture
early development mouse lungs on thin membranes which sit on culture media, in
a 2D air-liquid interface (ALI). These ex vivo cultures have provided an essential
understanding of how the lung branches and have helped to define many of the fac-
tors involved in the branching process [Del Moral and Warburton, 2010, Seth et al.,
1993, Jaskoll et al., 1988]. This technique allows researchers to not only study nor-
mal branching morphogenesis programs but also to analyse genetically engineered
lungs to provide further insights into their phenotypes. Additionally, treatment of
the culture media with drugs and inhibitors to the media upon which the lungs
are grown can give insights into pharmacological effects on lung branching mor-
phogenesis. Work from the Rawlins laboratory showed that this technique could
also be used for grafting assays. They transferred distal "tip" or proximal "stalk"
pieces from E12.5 and E16.5 lungs expressing tdTomato onto the mesenchyme in
the proximal wild-type E12.5 lungs. They observed that the transplanted pieces
responded to their environment and even the distal epithelial graft differentiated
into proximal lineages. Microinjection of an adenovirus expressing GFP and vari-
ous transcription factors was also performed in the ex vivo cultures. This labelling
of cells that also expressed important transcription factors of interest led to the
conclusion that Stat genes promote an alveolar fate [Laresgoiti et al., 2016]. Al-
though these "mini-organs" recapitulate the developing lung well, their small size,
fragility, complexity and 2D plane make them unsuitable for many experiments
[Nikolić and Rawlins, 2017].
1.5.2.2 Spheroid and organoid model systems
As in vitro culturing techniques improve and the large field of "organoids" grows
it is important to define the definition of an organoid. Organoids are defined as
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3D structures that self-organise and develop from stem cells or progenitor cells
differentiating into multiple different cell types of the organ they are mimicking
[Clevers, 2016, Lancaster and Knoblich, 2014, Rossi et al., 2018]. Therefore, other
methods, such as cell lines or cells that are free-floating or in Matrigel that form
unorganised spheres are not classified as organoids.
Spheroids
Part of the difficulty of studying lung development is that we currently do not have
a way to culture post-gastrulation embryos outside of the mouse in the laboratory
and if this technology does evolve, the added difficulty of the position of the lung in
the central body cavity prevents easy access to observation without removing other
tissues. Therefore, it is necessary to isolate cells of embryonic lung and culture
them in vitro. A recent paper described using a Sox9+GFP reporter mouse line to
isolate Sox9+ progenitors from the E12.5 lung [Nichane et al., 2017]. These cells
were grown in the laboratory for many weeks in a 3D Matrigel supported culture,
where they formed an undifferentiated Sox9+ spheroid, that could continuously
replicate itself without differentiating. RNAseq of these cultures showed that
they remained transcriptionally similar to their freshly isolated Sox9+ cells and
also retained this signature over many passages. Additionally, it was found that
these cells could be differentiated into both the bronchiolar and alveolar lineages
using previously defined differentiation protocols such as lung progenitor media,
transwell-differentiation assay or ALI culture. Cultured Sox9+ cells could also be
injected into the lung of adult mice and repopulate the damaged airway, though
at a very low percentage of overall contribution [Nichane et al., 2017]. This type
of 3D spheroid lung development model is a relatively easy and cheap way of
investigating early lung epithelial cells and in particular the stem cell population
of the E11.5 lung.
Organoids
Lung organoids have been generated from several regions of the mouse adult lung,
including: trachea and bronchus [Rock et al., 2009], bronchioles [Vaughan et al.,
2006, Peng et al., 2015], bronchoalveolar duct junction [Kim et al., 2005], and
the alveolus [Barkauskas et al., 2013]. Through these studies further insight into
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the factors that drive self-renewal and differentiation has been discovered. For
example, it was previously described that in the developing lung AT2 cells are
the progenitors for AT1 cells [Evans et al., 1973]. Through organoid co-culture of
adult AT2 cells with adult mesenchymal cells it was shown that AT2 cells remain
the alveolar progenitors in the adult lung and can self-renew and differentiate into
AT1 cells [Barkauskas et al., 2013]. In addition to studying normal homeostatic
conditions, organoids can be used to model lung disease. For example, cystic
fibrosis is caused by defects in the Cftr gene and induces swelling in organoids
that have the same Cftr defects as the disease. Modelling this disease also allowed
researchers to correct the defect using CRISPR/Cas9 gene editing [Dekkers et al.,
2013]. Recently embryonic lung organoids have been made from foetal human
lung. Researchers found that distal tips harvested from embryonic human lungs
can be cultured long term and have the ability to self-renew and differentiate
into both alveolar and bronchiolar epithelium in vitro. These cultures maintained
many of the original tissues transcriptional program and were able to highlight the
differences between mouse and human development while also providing significant
evidence that many of the same distal tip transcriptome is conserved across the
two species [Nikolić et al., 2017]. Creating adult human lung organoids will be
necessary for disease modelling as the mouse lung does not always replicate human
lung diseases. There are several methods for culturing human basal stem cells
in air-liquid interface-based cultures [Fulcher and Randell, 2013]. Furthermore,
there are plenty of emerging studies that are applying gene editing techniques to
organoids to further mimic homeostasis and disease [Gao et al., 2015].
1.5.2.3 Bioengineered models
Organ-on-a-chip modelling is a microfluidic based approach to studying organo-
genesis and disease. Bioengineering models have long been used, such as specially
designed air-liquid interface cultures that can be used for measuring electrical re-
sistance of adult cultured lung epithelial cells [Bals et al., 2004]. However, these
models lack in vivo aspects of the lung such as shear stress and stretch. Organ-
on-a-chip devices aim to supplement more traditional models by providing 3D
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environments that provide cell to cell interactions and can be monitored in real
time. Other organ-on-a-chip devices can be connected to explore more interactions
between organs [Esch et al., 2011]. These devices provide a more holistic view of
the lung. For example, computational fluid dynamics have been used to mimic
pulmonary capillary gas exchange an obvious and yet under explored area of lung
research due to the difficult nature of studying this process [Long et al., 2012].
Bioengineered model systems can also be utilised to address the effect of mechan-
ical forces and pressure on lung development. Nelson et al. created ’microfluidic
chest cavities’ for intubated embryonic mouse lungs and found that fluid pressure
in the airways controls branching morphogenesis and the rate of maturation of the
lung. The pressure within the airway epithelium also controlled the smooth muscle
cell contractions where gain of pressure increased the contractions of the airway
smooth muscle. This increase in pressure was accompanied by faster maturation
of the lung suggesting that the two are linked [Nelson et al., 2017].
Mechanical force was also examined by embedding embryonic mouse lungs in a
stretchable gel to determine the events that control the orientation of epithelial
proliferation during branching morphogenesis. By labelling the chromatin and
using time-lapse microscopy they could look at the effect of stretching on spindle
orientation was evaluated. Tang et al. found that mechanical force played an
important role in determining the spindle orientation of the proliferating cells
during early lung development [Tang et al., 2018]. Another paper by the same
laboratory addressed mechanical force during sacculation and alveolarization by
pumping fluid in and out of the lungs in ex vivo cultures. Using this technique,
they discovered that mechanical force is needed to induce AT1 cell flattening and
that AT2 cells have small actin-based protrusions that prevent this mechanism
from happening and to maintain their round shape [Li et al., 2018a].
1.5.2.4 Pluripotent stem cells
Induced pluripotent stem cells (iPSCs) have changed the way we view stem and
progenitor cells and opened up a huge array of possibilities for studying self-renewal
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and differentiation [Takahashi and Yamanaka, 2006]. Lung epithelial cells derived
from endodermal derivatives have typically been more difficult to re-differentiate
than mesodermal or neural cell types. Recently though, there have been sev-
eral studies detailing the appropriate factors needed to induce differentiation of
mouse and human embryonic stem cells (ESCs) and iPSCs into lung epithelial
lineages [Longmire et al., 2012, Mou et al., 2012, Huang et al., 2014, Nikolić et al.,
2017, Miller et al., 2019, Miller et al., 2018]. Differentiation of ESCs and iPSCs
have required the signalling pathways critical for lung development, such as the
fibroblast growth signalling (FGF) and the Wnt signalling pathways. Despite the
advances in generating lung cells from iPSCs and ESCs, the biggest downfall is
that the induced cells never fully represent the differentiated cell type and remain
somewhat immature [Nikolić and Rawlins, 2017]. Despite this observation, iPSCs
grown in Matrigel will form organoids that share many of the same similarities
with normal airway cells by RNAseq [Nikolić et al., 2017]. Currently there are
several institutions generating large banks of iPSCs, ESCs, and organoids that
harbour lung disease-associated genetic mutations. These banks will create vast
opportunity for drugs screening and will prove an important resource for furthering
our understanding of respiratory disease.
1.6 The Cell Cycle
Cell division is the process by which a parent cell divides into two or more daughter
cells. In eukaryotic cells there are two types of cell division: mitosis where the
daughter cell is identical to the parental cell; or, meiosis where the daughter cell
only contains half the number of chromosomes as the parental cell and is used in
reproduction [McIntosh and Koonce, 1989].
The average human cell will take 24 hours to complete a full cycle of cell division.
However, certain cell types, such as embryonic stem cells proliferate much faster.
The replication cycle of a cell can be broken down into phases (Figure 1.5). In-
terphase includes the G1 phase, S-phase and G2 phase, where the cell will spend
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95% of its time during the cell cycle. It is during interphase that DNA replication
and cell growth occurs in an organised and regulated manner to prepare for mi-
tosis. Following interphase is mitosis, which can be broken down into five phases,
prophase, prometaphase, metaphase, anaphase and telophase. The end of mitosis
and cell division is cytokinesis were the two daughter cells separate from one an-
other. Somatic, non-proliferating cells, exit the cell cycle at G1 into the G0 phase
which is a quiescent but metabolically stable state [Morgan, 2007, Cooper, 2000]
1.6.1 Cyclin dependent kinases
The Cyclin dependent kinases (Cdk) 1 and 2 are master regulators of cell cycle
progression. Upon binding of a regulatory subunit, cyclin, the Cdks are able to
phosphorylate their substrates and regulate expression. Cyclins oscillate through-
out the cell cycle and thus regulate the Cdks in a cell cycle dependent manner.
Transcription in the cell cycle coincides with transition points, G1 to S, G2 to
M and M-G1 and these dynamic changes are regulated by the Cdks. Cdk1 be-
gins to increase in late G1 which triggers the cell to enter S-phase. Expression of
Cdk1 continues to rise throughout G2 with activity peaking during prometaphase.
For the cell to transition from metaphase to anaphase Cdk1 must be phosphory-
lated preventing its interacting with cyclins and thus inhibiting its kinase function.
Therefore, early Cdk1 expression restricts the proteins required later in mitosis and
inactivation of Cdk1 releases these proteins to perform their late mitotic functions
(Reviewed in [Bertoli et al., 2013, Malumbres, 2014, Benanti, 2016]).
1.6.2 Interphase
1.6.2.1 G1 phase
The Gap 1 (G1) phase is the first stage of the cell cycle where the cell synthesises
all the necessary mRNA and proteins needed for DNA replication in S phase. In
human cells the average time spent in G1 is around 11 hours, the longest of all
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Figure 1.5: The cell cycle
The cell cycle consists of of two phases, interphase and mitosis. Interphase, which consists of
G1, s-phase and G2, is where the cell prepares for cell division and involves replicating the DNA.
Mitosis is broken down into five stages in which the cell divides it’s DNA and begins to form




the phases. It is during this stage that the cell commits to cell division or to leave
the cell cycle and enter the resting G0 phase [Schafer, 1998].
1.6.2.2 S phase
S phase occurs between G1 and G2 phases and a typical human cell will spend
eight hours in S phase. It is during this time that the DNA is replicated and
the chromosomes are duplicated. Replication origins are defined sites along the
DNA, that unravel the DNA to allow replication machinery to initiate duplication.
The machinery works up and down from the replication origins to copy the en-
tire chromosome. In parallel, histone proteins and other packaging proteins such
as cohesin, are being produced to be deposited along the chromosomes, linking
the two sister chromatids together and preparing them for condensation prior to
separation [Schafer, 1998, Morgan, 2007, Cooper, 2000].
1.6.2.3 G2 phase
The Gap 2 (G2) phase lasts around four hours in human cells, during which the
cell translates all the proteins, such as the microtubules, necessary for mitosis
[Schafer, 1998, Morgan, 2007, Cooper, 2000].
1.6.3 Mitosis and cytokinesis
Mitosis is the nuclear division of duplicated chromosomes into separate daughter
cells. The process of mitosis can be broken down into five stages and including
cytokinesis only lasts for approximately one hour in human cells [Morgan, 2007].
1.6.3.1 Prophase
Prophase is the first stage of mitosis and is characterised by the compaction of
DNA. During prophase the chromosomes are compacted by DNA binding proteins
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such as cohesin and condensin. As their names suggest, condensin coils the chro-
mosomes into their compact configuration while cohesin forms rings that holds the
sister chromatids together. The two identical sister chromatids are joined at the
centromere. The cell’s two centrosomes move to the spindle poles and the mitotic
spindle begins to develop. Microtubules will start to develop attached to either
end of the centrosomes [O’Connor et al., 2010, McIntosh, 2016].
1.6.3.2 Prometaphase
Prometaphase sees the disassembly of the nuclear membrane and formation of
the microtubules. Phosphorylation of nuclear lamins by Cdks breaks down the
nuclear membrane and the membrane fragments are packaged into vesicles to be
used to rebuild the nuclear membrane when the cell has been split in two. The
microtubules grow out from the centrosomes attaching to the chromosome at the
kinetochore. The kinetochore is a group of proteins within the centromere. A
microtubule from each spindle pole must attach to the kinetochore to ensure proper
separation of the sister chromatids. The number of microtubules that attach each
pole to the kinetochore differs between species but at least one from each pole
must be attached [O’Connor et al., 2010, McIntosh, 2016].
1.6.3.3 Metaphase
Metaphase arranges the chromosomes along the midbody of the cell, positioning
the chromosomes in a similar orientation. The tension between the microtubules
attached to the spindle poles and chromosomes must become balanced for the chro-
mosomes to be held rigid along the cell equator [O’Connor et al., 2010, McIntosh,
2016].
1.6.3.4 Anaphase
Anaphase is characterised by the splitting of the sister chromatids. During anaphase
the cohesin rings which held the sister chromatids together are broken down and
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each chromatid is pulled to one of the spindle poles. The microtubules also fa-
cilitate in the separation by shortening and drawing the chromatids to the poles
[O’Connor et al., 2010, McIntosh, 2016].
1.6.3.5 Telophase
Telophase is the last stage of mitosis which sees the spindle poles disassembled
and the reformation of the nuclei from the old nuclear fragments contained in the
vesicles begins around the new chromosomes. The chromosomes begin to relax
and resemble the interphase structure [O’Connor et al., 2010, McIntosh, 2016].
1.6.4 Cytokinesis
Cytokinesis is the physical separation of the original cell and replicated cell. At the
midbody the cell membrane forms a cleft called the cleavage furrow. This cleavage
furrow is formed by a contractile ring made of actin and myosin filaments. As these
proteins contract the ring gets smaller. Finally, this contracting ring completely
bisects the cell at its centre and two daughter cells are created [O’Connor et al.,
2010, McIntosh, 2016].
1.6.5 Features of cell division machinery
To fully define and understand the localisation and function of Aurora kinase B
it is necessary to define a few important features of the chromosomes and the
machinery that drive cell division.
1.6.5.1 Centromere and kinetochore
The centromere is a location on the chromosome, that intersects the two sister
chromatids and defines the centre of the inter-kinetochore axis (Figure 1.6). The
centromere promotes the assembly of the kinetochore which is the attachment
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Figure 1.6: Schematic of the chromosome centromere and
kinetochore
During mitosis the two sister chromatids are held together by rings of cohesion. At the centre of
the chromatids is the centromere (purple), which is enriched with the protein CENP-A bound to
H3. CENP-A recruits the constitutive centromere-associated network (CCAN) proteins which
make up the inner kinetochore (green). Attached to the CCAN is the KMN protein complex
which makes up the outer kinetochore (green) which attachments to the microtububles from the
spindle poles to facilitate separation of the sister chromatids.
point for microtubules attached to the spindle poles [Tanaka et al., 2002a]. The
centromere is enriched with the histone H3 variant centromere protein A (CENP-
A). This local enrichment of CENP-A recruits the kinetochore proteins during
the cell cycle. This area is called the constitutive centromere-associated network
(CCAN) and together these proteins form the "inner kinetochore" [Perpelescu
and Fukagawa, 2011]. Further recruitment of another protein complex, the KMN
(composed of Knl1, Mis12 complex, NDC80 complex) complex and the proteins
BUB1 and MPS1, form the "outer kinetochore" which will interact directly with
the microtubules [Cheeseman and Desai, 2008].
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1.6.5.2 Cell cycle checkpoints
Throughout the cell division process the cell must monitor the replication to en-
sure faithful development of the two daughter cells. Cell cycle checkpoints are not
always checking for problems or monitoring for aberrations, rather they are consti-
tutively active and a block in the cell cycle occurs not because it was activated but
because the checkpoint was not satisfied (i.e. inactivated). Cell cycle checkpoints
control the key cell cycle transitions including, G1/S, G2/M and metaphase to
anaphase (G/A) [Rieder, 2011]. Cell cycle checkpoints and are controlled by the
Cyclin-dependent kinases (Cdks) at specific points. For cell cycle to progress it re-
quires the right amount of Cdk proteins to be activated or inactivated at different
times in a very rigid program. The disruption to these kinases at the checkpoints
can stall cell cycle progression and prevent segregation defects and if necessary
induce apoptosis to prevent abnormal cells [Morgan, 2007].
1.6.5.3 Spindle assembly checkpoint (SAC)
The mitotic checkpoint or spindle assembly checkpoint (SAC) is regulatory control
system to ensure proper chromosomes alignment during anaphase before chromo-
some segregation. The SAC complex is composed of Mad1, Mad2, Mad3, Bub1,
Bud3 and Mps1 which monitors microtubule attachments to the kinetochores.
In the presence of unattached or aberrant microtubule attachments the SAC sup-
presses the anaphase-promoting complex/cyclosome (APC/C) prevent progression
into anaphase and through the cell cycle. Upon correct attachment and detection
of tension the SAC is switched off, the APC pathway is activated, and progression
through mitosis can continue (reviewed in [Musacchio, 2015]).
1.6.5.4 Anaphase promoting complex/cyclosome (APC/C)
The anaphase promoting complex/cyclosome (APC/C) is a ubiquitin E3 ligase
complex that is necessary for cell to progress through the cell cycle in anaphase
(reviewed in [Peters, 2006]). Upon activation by Cdc20, the APC/C tags proteins
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for destruction by assembling polyubiquitin chains on its substrates which will be
degraded by the 26S proteasome. The main function of the APC/C is to degrade
Cyclin B and Securin which activates Separase. Separase is what dissolves the
cohesin rings holding the sister chromatids together [Nasmyth et al., 2000]. The
APC/C through its degradation capacity also inactivates many of the catalytic
proteins necessary in metaphase for production of the mitotic machinery such as
the Aurora Kinase proteins and the cyclin-dependent kinases (Cdks) (reviewed in
[Watson et al., 2019]).
1.7 Aurora kinases
Aurora kinase protein was first identified in Drosophila (by the same name) and
in yeast (Ipl1 kinase) [Francisco and Chan, 1994, Glover et al., 1995]. Based
on these amino acid sequences, two human proteins AURORA1 and AURORA2
were identified in 1998 [Bischoff et al., 1998, Gopalan et al., 1997, Kimura et al.,
1999, Kimura et al., 1997, Kimura et al., 1998, Terada et al., 1998]. To date three
aurora kinase proteins have been identified in mammals, referred to as Aurka,
Aurkb, and Aurkc. They are all expressed during the cell cycle, peaking during
the G2/M transition, suggestive of a role in cell cycle regulation [Bischoff et al.,
1998, Kimura et al., 1998, Terada et al., 1998]. Although they share a high level
of homology the three kinases have different roles and localisations during cell
division.
The Aurora kinases are a group of highly conserved serine/threonine kinases. The
human AURKA shares an 82% sequence identity with the rodent protein [Golden-
son and Crispino, 2015]. Aurkb is composed of 344 amino acids while Aurka and
Aurkc have 403 and 309 amino acids respectively. Each protein has a C-terminal
domain, containing the destruction box (D-box), a kinase domain and a N-terminal
domain, which determines the localisation of each Aurora kinase [Goldenson and
Crispino, 2015]. All three of the Aurora kinases have a high sequence identity of
67-76% homology in their catalytic domain [Bischoff et al., 1998, Kimura et al.,
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1998, Terada et al., 1998]. Aurkb and Aurkc are the most similar, a major dif-
ference being that Aurkc lacks the KEN motif found in Aurkb. Although their
catalytic domains are highly similar, the N-terminal domains are different and
convey unique localisation and protein-protein interactions abilities to each kinase.
Aurka localises to the centrosomes of cells in interphase as well as to the spindle
poles during metaphase [Bischoff et al., 1998, Kimura et al., 1997, Gopalan et al.,
1997]. Aurkb is found at the kinetochores and centromeres during prophase to
metaphase, it then localises to the midbody of cells in anaphase and finally to the
post-mitotic bridge of cells in telophase [Bischoff et al., 1998, Terada et al., 1998].
Aurkc, which is only found during oocyte development and spermatogenesis, is
localised to the centrosomes of anaphase cells [Kimura et al., 1998]. Interestingly,
in vitro experiments in human cell lines have been performed to show that a sin-
gle amino acid change at G198N in the Aurka N-domain can cause co-localisation
with Aurkb [Fu et al., 2009, Hans et al., 2009]. Overall, although there is a high
sequence identity and their catalytic regions perform the same function, the local-
isation to different regions during the cell cycle conveys important differences that
make each of the Aurora kinases indispensable for certain aspects of cell division.
Regulation of expression and activity of the Aurora kinases happens at multi-
ple levels. Transcriptionally, the aurora kinases are not expressed in adult tis-
sues and lowly proliferating cells. However, in highly proliferative cells such as
the hematopoietic cells, germ cells, and the developing embryo, Aurora kinase
expression is high. The Aurora kinases are transcribed due to the cell cycle-
dependent element (CDE) and cell cycle gene homology region (CHR) in their
promoters. Binding to these sequences by G2/M regulators such as Cyclin A and
Cdk1 induce transcription at the beginning of the G2/M transition [Tanaka et al.,
2002a, Willems et al., 2018]. Aurka appears first, localised to the centrosomes,
followed shortly by Aurkb at the centromeres [Bischoff et al., 1998, Kimura et al.,
1997]. Regulation of the kinase activity of the auroras is through the T-loop, a
key threonine that must be phosphorylated to activate kinase activity. This occurs
through autophosphorylation of residue T232 in Aurkb, T288 in Aurka, and T195




Similarly, the degradation of the Aurora kinases is also highly regulated. Within
the C-terminus domain, the kinases contain a D-box. This region is recognised by
the anaphase promoting complex/cyclosome (APC/C) which is an E3-ubliquitin
ligase that mediates proteasomal degradation. Ubiquitylation by this complex in
association with cdc20 homolog 1 (Cdh1), tags the kinases for degradation at the
end of mitosis [Walter et al., 2000, Taguchi et al., 2002, Nguyen et al., 2005, Crane
et al., 2004, Littlepage and Ruderman, 2002, Stewart and Fang, 2005]. Although
both Aurka and Aurkb are substrates of APC/C-Cdh1, Aurka is ubiquitinated
more efficiently than Aurkb. Aurka contains an additional phosphorylation site at
the N-terminus, called the NH2-terminal A-box, or the D-box activation domain,
that is not found in Aurkb. It has been suggested that this higher affinity of
Aurka for the APC/C-Cdh1 pathway is to ensure its degradation before Aurkb,
as Aurka is expressed before Aurkb and utilised earlier in mitosis, whereas Aurkb
is necessary for the end of mitosis and cytokinesis [Stewart and Fang, 2005].
1.7.1 Functions of the Aurora kinases
All three Aurora kinase proteins are involved in the cell cycle but have different
functionality. Aurka is involved at the spindle poles and regulates the maturation
of the centrosome. Aurkb is a member of the chromosome passenger complex
(CPC) and regulates correct kinetochore attachments. It also has a role in cy-
tokinesis and condensation of the chromosomes. Aurkc has overlapping functions
with Aurkb but is only active in the germ cells and in the preimplantation embryo
[Willems et al., 2018]. A very brief overview will be given on the function and
roles of Aurka and Aurkc as they are not the main focus of this thesis.
1.7.2 Aurora kinase a
Aurka is first expressed during metaphase when it localises to the centrosome and
spindle poles where it regulates maturation of both. Its localisation is dependent
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upon the microtubule-associated protein TPX2 and the bora aurora kinase A acti-
vator (BORA). Loss of either of these proteins in mice disrupts Aurka localisation
to the spindle poles, resulting in abnormal spindle morphologies and misaligned
chromosomes [Carmena and Earnshaw, 2003, Yao et al., 2004, Saskova et al.,
2008, Eyers et al., 2003, Eyers and Maller, 2004, Tsai and Zheng, 2005, Aguirre-
Portolés et al., 2012].
1.7.2.1 Loss-of function of Aurka
Disruption of Aurka results in many defects in the mitotic process including, cell
cycle progression, spindle pole organisation, chromosome segregation, centrosome
maturation and microtubule stability [Schumacher et al., 1998, Portier et al., 2007,
Hachet et al., 2007, Marumoto et al., 2002, Liu and Ruderman, 2006, Peset et al.,
2005, Macůrek et al., 2008, Hirota et al., 2003, Wysong et al., 2009]. Knockout
of Aurka in cell lines, however, does not lead to cell cycle arrest only a delay in
exiting mitosis. Aurka knockout cells display spindle and chromosome alignment
defects and cells exited mitosis with 4N DNA content. These 4N cells died during
interphase or were arrested, at the G1 to S checkpoint when they tried to enter
cell division [Marumoto et al., 2003, Hégarat et al., 2011]. Interestingly loss of
both Trp53 and Aurka eludes the G1 to S checkpoint and double knockout cells
can enter into another round of cell division [Hégarat et al., 2011]. This is of
particular importance as Aurka has been implicated in many cancers although
usually expression is upregulated. This points to an interesting dynamic between
Aurka and the tumour suppressor Trp53 (reviewed in [Tang et al., 2017]).
Germline deletion of Aurka in mice, results in pre-implantation lethality due to
loss of mitotic spindle assembly [Lu et al., 2008, Cowley et al., 2009, Yoon et al.,
2012]. However, mice heterozygous for Aurka spontaneously developed tumours
in various organs including: thymus, liver, lymph nodes and lung. Due to the
common observation that Aurka is overexpressed in many cancers, Lu et al. sug-
gested that a balance of Aurka is necessary for maintain genome stability. An
abundance of Aurka could cause chromosomal segregation defects due to aberrant
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mitosis while insufficient Aurka could also lead to chromosomal segregation defects
due to mitotic delay. Overall concluding that Aurka could be a haploinsufficient
tumour suppressor [Lu et al., 2008].
Conditional deletion of Aurka at different post-implantation stages impacts embry-
onic development differently depending on which germ layer was affected. Deletion
of Aurka in the epiblast led to embryos with a disorganised anteroposterior axis
that died during gastrulation. Interestingly when Aurka was deleted in the vis-
ceral endoderm, an extra-embryonic component, a lack of elongation along the
anteroposterior axis was observed and death at E6.5. Yoon et al. concluded that
deletion of Aurka in different tissues post-implantation can have different impacts
on embryo development, but at a cellular level Aurka plays the same role pre and
post implantation [Yoon et al., 2012].
1.7.2.2 Aurka and disease
Polymorphisms in the Aurka gene locus are associated with an increased risk
for many cancers including: breast, ovarian, oesophageal and non-small-cell lung
cancers [Gu et al., 2007, Sakakura et al., 2001, Zhou et al., 1998]. The mecha-
nism of action by which Aurka overexpression participates in cancer initiation and
progression is still controversial. Some studies to suggest that activating muta-
tions in Aurka alone can lead to the formation of tumours in nude mice [Bischoff
et al., 1998, Littlepage and Ruderman, 2002]. However, it is more likely that
Aurka participates in cancer initiation and progression through phosphorylation
of oncogenic substrates. For example, it has been demonstrated that Aurka can
phosphorylate the tumour suppressor, RAS-association domain family 1, isoform
A (RASSF1A). RASSF1A stabilises microtubules and can induce cell cycle arrest
in a mitosis checkpoint manner. Phosphorylation of RASSF1A prevents it from
arresting cells and can lead to uncontrolled proliferation, a hallmark of cancer
[Rong et al., 2007]. Furthermore, Aurka has been implicated in cell survival in
cancer cells. In human acute myeloid leukaemia (AML), Aurka was found to be
overexpressed and targeting the cancerous cells in vitro with an Aurkb inhibitor
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led to an increase in Bax/Bcl2 expression and subsequent apoptotic death in cell
lines that overexpressed Aurka [Huang et al., 2008, Yang et al., 2013]. Similar
studies have implicated Aurka overexpression in cancer cell lines and the phos-
phorylation of proapoptotic signals such as Bim [Moustafa-Kamal et al., 2013],
PUMA [Sun et al., 2014], BAX and NOXA [Dar et al., 2008]. Thus far, there have
been no studies implicating loss of Aurka in human cancers.
1.7.3 Aurora kinase c
In humans and mice, Aurkc expression is restricted to the sperm and pre-implantation
embryo [Bernard et al., 1998, Tseng et al., 1998, Kimura et al., 1999]. Although
there have been some reports that Aurkc is detected in other adult tissues, Au-
rkc expression is low and it is generally accepted that it functions exclusively in
the germ cells [Yan et al., 2005, Tang et al., 2017]. Within the germ cells, Au-
rkc localises to similar positions as Aurkb in somatic cells and is reported to have
overlapping functions with Aurkb. Aurkc can bind to member of the chromosomal
passenger complex (CPC) and act as the catalytic domain in a similar fashion to
Aurkb. Aurkc preferentially binds to members of the CPC in germ cells, but to
Aurkb in somatic cells [Assou et al., 2006]. However, inhibition of Aurkc in mouse
oocytes in vitro does not affect the localisation of CPC, indicating that Aurkb
can compensate for such Aurkc inhibition [Balboula and Schindler, 2014]. Aurkc
can also phosphorylate serine 10 on Histone 3 in germ cells, an important mark
for chromosomal condensation during mitosis [Avo Santos et al., 2011]. Aurkc
additionally phosphorylates Centromere protein A, in the mouse oocyte, which is
required for cell cycle progression [Sasai et al., 2004]. Due to their overlapping
functions, there is evidence that upon depletion or knockdown of Aurkb in so-
matic cell lines, overexpression of Aurkc can rescue the phenotype in vitro [Sasai
et al., 2004, Yan et al., 2005]. Interestingly, mice that are null for Aurkc are viable
however male Aurkc−/− mice display defects in cytokinesis and develop polyploid
cells in spermatogenesis and only around 40% of adult males produced offspring
[Kimmins et al., 2007]. Inactivating mutations in AURKC in humans results in
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infertility however affected individuals do not appear to have any other phenotype,
supporting the notion that Aurkc is not involved in somatic cells [Dieterich et al.,
2007].
1.7.3.1 Aurkc and disease
Similar to Aurka, Aurkc overexpression is found in many cancer cell lines
[Zekri et al., 2012]. Additionally, overexpression in the 3T3 cell line can induce
transformation [Khan et al., 2011]. Tsou et al. observed that overexpression of
Aurkc leads to abnormal cell division resulting in multinucleation and increased
proliferation and migratory activity of cultured HeLa cells. High levels of Aurkc
have also been detected in epithelial cells in human cervical cancer samples [Tsou
et al., 2011]. It is likely that overexpression of Aurkc plays a similar role as Au-
rka and Aurkb in cancer progression, however more research is needed to further
elucidate Aurkc role [Quartuccio and Schindler, 2015].
1.8 Aurora kinase b
Aurora kinase b is an important protein involved in many different processes
throughout mitosis. Of all the Aurora kinases, Aurkb has the most functions, par-
ticipating in necessary mitotic mechanisms from the onset of prophase until mitotic
exit and cytokinesis. A schematic of Aurkb’s localisation throughout mitosis can
be seen in Figure 1.7. Aurkb functions in somatic cells, and its role during meiosis
in germ cells is less defined due to the difficulty of dissecting out the overlapping
functions of Aurkc. However, Aurkb is likely to play a role in meiosis as only
overexpression of Aurkb and not Aurka or Aurkc can rescue chromosomal align-
ment defects caused by the Aurkb/c small molecular inhibitor ZM447439 in mouse
oocytes [Shuda et al., 2009]. Within somatic cells, Aurkb functions primarily as
part of the chromosomal passenger complex (CPC). Aurkb is the key catalytic com-
ponent of the CPC which is involved in: chromosomal condensation; cohesin re-
moval from chromosome arms during prophase; detection of erroneous kinetochore
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Figure 1.7: Localisation of Aurkb during mitosis
Aurkb is important at all stages of mitosis and its localisation can be seen in yellow. Aurkb is
recruited to the chromosomes at prophase, at prometaphase and metaphase Aurkb is localised to
the centromeres. During anaphase and telophase Aurkb relocates to the spindle midbody where
it assists in the formation of the contractile ring for separation of the daughter cells during
cytokinesis.
to microtubule (K-MT) attachments; regulation of mitotic checkpoint; shortening
of segregated chromosomes; and cytokinesis [Carmena, 2012, Steigemann et al.,
2009, Kelly and Funabiki, 2009, Guse et al., 2005, Nezi and Musacchio, 2009]
[Johansen and Johansen, 2006, Santaguida et al., 2011]. As the cell enters mitosis,
the C-terminal domain regulates localisation, targeting Aurkb to the centromeres
at prophase where it forms a complex with INCENP, Borealin and Survivin to
form the CPC [Hindriksen et al., 2017].
1.8.1 Chromosomal passenger complex (CPC)
CPC subunits are observed along the chromosome arms in late S-phase, but quickly
localise to the centromeres where they bind to form the CPC. The CPC is specif-
ically found at the inner centromere, where it has a very short lifespan with
the components turning over at a rate of less than a minute [Beardmore et al.,
2004, Murata-Hori and Wang, 2002, Ahonen et al., 2009]. The CPC contains
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Figure 1.8: Schematic of the chromosomal passenger complex
The chromosomal passenger complex (CPC) is found at the centromeres during mitosis and is
reponsible for a number of functions to ensure correct division of the cell. The CPC is composed
of the scaffolding protein INCENP, the localisation proteins Borealin and Survivin and the
catalytic unit, Aurkb.
the scaffold protein inner centromere protein (INCENP), to which all the other
complex proteins are bound (Figure 1.8). Aurkb is the catalytic component of
the complex. Aurkb phosphorylates INCENP which triggers the autophosphory-
lation of Aurkb at Thr232 and stimulates the Aurkb kinase activity [Bishop and
Schumacher, 2002]. The proteins Borealin and Survivin also bind to INCENP
and are required for the localisation of the CPC to the centromeres [Vader et al.,
2008, Jeyaprakash et al., 2011, Wu et al., 2015, Gassmann et al., 2004, Goldenson
et al., 2015].
Crucial for the localisation of the CPC to the centromere is the histone kinase
Haspin. Haspin phosphorylates histone H3 on threonine 3 (H3T3ph) at the cen-
tromeres. This mark is then recognised by Survivin, which binds the CPC directly
to the histone mark. The critical role of Haspin in localisation of the CPC is shown
by the effect of Haspin depletion or inhibition, where the CPC is dispersed over the
chromosome arms rather than localised to the centromere [Kelly et al., 2010, Wang
et al., 2010, Wang et al., 2012, Yamagishi et al., 2010, De Antoni et al., 2012].
Haspin itself is regulated by Cdk1, which phosphorylates Haspin and induces it’s
H3T3 phosphorylation activity. At the same time, the mitotic checkpoint ser-
ine threonine kinase (BUB1) phosphorylates histone 2A at Thr120 (H2AT120ph)
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which also co-localises with the CPC between the two sister chromatids at the
centromere [Wang et al., 2011, Tsukahara et al., 2010, Kawashima et al., 2010]
[Yamagishi et al., 2010]. The H2AT120ph mark then recruits the Shugoshin pro-
teins, Sgo1 and Sgo2, which localise to the centromere. The Sgo proteins bind with
Borealin, which first must be phosphorylated by Cdk1 to promote Sgo-Borealin
binding [Tsukahara et al., 2010, Ghenoiu et al., 2013]. Inhibition of Sgo1, Sgo2
or Bub1 all lead to a loss of CPC localisation at the centromere and subsequent
kinetochore attachment defects [Huang et al., 2007, Yamagishi et al., 2010, baron
et al., 2016]. Interestingly, Wang et al. observed that Aurkb phosphorylates
Haspin prior to Haspin phosphorylating H3T3, adding another layer of feedback
control of the localisation of the CPC to the centromeres. Wang et al. suggested
that phosphorylation of Haspin by Aurkb triggers the H3T3ph mark which induces
localisation of the CPC to H3T3ph. At the same time, Bub1 phosphorylation of
H2AT120ph recruits Sho1 and Sgo2 which in turn adds additional centromere lo-
calisation signals, boosting the CPC-Haspin-H3T3ph feedback loop [Wang et al.,
2011].
Removal of the H3T3 phosphorylation mark is performed by PP1 which is recruited
by the scaffolding protein, Repo-man. During pro-metaphase, the H3T3ph mark
is prevented from spreading out over the chromosome arms by PP1/Repo-Man
which restricts the mark to the centromeres to ensure the CPC monitors K-MT
interactions and regulates the SAC [Trinkle-Mulcahy et al., 2006, Qian et al., 2011].
At the centromere, Aurkb phosphorylates and inactivates Repo-Man preventing
it from dephosphorylating H3T3 [Qian et al., 2013]. This is also controlled by
Cdk1 which also phosphorylates Repo-Man preventing association with PP1 and
dephosphorylation of H3T3. When the cell enters anaphase, Cdk1 is inhibited and
subsequently releases Repo-Man to interact with PP1. The CPC during anaphase
is released from the centromeres through ubiquitination and therefore degradation
of Aurkb and relocates to the spindle midzone, preventing further phosphorylation
of Repo-Man. Repo-Man interacts with PP1 and removes the H3T3ph mark from
the centromeres [Maerki et al., 2009, Qian et al., 2015].
As the sister chromatids separate in anaphase, the CPC disassociates with the
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centromeres. As the chromatids head towards the opposite spindle poles, the
CPC is left at the spindle midzone. The CPC is also transferred to the equatorial
cortex and to the forming contractile ring [Cooke et al., 1987]. These relocations
are important for orchestrating mitotic exit. Movement of the CPC away from the
chromosomes, facilitates new roles for Aurkb while also preventing Aurkb activity
where it is no longer needed.
Localisation of the CPC to the midzone is controlled by interaction with MKLP2,
the mitotic motor kinesin [Gruneberg et al., 2004]. Kinesin proteins use ATP
to actively move along microtubules and perform mitotic spindle and microtubule
changes to facilitate correct cell division. MKLP2 is necessary for CPC localisation
as well as cleavage furrow ingression through interaction with myosin II [Atherton
et al., 2017]. Prior to anaphase, MKLP2 is phosphorylated by Cdk1, preventing
MKLP2 from prematurely binding and stabilising microtubules before chromatid
separation [Kitagawa et al., 2014]. When Cdk1 is downregulated at the metaphase
to anaphase transition, MKLP2 is released and binds to INCENP. Interestingly,
inhibition of Aurkb traps MKLP2 with the CPC on the chromosomes rather than
localising to the spindle midbody. This suggests that Aurkb could be necessary to
activate the motor activity of MKLP2 or facilitate in removing MLKP2 from the
chromosomes during anaphase [Kitagawa et al., 2013].
1.8.1.1 Function of the CPC in early mitosis
Correct cell division requires an exact copy of the genome to be replicated from
parent to daughter cells. This requires the sister chromatids to be separated
equally and for the duplicated sets of genetic material to be packaged correctly
into two cells. Necessary for faithful separation of the two sister chromatids is the
correct alignment along the mitotic spindle which is coordinated by microtubule
attachment of the chromosomal centromere kinetochores to either end of the spin-
dle pole. The major regulator of this bi-orientation is the CPC through K-MT
regulation and SAC control.
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1.8.1.2 Regulation of kinetochore-microtubule attachments
The KMN complex is what attaches the microtubules to the kinetochore on the
chromosomes (Figure 1.9) [Cheeseman et al., 2006, DeLuca et al., 2006]. Many of
the proteins involved in the KMN complex are substrates of Aurkb, which low-
ers the binding affinity of the KMN complex to the microtubules. By creating a
dynamic K-MT interface, microtubules can continuously bind to and release the
kinetochores until the correct attachments are established [Lampson and Cheese-
man, 2011, Thompson et al., 2010]. This process prevents syntelic attachments,
sister chromatids bound to the same spindle pole, and merotelic attachments, one
of the sister chromatids has two connections from each pole (Figure 1.10). Inhibi-
tion of Aurkb leads to incorrect K-MT attachments while overexpression of Aurkb
leads to continual disruption of K-MT attachment and subsequent reactivation of
Aurkb [Tanaka et al., 2002b, Hauf et al., 2003, Ditchfield et al., 2003, Kallio et al.,
2002, Munoz-Barrera and Monje-Casas, 2014, Lampson et al., 2004, Knowlton
et al., 2006, Cimini et al., 2006]. Through this process, often called the "error
correction", the mitotic checkpoint is activated and the cell is prevented from en-
tering anaphase until all the kinetochores are stably connected to a microtubule
[Krenn and Musacchio, 2015].
The mechanism by which the dynamic nature of K-MT occurs and stabilisation
is achieved is still largely speculative. It is suggested that the error correction
detects tension or lack of tension when the microtubules are not attached cor-
rectly. Tension is created when microtubules attached to the spindle poles bind
to the kinetochore. The sister chromatids are held together by cohesin while
the inner kinetochore proteins CENP-T, CENP-B,H/I/K/M and CENP-C hold
to the centromere protein CENP-A [Nicklas and Koch, 1969, AULT and Nicklas,
1989, Suzuki et al., 2014, Musacchio and Desai, 2017]. In vitro this tension can
stabilise the K-MT attachments [Akiyoshi et al., 2010].
Tension increases the distance between the sister kinetochores due to the micro-
tubules pulling the kinetochores to the spindle poles and away from the inner
centromere where Aurkb is found. This distance of kinetochore from Aurkb is
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Figure 1.9: Schematic of the the KMN complex
The KMN complex is composed of the proteins, Knl1, Mis12 and Ndc80. This complex attaches
the kinetochore to the microtububle. Aurkb interacts with all of the KMN complex members
lower the binding affinity of the KMN to the microtububles, allowing repeated binding and
unbinding of the microtubule to the KMN until the correct attachments are made.
suggested to increase the stability of the K-MT attachment, because when the mi-
crotubule is attached in a bi-oriented way it is pulled further from Aurkb whereas
an erroneous attachment is still within reach of the inner centromere and Aurkb
due to a lack of tension. This model is called the "spatial separation" model
[Tanaka et al., 2002b, Andrews et al., 2004, Liu et al., 2009]. Experiments have
shown that when a fluorescence resonance energy transfer (FRET) sensor is at-
tached to CENP-B, a member of the inner kinetochore, the sensor is continuously
phosphorylated by Aurkb. However, when the FRET sensor is attached to a
member of the outer kinetochore Aurkb is able to phosphorylate the sensor until
the chromosomes are under tension at which time the sensor becomes increas-
ingly de-phosphorylated. Furthermore, artificial positioning of Aurkb to the outer
kinetochore prevented microtubule stabilisation and activated the SAC, indicating
that the physical distance from Aurkb caused by tension leads to the stabilisation
and progression through the cell cycle [Liu et al., 2009]. Additionally, it has been
observed that substrates of Aurkb at the centromere, such as Hec1 become dephos-
phorylated when tension is applied across the kinetochores and hyper-stretching
caused by knockout of CENP-T or CENP-C leads to an even greater loss of Hec1
phosphorylation by Aurkb [Welburn et al., 2010, DeLuca et al., 2011, Suzuki et al.,
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Figure 1.10: Schematic of the microtubule attachments to the
kinetochore
Correct sister chromatid separation requires a microtubule from the spindle poles to be attached
to the kinetochore on each side of the chromosome, this normal attachment is called amphitelic at-
tachment (green). There are several incorrect attachments that will prevent progression through
the cell cycle until amphitelic attachments are made, including: monotelic when only one micro-
tububle is attached, syntelic attachments when kinetochores are attached to the same spindle




2014]. INCENP may also play a role in the spatial separation model as it contains
a "stretchy" single alpha helix. This single alpha helix may act as a "dog-leash",
tethering Aurkb to the inner centromere but with enough of a "leash" to allow Au-
rkb to phosphorylate outer kinetochore substrates until tension puts the substrates
out of "leash" length for Aurkb [Santaguida and Musacchio, 2009, Samejima et al.,
2015].
1.8.1.3 CPC regulation of spindle assembly checkpoint and the
mitotic checkpoint complex
The SAC prevents separation of the sister chromatids and entry into anaphase
until all the kinetochores are attached and the chromosomes are aligned [Carmena,
2012]. Incorrectly attached or destabilised microtubules are detected by the SAC
pathway which triggers a signalling cascade that diffuses out from the kinetochores
[Rieder et al., 1995]. These signals trigger the formation of the mitotic checkpoint
complex (MCC) which in turn inhibit the anaphase-promoting complex (APC/C),
preventing the cell from leaving metaphase and entering anaphase.
Microtubules bind to the outer kinetochore KMN network. In the presence of
unattached microtubules this exposes the KMN to the primary activator of the
SAC, Mps1. Mps1 is a kinase, recruited by NDC80, that phosphorylates KNL1
which starts the SAC signalling cascade, recruiting SAC proteins to unattached
kinetochores. When the microtubules are attached, MPS1 is displaced and the
SAC is inactivated [Hiruma et al., 2015, Ji et al., 2015, Dou et al., 2015, Kemmler
et al., 2009]. MPS1 phosphorylation of KNL1 recruits the Bub3-Bub1 complex
which simultaneously recruits the Mad1-Mad2 complex and BubR1. BubR1 in
turn recruits Cdc20 in a signalling cascade that ensures all components of the
MCC are localised to the unattached kinetochore [Jia et al., 2016, Di Fiore et al.,
2015, London and Biggins, 2014]. Once all proteins have been recruited the MCC
is composed of the proteins: Mad2, Bub3, BubR1 and Cdc20. This inhibits the
APC/C progression from metaphase to anaphase by sequestering the APC/C pro-
tein Cdc20. The MCC then binds to the APC/C and inhibits its activity [Izawa
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and Pines, 2015]. Furthermore, upon APC/C inactivation, the APC/C tags Cdc20
for degradation [Nilsson et al., 2008].
The role of Aurkb in the SAC is less defined due to the complexity of teasing out
Aurkb error correction involvement from SAC signalling. Nocodozole is a chemical
which prevents the formation of microtubules. It is often used to synchronize cells
as it causes cells to arrest in G2-M due to an inability to form the mitotic spindle.
Many studies have observed that Aurkb inhibition is insufficient to completely res-
cue nocodazole-induced mitotic delay, although the delays are significantly shorter
[Yang et al., 2009, Ditchfield et al., 2003, Hauf et al., 2005]. Saurin et al. found
that Aurkb enhances MPS1 recruitment to the kinetochores in early mitosis to en-
sure the metaphase-anaphase checkpoint is secure, but after the initial activation,
signalling from the unattached kinetochore protein NDC80, is sufficient to recruit
Mps1. Therefore, despite Aurkb inhibition the SAC is still active, preventing cells
from entering anaphase [Saurin et al., 2011]. In another study by Santaguida et
al., they observed that Aurkb and Mps1 strongly synergise at the checkpoint. By
inhibiting Aurkb or Mps1 they saw a defect in SAC signalling and suggested that
previous studies did not achieve complete Aurkb inhibition [Santaguida et al.,
2011]. Additionally, Nijenhuis et al. found that it is through phosphorylation of
HEC1 by Aurkb that recruits MPS1 to the kinetochores. Examining the structure
of MPS1 they observed a TPR localisation domain which switches between an
active (binds to the kinetochores) and inactive confirmation. When Aurkb is in-
hibited MPS1 only weakly localises to the kinetochores. They found HEC1, which
is phosphorylated by Aurkb, binds to MPS1 which activates MPS1 and localises
it to the kinetochores [Nijenhuis et al., 2013].
In summary Aurkb is an important regulator of early mitotic events. Aurkb plays
a role in the Error Correction pathway, ensuring that kinetochores are correctly
attached to the spindle poles for the correct separation of the sister chromatids.
Aurkb has also been implicated in the spindle assembly checkpoint, although its
function is less defined. Aurkb is necessary for the recruitment of important SAC
regulators and inhibition of the APC/C.
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1.8.2 Aurkb in regulation of condensin and cohesin
1.8.2.1 Condensin
As briefly mentioned in section 1.7 condensation of the chromosomes requires the
condensin complexes, condensin I and condensin II, which utilises the proteins
SMC2 and SMC4 as well as non-SMC subunits, to organise the chromosomes into
tight organised structures at the beginning of cell division [Nasmyth and Haering,
2005]. Condensin II is nuclear during interphase and contributes to the assembly of
the chromosomes in prophase. Condensin I only gains access to the chromosomes
after the nuclear envelope breaks down in prometaphase, where it stabilises the
chromosomes and facilitates release of cohesin [Ono et al., 2004].
Aurkb is known to play a role in condensin localisation [Ono et al., 2004, Lipp et al.,
2007, Nakazawa et al., 2011, Tada et al., 2011, Collette et al., 2011]. Work by Ono
et al. showed that upon depletion of Aurkb in HeLa cells, condensin localisation to
the centromere was disrupted but not to the chromosome arms [Ono et al., 2004].
Aurkb phosphorylates subunits of condensin I but not condensin II and without
Aurkb condensin I cannot load onto the chromosomes resulting in segregation
defects [Lipp et al., 2007, Nakazawa et al., 2011, Collette et al., 2011, Tada et al.,
2011]. Poonperm et al. also found the kinase KIF4 is necessary for establishing the
chromosome scaffolding with condensin I but not condensin II. Phosphorylation
of KIF4 by Aurkb is required for KIF4 to interact with condensin I [Poonperm
et al., 2017].
Additionally, compaction of the chromosomes is not maximal until late anaphase,
although it is necessary to ensure faithful segregation [Mora-Bermudez et al.,
2007, Neurohr et al., 2011]. Mora-Bermudez et al, proposed that localisation
of Aurkb to the central spindle is necessary to facilitate this compaction. They
found that inhibition of Aurkb led to failure to compact chromosomes at anaphase
in mouse kidney cells. However, the mechanism of Aurkb involvement in anaphase




Cohesin is a ring-shaped complex composed of SMC1, SMC3 and RAD21, which
holds the sister chromatids together during prophase. Cohesin interacts with
WapL-Pds5 which induces the ring to open, cohesin is loaded onto the chro-
matin and then acetylation of the SMC subunits recruits Sororin which displaces
WapL-Pds5 and "closes" the ring around the two sister chromatids [Gandhi et al.,
2006, Rankin et al., 2005, Nishiyama et al., 2010]. Cohesin at the centromeres is
vital to the stabilisation during kinetochore attachment, and this tension between
the cohesin-centromere and the spindle poles is necessary for correct separation
[Kitajima et al., 2005, McGuinness et al., 2005]. At the chromosome arms, phos-
phorylation of Sororin by Aurkb releases the protein from cohesin and the sister
chromatid arms are released [Liu et al., 2013a, McGuinness et al., 2005, Bor-
ton et al., 2016]. Cohesin at the centromeres is regulated by the shugoshin pro-
teins (Sgo) 1 and 2 until metaphase. Sgo1 interacts with serine-threonine protein
phosphatase 2A (PP2A) to prevent centromeric cohesin phosphorylation and pre-
mature disassociation [Salic et al., 2004, Kitajima et al., 2005, Kitajima et al.,
2006, McGuinness et al., 2005, Watanabe and Kitajima, 2005]. Binding of Sgo1
to PP2A counteracts Aurkb phosphorylation of Sgo1 and displaces the CPC. This
mechanism regulates the K-MT attachment stability by balancing Aurkb activity
[Meppelink et al., 2015]. Less is known about the role of Sgo2, but it is thought to
act redundantly with Sgo1. Interestingly Tanno et al., found that phosphorylation
of Sgo2 by Aurkb is necessary for the recruitment of PP2A to prevent cohesin
degradation at the centromere. However, phosphorylation of Sgo1 by Aurkb is
not observed [Tanno et al., 2010].
As the cell enters anaphase, the cell prepares to separate the centromere and
cohesin must be dissolved [Hauf et al., 2005]. The protease separase is one of the
key proteins involved in dissolving cohesin at the centromere and ensuring correct
separation of the sister chromatids. Recruitment of separase to the centromere is
regulated by Aurkb. Loss of Aurkb by RNAi or by small molecular inhibition leads
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to a decrease in separase at the mitotic chromosomes and as mentioned before a
failure of the chromosomes to segregate [Yuan et al., 2009].
1.8.3 Phosphorylation of histones by Aurkb
Aurkb is responsible for phosphorylation of serine 10 and serine 28 on histone 3
(H3S10ph and H3S28ph) during the cell cycle [Goto et al., 1999, Goto et al., 2002].
The H3S10ph mark is most commonly associated with chromosome compaction
during mitosis although it does have roles outside of cell division, however, regu-
lation of H3S10ph outside of the cell cycle is not regulated by Aurkb [Zippo et al.,
2009, Sawicka and Seiser, 2012]. After replication of the DNA during S-phase the
chromosomes must be condensed before being separated into the two daughter
cells. This compaction happens during the interphase to M phase. Phosphoryla-
tion of H3S10 by Aurkb starts in early G2/M, at the centromeric region of the
chromosome and spreads out along the arms of the chromosomes, laying down the
mark over all the chromosomes by metaphase [Crosio et al., 2002]. The adjacent
position, lysine 9 on histone 3 (H3K9), is well studied and has many important post
translation modifications outside of the cell cycle and can be acetylated and mono,
di and tri-methylated. It has been found that during the cell cycle however, upon
phosphorylation of H3S10 by Aurkb, no other H3K9 modifications are identified
with the exception of H3K9me3. Interestingly, HP1 which binds to H3K9me3 is no
longer able to access this mark due to the phosphorylation of S10. This displace-
ment of HP1 prevents it from performing its role in regulating gene expression as
well as chromatin packaging and the formation of heterochromatin which are not
necessary during the cell cycle [Fischle et al., 2005, Jeong et al., 2010, Hirota et al.,
2005]. When cells exit the cell cycle and H3S10 is dephosphorylated, H3K9me3
is re-established and HP1 can return to its role in heterochromatin organisation.
Interestingly, the shield that H3S10ph provides to most H3K9 marks does not
extend to H3K27/H3S28ph and H3K27 methylation and binding partners such as
HP1, remained throughout the cell cycle [Jeong et al., 2010].
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In contrast to H3S10ph, far less is known about the role of H3S28ph in mitosis.
Both H3S10 and H3S28 exist within the same sequence motif -ARKS- and are
very similar in their temporal modification patterns throughout cell division. Like
H3S10ph, the phosphorylation of H3S28 starts at the centromere and spreads to
the chromosome arms and is also associated with chromosome condensation [Saw-
icka and Seiser, 2012]. PP1/Repo-Man, in addition to regulating the H3T3 mark
is also able to dephosphorylate H3S10 and serine 28 (H3S28) and the completion
of cell division [de Castro et al., 2017].
More recently Aurkb was found to phosphorylate S121 on histone 2AX (H2AXS121ph).
Phosphorylation of H2AX is involved in DNA damage responses and has the ca-
pability to recruit DNA repair proteins and cell cycle checkpoints. Shimada et
al. proposed an important feedback loop that enhances Aurkb presence at the
centromeres. They found that Bub1 phosphorylates H2AT120ph which begins re-
cruitment of the CPC to the centromeres. Once the CPC has been recruited, a
partially active Aurkb phosphorylates H2AXS121 which leads to a rapid accumu-
lation of Aurkb at the centromeres. Aurkb now activates Haspin which leads to a
further positive feedback upon Haspin phosphorylation of H3T3 and recruitment of
Aurkb. This extensive signalling network is needed to ensure an adequate amount
of Aurkb is recruited to the centromere to phosphorylate its many substrates and
progress the cell through the cell cycle [Shimada et al., 2016].
1.8.4 Regulation of late mitotic events
After the chromatids have been successfully separated the cell must begin the
process of rebuilding the nucleus and separating the two cells. A drop in Cy-
clin B1/Cdk1 activity coincides with Aurkb release from the centromeres during
the metaphase to anaphase transition. This reduction of Cdk1 activity causes
PRC1, INCENP and MKLP1 and MKLP2 to relocate to the spindle midzone.
INCENP interacts with MKLP2 which causes the localisation of the CPC and
Aurkb to the spindle midzone. Aurkb recruits and phosphorylates MKLP2 which
further recruits MgcRacGAP/CYK4. The complex, formed between MKLP1 and
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MgcRacGAP, called the centralspindlin complex is necessary for spindle midzone
integrity [Mishima et al., 2002, Afonso et al., 2017]. MKLP1 is responsible for the
overlapping microtubule bundling to form the spindle midzone. This is negatively
regulated by the protein 14-3-3 which binds to MKLP1 in the centralspindlin com-
plex prevents MKLP1 from accumulating. Aurkb can prevent binding of 14-3-3 to
MKLP1 by phosphorylation of the binding motif that 14-3-3 binds to in MKLP1
[Douglas et al., 2010]. This subsequently allows centralspindlin to cluster and form
the spindle midzone. This feedback loop ensures sufficient MKLP1 expression and
formation of the spindle midzone formation [Basant et al., 2015].
At anaphase, after Aurkb has been released from the centromere, and relocates to
the spindle midbody, it forms an activity gradient, starting at the spindle midzone
and spreading throughout the interchromosomal area [Tan and Kapoor, 2011]. The
spindle midzone is formed by microtubules from each spindle pole overlapping at
the centre like fingers interlacing (Figure 1.11). The microtubules that form the
central spindle have opposite polarities, with the minus end close to the spindle
poles and the plus ends interdigitating at the spindle midzone. At these overlap-
ping plus ends of the microtubules binding scaffolding forms which binds the plus
ends together and forms the stem bodies. Stem bodies provide the scaffolding for
the contractile ring which enables the cell to divide [Douglas and Mishima, 2010].
KIF2A, is a depolymerising microtubules kinase that controls the length of mi-
crotubules at the minus ends. Loss or overexpression of KIF2A caused defects in
spindle microtubule length and spindle midzone alignment. KIF2A is a substrate
of Aurkb leading to its inhibition. As mentioned, Aurkb is localised to the spindle
midbody where it diffuses out along the spindles. Uehara et al. suggested that
Aurkb prevents depolymerisation of the microtubules by KIF2A at the midbody
but as Aurkb expression decreases, KIF2A is able to depolymerise at the distal
minus ends [Uehara et al., 2013, Nunes Bastos et al., 2013].
After the separation of the sister chromatids but before the physical separation of
the two daughter cells, the nuclear envelope is required to reassemble. However,
formation of the nuclear envelope before clearance of the separated chromosomes
to the poles of the cell can lead to chromosomal loss [Janssen et al., 2011]. Aurkb
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Figure 1.11: Schematic of the spindle midzone at anaphase
Spindle midzone is formed from overlapping microtubules from each spindle pole. Aurkb is
localised to the spindle midzone (yellow). Aurkb localisation at the spindle midzone prevents
KIF2A from depolymerising the microtubules, where they will ultimately for the stem bodies, a
scaffold for the contactile ring.
monitors chromosome position along the divisional axis and retains the expression
of Condensin I before all of the chromosomes had migrated correctly. Inhibi-
tion of Aurkb at the midzone leads to decondenstaion of the chromosomes before
separation of the sister chromatids had completed, giving rise to polyploidy or
micronuclei. Aurkb does this through its gradient along the spindle midzone, act-
ing as a molecular ruler which can detect how far each segregated chromosome
has migrated. The further they are from the midzone, the less accessible they are
to Aurkb, thereby becoming dephosphorylated and driving mitotic exit [Afonso
et al., 2014, Afonso et al., 2017].
It is estimated that chromosome segregation defects occur in 1% of somatic cells
during cell division, and at a higher rate in transformed cells. Abscission, or the
cleavage of the two daughter cells, needs to wait until the split chromosomes have
cleared the cleavage plane. Incorrect chromosome segregation is usually caused
by lagging or bridged chromosomes. Bridged chromosomes are caused by many
different mechanisms such as defects in the enzyme topoisomerase II which de-
tangles the two sister chromatids after replication (S-phase), defects in cohesin
degradation which holds the two chromatids together during metaphase and DNA
repair-triggered fusion [Pampalona et al., 2016]. Mechanisms for surveillance have
been described to monitor for incorrectly segregated chromosomes. The NoCut or
abscission checkpoint delays abscission when defects are detected [Norden et al.,
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2006]. Once again, Aurkb plays an important role in this checkpoint. It was found
that Aurkb inactivation promotes abscission but in the presence of chromosome
bridges, Aurkb expression is retained and abscission is delayed [Steigemann et al.,
2009].
Aurkb is an essential regulator of the cell cycle. It’s catalytic involvement in the
CPC ensures correct microtubule to kinetochore attachments, preventing incor-
rect segregation of the chromosomes. Additionally, its putative role in the spin-
dle assemble checkpoint ensures that the cell cannot progress from metaphase to
anaphase in the presence of aberrant microtubule-kinetochore attachments, adding
another layer of surveillance regulating correct separation. Along with Aurkb’s
role in early mitosis, Aurkb has been found to phosphorylate a number of histone
marks involved in maintaining the structural integrity of the chromosomes during
the cell cycle. Finally, Aurkb has been observed in numerous processes in late
mitosis and abscission including: spindle midzone organisation and progression
and initiation of cytokinesis. Overall, Aurkb is a key player in almost every step
of the cell cycle and it is likely that further functions are yet to revealed.
1.8.5 Similarities between Aurkb and Aurka/Aurkc
Although Aurka and Aurkb are expressed at slightly different times and have dif-
ferent roles during cell cycle, their high homology means that there can be some
functional overlap. This overlap has only been observed when either protein has
been modified. For example, a single amino acid substitution in AURKA, Gly198
to Asn, enables AURKA to interact with the AURKB binding partner, inner cen-
tromere protein (INCENP) and phosphorylate AURKB’s substrates in vitro. In
AURKB-depleted cells this mutant form of AURKA is sufficient to rescue chro-
mosome alignment defects and progression through the cell cycle. Interestingly
though, mutation of the same residue, Asn142 to Gly in AURKB, the mutated
AURKB localises to centrosome and spindles like AURKA but still retains a mod-
erately strong affinity for binding with INCENP suggesting there are other impor-
tant residues in AURKB that mediate binding with INCENP [Fu et al., 2009].
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As mentioned, the most striking functional difference between Aurkb and Aurkc
is seen in mitosis versus meiosis where Aurkc is the primary kinase in meiosis
but Aurkb functions solely in somatic cells. Aurkc null mice survive, but males
have reduced fertility [Kimmins et al., 2007]. In another Aurkc knockout study by
Schindler et al. they reported female Aurkc null mice have lower fertility, averaging
25% fewer pups per litter than WT counterparts. Examination of female germ
cells revealed mild chromosome misalignments and arrest of some cells in oocyte
maturation. In Aurkc−/− oocytes that did survive they found that Aurkb had
compensated for loss of Aurkc. They also found Aurkc is more stable than Aurkb,
which turns over almost 50% faster than Aurkc. Schindler et al. suggested that
this stability of Aurkc is to compensate for the short half-life of Aurkb in the
longer process of meiosis [Schindler et al., 2012].
1.8.6 Aurkb outside of the cell cycle
Aurkb expression levels increase rapidly upon entry to the cell cycle at the G2/M
transition and decrease sharply upon exit from the cell cycle, leading to the as-
sumption that Aurkb activity is exclusively bound to the cell cycle. While this
appears mostly true, a study examining the regulation of quiescent B and T cells
found that Aurkb is responsible for establishing and maintaining a resting state.
Aurkb phosphorylates H3S28 at promoters of the few active genes required to
maintain the cell in its quiescent state [Frangini et al., 2013].
Another study in plasma cells found that Aurkb mediates the H3K9me3/H3S10ph
modification outside of the cell cycle. Similarly to observations seen in the cell
cycle, the post-mitotic modification of this mark displaces HP1. Sabbattini et
al. suggested that in conjunction with the epigenetically silent H3K9me3 the
addition of H3S10ph could recruit other proteins that would help form a permanent
repressive structure [Sabbattini et al., 2007].
In zebrafish, Aurkb has been found in developing neurons as well as post-mitotic
neurons in the brain and spinal cord. They found that overexpression of Aurkb led
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to neuronal axon elongation while the inverse was true when Aurkb was inhibited.
Additionally, they found that inhibition of Aurkb in an injury model affected
the rate of regeneration of axons. They suggest that Aurkb in both cases is
regulating microtubule dynamics through phosphorylation of Kif2A which has
found to be important in regulating microtubule cytoskeleton within neurons of
zebrafish [Gwee et al., 2018].
In mammalian X inactivation XIST RNA spreads across the inactive X (Xi) and
is essential for normal female cell survival. XIST is bound tightly to the Xi at
interphase at multiple locations and to many different sites and is hard to remove
once established. Hall et al. wanted to determine if there were any factors im-
portant during the cell cycle that could be extrapolated to displace Xist binding
from the Xi. In doing so, there is hope that it could provide the potential to
treat x-linked diseases. They found that ubiquitination of H3S10ph, H3S28ph,
HP1 as possible candidates. It is known that Aurkb localises to the chromosome
arms for a very brief time during prophase, which overlaps with the timing of
XIST RNA binding changes. When Aurkb expression was reduced using RNAi,
it was sufficient enough to cause retention of XIST on the Xi but not to induce
mitotic failure [Hall et al., 2009]. In a similar Xi reactivation study, Lessing et al.
conducted a high-throughput small molecule screen to identify pathways for Xi
reactivation. They identified three Aurora kinase specific inhibitors which led to
increased transcription from the Xi. They further investigated this phenotype by
knocking down Aurkb and Aurka. Individually they did not observe any effect but
double knockdown led to significant transcription from the Xi, further implicating
the aurora kinases in X inactivation [Lessing et al., 2016].
Aurkb may also be involved in telomere maintenance. The telomeres are structures
found at the ends of chromosomes composed of many repeat sequences. The length
of telomeres is related to the replication capacity of the cell and the telomeres
shorten each time the cell divides which will eventually trigger cell death when they
become too short. Stem cells however, express an enzyme called telomerase which
can add telomere DNA to the ends of the telomeres to prevent shortening. Recently
it was found that Aurkb localised to the telomeres of embryonic stem cells (ESCs)
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where it interacts with the protein TERF1 and important regulatory protein of
telomere length. Aurkb phosphorylated TERF1, leading to its inactivation and
release from the telomeres, preventing TERF1 from sending out telomeric signals
that lead to telomere fragility. The same localisation of Aurkb to the telomeres
was not found in somatic cells indicating an important role for Aurkb in stem cell
maintenance [Chan et al., 2017].
1.8.7 Loss of function of Aurkb in vivo during development
Unlike Aurka mutants, conditional deletion of Aurkb in zygotes using a ubiquitous
Cre mouse, result in normal implantation but Aurkb deleted embryos die in early
post-implantation stages. It was found that Aurkc compensates for loss of Aurkb in
pre-implantation but downregulation of Aurkc after implantation leads to lethality
[Fernández-Miranda et al., 2011]. Examination of the role of Aurkb in later stages
of development, post implantation, has not been investigated so far.
1.8.8 Aurkb and disease
Much of the focus around Aurkb has been examining its expression and targeting
it to treat cancer. Like its family members, Aurkb overexpression is detected in
many primary tumours and is associated with multinucleation and polyploidy of
cancerous cells [Schwartz et al., 2013, Nguyen et al., 2009]. Aurkb is found at the
locus 17p13.1, an unstable region associated with frequent amplifications, deletions
and mutations [Bischoff et al., 1998]. Aurkb overexpression is a poor-prognosistic
factor in many cancers such as non-small cell lung cancer [Vischioni et al., 2006],
oral squamous cell carcinoma [Qi et al., 2007], breast cancer [Liao et al., 2018],
hepatocellular carcinoma [Lin et al., 2010] and many more. Interestingly, there is
little evidence to support overexpression of Aurkb being the initiating factor in
the human disease. However, there has been some evidence to show that over-
expression of Aurkb in mouse epithelial cells generated tetraploid cells. When
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these mutated cells were transplanted into nude mice they formed mammary ep-
ithelial cancers. Genomic analysis of the tumours showed many amplifications
and duplications of chromosomal regions where known tumour suppressor genes
or oncogenes are located. The authors suggested that the tetraploidy induced by
overexpression of Aurkb led to genomic instability and the development of tumour
initiating factors [Nguyen et al., 2009].
Analysis of overexpression models of Aurkb have also shown that increased levels of
the kinase caused a defect in the DNA damage response. Overexpression of Aurkb
led to a decrease in p21Cip1 (human CDKN1A). p21Cip1 inhibits cyclin-dependent
kinases that drive the cell cycle and is a transcriptional target of the tumour
suppressor Trp53. High levels of p21Cip1 either independently or in response
to Trp53 signals, cause cell-cycle arrest [Cox, 1997]. Overexpression of Aurkb
can triggered tumour development in vivo due to decreased level of p21Cip1 and
aberrant progression through the cell cycle [González-Loyola et al., 2015].
1.8.9 Chemical inhibition of Aurkb
Many inhibitors against the Aurora kinases exist and have been recently reviewed
in de Groot et al. 2015. As the Aurora kinases are often overexpressed in cancers,
most therapeutics have been designed as anti-cancer drugs and at least 30 au-
rora kinase inhibitors have been preclinically or clinically evaluated. While many
compounds target all of the aurora kinases due to their high sequence homology
there are selective inhibitors, specific to each aurora. The compound AZD1152 or
basasertib is an Aurkb specific inhibitor and is 3760-fold more specific for Aurkb
over Aurka. This compound is routinely used in laboratory experiments and has
been shown to effectively inhibit the phosphorylation marks on H3S10 and H3S28.
It has also been shown to disrupt cell cycle progression, delaying cells in G2 and
preventing cytokinesis. AZD1152 was also tested for off target effects and was not
found to interact with any of the 363 human kinases tested in the de Groot et al.
2015 study [de Groot CO et al., 2015].
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Aurkb is an important kinase throughout the cell division and in disease. Its
involvement in numerous mechanisms throughout mitosis and abscission have been
well studied. However, due to the many process Aurkb is involved in, it has been
difficult to elucidate its exact mechanistic function in animal models. With recent
creation of the Aurkb floxed mouse, which to date has not been extensively used,
will greatly facilitate further studies in vivo. Most of the work presented above
has been conducted in lower order organisms such as yeast and drosophila and
confirmed in human cell lines. Despite this, it is clear that Aurkb is a necessary
factor in the progression of the cell cycle and will no doubt play important roles




This project is focused on early lung progenitor cells and identifying and charac-
terising a novel epigenetic regulator of early lung development.
Aim 1 To develop a culture method for primary lung stem cells
There are no cell lines that faithfully resemble the embryonic lung stem cell.
Therefore, the first aim of this project was to further refine a culture method
for E11.5 embryonic lung stem cells that would allow long term culture and
manipulation of the cells.
Aim 2 To conduct an shRNA screen targeting epigenetic regulators on
primary lung stem cells to look for novel regulators of early lung de-
velopment
The second aim of this project was to conduct a large epigenetic regulator
knockdown screen on cultured lung embryonic stem cells to identify impor-
tant regulators of stem cell function.
Aim 3 To determine the role of Aurora kinase b in early lung development
Aurora kinase b is one of the hits from the epigenetic regulator screen. Aim





All mice were bred and maintained using standard animal husbandry procedures
as mandated by the WEHI Animal Ethics Committee under animal ethics num-
ber AEC 2013.028 followed by AEC2016.024. The Aurkbflox strain carries LoxP
sites upstream of exon 2 and exon 7 which upon expression of Cre recombinase
causes excision of exons 2-6 resulting in the Aurkb null allele [Fernández-Miranda
et al., 2011]. The Shh-Cre strain has been previously described and mice were
maintained on a C57Bl/6 background [Harfe et al., 2004]. The Trp53 strain has
been previously described and mice were maintained on a C57Bl/6 background
[Jacks et al., 1994].
2.1.1 Genotyping
Tail tips and embryonic tissue was digested for at least 2 hours at 55◦C in DNA
lysis buffer with 200 µg/mL proteinase K (Roche). Digestion was stopped by
heating samples to 85◦C for at least 15 minutes. Genotype was determined by
PCR. The PCR reaction contained 1 µl of digested tissue, 1X GoTaq Green Mix
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(Promega) and 0.5 µM per forward and reverse primers. PCR cycle conditions for
the Aurkbflox strain were 94◦C for 5 minutes; 35 cycles of 94◦C for 30 seconds, 60◦
for 30 seconds and 72◦C for 1 minute; 72◦C for 10 minutes. PCR cycle conditions
for the Cre strains were 96◦C for 5 minutes; 30 cycles of 94◦C for 30 seconds, 55◦
for 30 seconds and 72◦C for 1 minute; 72◦C for 4 minutes.
2.2 Derivation and culture of cell lines
2.2.1 Pneumospheres
Lungs were dissected from E11.5 embryos and disassociated in trypsin. Cells were
filtered and resuspended at 200,000 cells/ml/well and plated in PSM (DMEM-
Ham’s F-12 + Glutamax (Gibco), 2% B27 supplement (Life Technologies), 1xITS
(Gibco), 20 ng/ml bFGF (Becton-Dickinson), Heparin (Sigma), 10 ng/ml EGF
(Becton-Dickinson)) for 1 hour in a 6-well regular tissue culture plate. Supernatant
was harvested and cells were then resuspended at 50,000 cells/ml/well in PSM in
a 24-well ultra-low attachment plate (Corning). Cells were split at day 3 and
day 7 and replated at 50,000 cells/ml/well. End point was reached at day 10.
Appropriate harvests were taken at each time point and snap frozen for RNA or
protein or fixed in 2% PFA for imaging.
2.2.1.1 Competition assay
E11.5 lungs were processed as per the pneumosphere protocol. Epithelial enriched
E11.5 cells were transduced according to Methods section 2.4.3 and were left un-
selected. Experiments always included a test shRNA and a non-silencing control
shRNA. BFP expression was monitored by flow cytometry every 3, 7 and 10 days.
BFP expression was normalised to day 3 expression and compared to non-silencing.




Pneumosphere differentiation was based off previously published protocols [Nichane
et al., 2017, Barkauskas et al., 2013]. Briefly, E11.5 lungs were processed as per
the pneumosphere protocol and transduced according to Methods section 2.4.3.
After 8 hours transduced E11.5 epithelial enriched progenitor cells were mixed at
2:5 ratio with adult CD31+, CD45+, EpCAM-, Ter119- fluorescent activated cell
sorted (FACS) mesenchymal cells in MTEC/Plus media (DMEM-Ham’s F-12 +
Glutamax (Gibco), 15 mM HEPES (Gibco), 10 µg/ml ITS (Corning), 0.1 µ/ml
cholera toxin (Sigma), 25 ng/ml epidermal growth factor (Becton-Dickinson), 30
µ/ml bovine pituitary extract (Corning), 0.01 M retinoic acid (Sigma), Rock in-
hibitor (StemCell Technologies). Cells were mixed at a 1:1 ratio with Matigel (BD
Biosciences) and plated in a 24-well 0.4 µM Transwell insert (Corning), MTEC/-
Plus media was added to lower chamber and media was changed every 2 days.
Cells were grown for 16 days.
2.2.1.3 BrdU incorporation assay
E11.5 lungs were processed as per the pneumosphere protocol. Epithelial enriched
E11.5 cells were transduced according to Methods section 2.4.3 and were left un-
selected. Experiments always included a test shRNA and a non-silencing control
shRNA. After 3 days BrdU was added to the culture media and left for 2 hours.
Cells were then processed using the BD APC BrdU Flow kit as per the manufac-
turers’ instructions.
Cells were analysed on a BD LSRFortessa 1 or BD LSRFortessa X20.
2.2.1.4 MTS assay
E11.5 lungs were processed as per the pneumosphere protocol. Epithelial enriched
E11.5 cells were plated at 10,000 cells/well in 384-well, clear, flat bottomed plates.
BGJ398 or AZD1152 was added to triplicate wells at desired concentrations. Cell
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proliferation was determined 3 days later using a CellTiter96 R© Aqueous One So-
lution Cell Proliferation Assay (MTS) (Promega) and light absorbance read at 450
nM on the Wallac EnVision (Perkin-Elmer).
2.2.1.5 In vivo oncogenic capacity
Trp53−/− and wildtype E11.5 lungs were processed as per the pneumosphere pro-
tocol. Epithelial enriched Trp53−/− and wildtype E11.5 cells were transduced
with a pBABE-Puro-KrasG12V vector or pBABE-Puro empty vector according to
Methods section 2.4.3 and cells were selected with puromycin. Cells were grown for
10 days and then 1x106 cells were subcutaneously injected into the right flank of
NOD-SCID-IL2Rγ mice. Mice were monitored until tumours developed and were
culled when tumours reached a volume of 600 mm3. 1/4 of the tumour tissue was
transplanted into NOD-SCID-IL2Rγ mice and the remaining was fixed in 10%
formalin for histological analysis. Six mice were used per group. Transplanted
mice were treated as above.
2.2.2 Mouse embryonic fibroblasts (MEFs)
Embryos were harvested at E12.5-14.5 and foetal liver, intestines and head re-
moved. Remaining embryo body was vigorously pipetted to break down tissue
and create a single cell suspension. Cells were cultured in DMEM (Gibco) with
10% (v/v) FBS (Life Technologies) at 37◦C in a humidified atmosphere with 5%
v/v CO2 and O2. Cells were passaged every 2-3 days using 0.5% trpsin-EDTA
(Life Technologies) to detach adherent cells and replated at approximately 3000
cells/cm2 seeding density.
2.3 Ex vivo branching morphogenesis assay
A graphical protocol for the ex vivo lung branching morphogenesis assay can be
seen in Figure 2.1. E11.5 lungs were removed from the uterus, yolk sac and
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Figure 2.1: Schematic of the ex vivo branching morphogenesis assay
placenta. Lungs were dissected and oesophagus was removed. Lungs were placed
on a 0.8 µM membrane in a 12-well tissue culture plate. DMEM-F12 (Gibco)
media was added to the wells carefully to ensure membrane floated on top the
media. Outgrowth was monitored for 1-4 days.
2.4 Retrovirus production and transduction
2.4.1 Retrovirus production
293T cells were cultured in DMEM (Life Technologies) supplemented with 10%
FBS and grown at 37◦C in a humidified atmosphere with 10% (v/v) CO2. Retro-
virus was produced using a calcium phosphate mediated transient transfection of
293T cells. 293T cells at 80% confluency were transfected with VSVg envelope
vector, MD1-gag-pol structural vector and shRNA retroviral construct at a ratio
of 24:8:1. Plasmid DNA was added to a 250 mM CaCl2 solution and precipitated
in 1 volume of 2X HBS solution and then added drop-wise to 293T cells. 16 hours
post-transfection the media is changed. 48 hours post-transfection, supernatant
is harvested, passed through a 0.45 µM filter to remove residual 293T cells and
concentrated using Poly(ethylene glycol) (PEG).
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2.4.2 Concentration of retrovirus with PEG
Retroviral supernatant was added to 1/4 volume of 20% PEG solution pH 7.2
(20% Poly(ethylene glycol), 410 nM NaCl) and inverted 5 times over 90 minutes
then incubated at 4◦C for 16 hours. Solution was centrifuged at 4500 rpm for 45
minutes at 4◦C and supernatant removed and discarded. Retroviral pellet was
resuspended in 1/100 original volume of unconcentrated retroviral supernatant
before PEG addition, resuspended retrovirus was aliquoted at 10 µl and snap
frozen in dry ice before being stored at -80◦C.
2.4.3 Transduction of MEFs
MEFs were seeded 16-24 hours prior to transfection. At 50%-80% MEF confluence,
PEG concentrated viral supernatant was added to the culture. 24 hours later the
media was changed. As required cells were selected with 1 µg/mL of puromycin
(Sigma-Aldrich).
2.4.4 Transduction of pneumospheres
As described above, E11.5 lung cells were enriched for epithelial progenitors, PEG
concentrated viral supernatant was added to the culture and cells were plated on
a ultra-low attachment plate. 24 hours later the media was changed. As required
cells were selected with 1 µg/mL of puromycin (Sigma-Aldrich).
2.5 Quantitative real time PCR
2.5.1 RNA extraction
Cultured cells were harvested and washed in PBS and RNA extraction was per-
formed using RNeasy Minikit (Qiagen) as per the manufacturers’ instructions.
97
Methods
2.5.2 Reverse transcription of RNA
RNA was quantified using the Nanodrop RNA-40 program. 2 µg of RNA, 500
ng Oligo(dT)15 (Promega) and 200 U Superscript III Reverse Transcriptase (Life
Technologies) were used to generate cDNA as per the manufacturers’ instructions.
2.5.3 RT-qPCR
cDNA was used at 1/30 concentration in a 10 µl PCR reaction. PCR reaction mix
contained 0.2 µM forward and reverse primers, 0.1 µM UPL probe (Roche) and 1x
LightCycler R© 480 Probes Master Mix (Roche). PCR was run on LightCycler R©
480 Real-Time PCR instrument with cycle conditions of 95◦C for 10 minutes; 45
cycles of 95◦C for 10 seconds, 60◦C for 30 seconds, 40◦C for 30 seconds. Cycle
thresholds (Ct) were calculated using the standard curve method, using Hmbs
mRNA expression as a control for variation in cDNA concentration between sam-
ples [Larionov et al., 2005].
2.6 Microscopy
2.6.1 Histological immunostraining
Slides were dewaxed using standard histology protocols. Antigen retrieval was
performed using 10 mM pH 6 citrate buffer (0.1 M citric acid, 0.1 M sodium cit-
rate, H2O) in a DakoCytomation Pascal pressure chamber. Sections were blocked
in 10% goat/donkey serum for 1 hour and then incubated with antibodies in block
overnight at 4◦C. Slides were incubated in block solution containing secondary
fluorophore-conjugated antibodies for immunofluorescence or HRP-conjugated sec-
ondary antibodies (Vector) for immunohistochemistry for 1 hour. DAPI was added
for 10 minutes and slides were mounted with Fluoromount-G R© (Southern Biotech)
for immunofluorescence imaging. For immunohistochemistry Vectastrain ABC was
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added for 30 minutes at room temperature then slides were washed before DAB
solution was added and allowed to develop for 2-5 minutes. Slides were counter-
strained with haematoxylin and coversliped. All antibodies are detailed in Table
2.1 and 2.2.
Immunohistochemical slides were imaged with a Nikon Eclipse 50i inverted micro-
scope or a Zeiss Axioplan inverted microscope.
Immunofluorescence slides were imaged using a Zeiss LSM780 confocal microscope
or a Zeiss LSM880 NLO confocal microscope.
2.6.2 Wholemout immunostraining
2.6.2.1 Ex vivo branching morphogenesis imaging
E11.5 lungs grown on membranes were fixed with 4% paraformaldehyde (PFA)
(Sigma) after 3-4 days in culture. Lungs were permeabilised in 0.5% Triton X-
100 (Sigma) and then blocked in 10% goat/donkey serum for 1 hour at room
temperature. Primary antibodies were added and incubated overnight at 4◦C.
Secondary antibodies were added and incubated for 2 hours at room temperature
in the dark. All antibodies are detailed in Table 2.1 and 2.2. DAPI was added
at 1/1000 for 10 minutes. Membranes with lung were transferred to slides and
mounted with Fluoromount-G R© (Southern Biotech).
Samples were imaged using a Ziess LSM780 confocal microscope or a Zeiss LSM880
NLO confocal microscope.
2.6.2.2 Pneumosphere differentiation assay imaging
Differentiation assay was fixed in 4% paraformaldehyde (PFA) for 10 minutes at
room temperature and pipetted to dissolve Matrigel and break up colonies. Cells
were permeabilised in 0.3% Triton X-100 (Sigma) for 10 minutes and then blocked
in IF buffer (100 mg BSA (Sigma), 200 µl Triton X-100, 50 µl Treen20 (Simga), 1x
99
Methods
PBS) with 10% goat/donkey serum for 1 hour at room temperature. Primary an-
tibodies were added incubated overnight at 4◦C. secondary antibodies were added
and incubated at room temperature for 1 hour in the dark. All antibodies are
detailed in Table 2.1 and 2.2. DAPI was added at 1/1000 for 10 minutes. Mem-
branes with lung were transferred to slides and mounted with Fluoromount-G R©
(Southern Biotech).
Samples were imaged using a Ziess LSM780 confocal microscope or a Zeiss LSM880
NLO confocal microscope.
2.6.2.3 Lightsheet imaging
ShhKI/+; Aurkbfl/fl and Shh+/+; Aurkbfl/fl E11.5 lungs were collected for Light-
sheet imaging by first removing embryos from the uterus, yolk sac and placenta.
Bodies were dissected away and the lung was left attached to the head for tissue
processing. Experimental tissue was fixed in 4% paraformaldehyde (PFA) (Sigma)
for 1 hour. Samples were permeabilised in 0.5% Triton X-100 (Sigma) and PBS
for 1 hour at room temperature, and blocked by adding 10% goat/donkey serum
for 1 hour at room temperature. Primary antibodies were added and left for 2
days at 4◦C on a plate rocker. Samples were washed every hour for 6 hours and
then secondary antibodies were added and left for 2 days at 4◦C on plate rocker.
All antibodies are detailed in Table 2.1 and 2.2. Samples were washed every hour
for 6 hours. DAPI was added at 1/1000 for 30 minutes and the samples were re-
fixed in PFA for 1 hour. Samples were cleared using the Sca/eA2 protocol [Hama
et al., 2011]. Briefly, samples were added to Sca/eA2 clearing solution (4 M urea
(Sigma), 10% v/v glycerol, 0.1% v/v Triton X-100 (Sigma) and left for 1-2 weeks,
changing the solution every 3-4 days.
Samples were mounted in 1.5mm glass capillaries and imaged via the Zeiss Light-




Micro-CT tissue processing on ShhKI/+; Aurkbfl/fl and Shh+/+; Aurkbfl/fl E18.5
embryos was done using the STABILITY protocol published in [Wong et al.,
2013, Hsu et al., 2016]. Briefly, E18.5 Shh-Cre; Aurkb embryos were harvested and
removed from the yolk sac and placenta and placed in 4% paraformaldehyde (PFA)
(Sigma) for 3 days at 4◦C. Embryos were then transferred to 20 ml of STABIL-
ITY buffer (4% w/v PFA, 4% w/v acrylamide (Bio-Rad), 0.05% bis-acrylamide
(Bio-Rad), 0.25% w/v VA044 initiator (Wako Chemicals), 0.05% w/v Saponin
(Sigma), in 1x PBS) for 3 days at 4◦C. Samples were then placed in a desiccator
with nitrogen gas. Samples were then incubated at 37◦C for 3 hours to initiate
crosslinking reaction. Once the hydrogel had formed, extra gel was removed and
samples were placed into 0.1 N v/v iodine solution (Sigma) for 5 days, iodine
solution was changed every 2 days.
Samples were mounted in yellow capped tubes and imaged via the Skyscan 1276
Micro-CT scanner (Bruker) and reconstructed by Dr Lachlan Whitehead.
2.7 Genomic assays
2.7.1 shRNA library screen
Pneumospheres were made following the pneumospheres method 2.2.1. Pooled
screen virus was made by Mrs Kelsey Breslin and Ms Joy Liu. shRNA sequences
used in the library can be seen in appendix A. Single cells were infected with
pooled screen virus prior to plating at 50,000 cells/ml/well in an ultra-low attach-
ment plate (Corning). Cells were left for 17 hours and then media was removed
and replaced with fresh PSM. Cells were allowed to recover for 6 hours before
puromycin selection. PSM media with 2 µg/ml puromycin was added to each well.
At day 3 cells were collected, and counted and one third were taken for DNA by
pelleting cells and snap freezing in dry ice. Cell pellets were stored at -80◦C until
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all harvests were made. The remaining two thirds of the sample was replated at
50,000 cells/ml/well. At day 7 half of the sample was taken for DNA as above and
remaining replated at 50,000 cells/ml/well. At day 10 all cells were harvested for
DNA.
Once all the replicates were harvested DNA was extracted from cell pellets using
the Qiagen Blood and Tissue kit following the manufactures’ protocol until the
elution step. DNA was eluted from the column by adding 100 µl of ultra pure
water and incubating for 2 minutes then spun at 10,000 rpm for 1 minute and
repeated. DNA concentration was measured using Nanodrop ssDNA program.
shRNA libraries were prepared from 0.25 µg of DNA from each sample in a 50 µl
total volume PCR reaction. PCR reactions contained 0.25 µg DNA, 1X Phusion
High Fidelity Buffer (NEB), 2 µl 10 mM dNTPs, 2 µl P7R individual primer, 2 µl
P5F common primer, 1U Phusion DNA polymerase (NEB). PCR conditions were
95◦C for 10 minutes, 52◦C for 45 seconds, 72◦C for 45 seconds, 28 cycles of 95◦C
for 30 seconds, 55◦C for 45 seconds and 72◦C for 45 seconds; 72 for 7 minutes.
Samples were run on the TapeStation using the D1K ScreenTape for quantification.
45 ng from each sample was pooled for a total concentration of 200 ng and pooled
sample was run on a 1.5% agarose-TAE gel. An approximately 380 bp band was
cut from the gel and DNA was extracted using the GE Gel Extraction Kit as
per the manufacturers’ instructions. shRNAseq library sample was submitted to
the Australian Genome Research Facility for sequencing on the Illumina Hi-Seq
platform using 100 bp, single end reads.
2.7.2 RNAseq
E11.5 lungs were harvested and fluorescence activated cell sorted (FACS) for CD31-
, CD45-, EpCAM+ cells and snap frozen until required. Pneumospheres and Ep-
CAM+ E11.5 cells were washed in PBS and RNA extraction was performed using
RNeasy Minikit (Qiagen) as per the manufacturers’ instructions. Libraries were
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prepared using the Illumina TruSeq RNA kit from 1 µg total RNA as per the man-
ufacturers’ protocol. 200-400 bp sized products were selected and cleaned up using
AMPure XP magnetic beads. Final cDNA libraries were quantified using a Qubit
dsDNA Assay Kit (Life Technologies) and sequenced on the Illumina NextSeq
platform using 100 bp, single-end reads. Reads were mapped by Associate Pro-
fessor Matt Ritchie. RNAseq data was analysed in R studio and EdgeR statistics
were used to analyse the data [Robinson et al., 2010]. Comparison of RNAseq
data with Nichane et al. [Nichane et al., 2017] data was done by Dr Charity Law
[Law et al., 2016].
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Table 2.1: Primary antibodies
Antibody Use Host Manufacturer Catalogue No.
CD45-PE-Cy7 1:250 Rat BioLegend 103114
CD31-PE-Cy7 1:250 Rat BioLegend 102418
EpCAM-APC-Cy7 1:200 Rat BioLegend 118218
Aurkb 1:500 Rabbit Abcam ab2254
H3S10ph 1:500 Rabbit Abcam ab5176
H3S28ph 1:500 Rat Abcam ab10543
Cleaved caspase 3 1:100 Rabbit Cell Signalling 9661
Ki67 1:400 Rabbit Cell Signalling 12202
E-cadherin 1:500 Rat Invitrogen 13-1900
Sox2 1:1000 Rabbit Santa Cruz SC-17320
Sox2 1:200 Goat Abcam Ab97959
Sox9 1:1000 Goat Millipore AB5535
Sox9 1:200 Rabbit Merck AB5535
Nkx2.1 (TTF1) 1:200 Mouse Agilent Technologies 8G7G3/1
Pro-SPC 1:2000 Rabbit Millipore AB3786
T1a 1:500 Hamster DHSB clone 8.1.1
Keratin 5 1:2000 Rabbit Covance PRP-160P
Hmga2 1:1000 Rabbit BioCheck 59170AP
Trp63 1:100 Mouse BioCare CM163A, B, C
Table 2.2: Secondary antibodies
Fluorophore Use Anti- Manufacturer Catalogue No.
AF488 1:500 Rat Invitrogen A21208
AF488 1:500 Mouse Life Technologies A11029
AF488 1:500 Rabbit Life Technologies A28175
AF488 1:500 Goat Life Technologies A11055
AF594 1:500 Goat Invitrogen A11058
AF555 1:500 Rat Life Technologies A21434
AF555 1:500 Mouse Life Technologies A31570
AF555 1:500 Rabbit Invitrogen A27039
AF647 1:500 Rat Life Technologies A21247
AF647 1:500 Mouse Life Technologies A28181
AF647 1:500 Rabbit Invitrogen A27040
AF647 1:500 Hamster ThermoFisher A21451
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Pneumospheres: an in vitro culture
method for E11.5 lung progenitor
cells
3.1 Abstract
Techniques used to study lung development vary from mouse models to bioengi-
neered organs-on-a-chip. Each method has their own merits and pitfalls, often
being overly time consuming, expensive or requiring specialised skills. Here is de-
tailed a simple and quick method for studying early Sox9+ lung progenitor cells
which we have called pneumospheres. Pneumospheres are generated from E11.5
mouse lungs and are enriched for epithelial progenitors. They are highly prolif-
erative, and retain Sox9 expression throughout the life of the culture. Genomic
analysis reveals that pneumospheres recapitulate the E11.5 epithelial progenitor
population and do not express markers of bronchiolar or alveolar differentiation.
Pneumospheres can be genetically and chemically altered to assess the role of
signalling pathways or genes of interest on lung progenitor cell self-renewal or
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oncogenic transformation. Additionally, pneumospheres can be induced to differ-
entiate into more mature lung lineages. In conclusion the pneumosphere culture
method presented here offers a reliable and simple method for culturing Sox9+
lung progenitor cells and offers many possibilities to study and further understand
lung development.
3.2 Introduction
Investigating the embryonic lung is difficult due to its inaccessibility within the
developing embryo which is further hindered by difficulty in obtaining human foetal
lung tissue. To circumvent this issue, it is necessary to use alternative methods
including animal models and cell culture systems to study lung development. The
use of mouse models is the primary tool for studying lung development. Due
to their short lives and fast embryonic development, mice are the gold standard
in embryonic research. However, like all models, they have their limitations, the
most obvious being that mice and humans are significantly different and the mouse
does not and cannot always recapitulate the human. The second limitation of using
mouse models remains more specific to embryology as a whole, in that we cannot
grow embryos for the entire gestational period outside of the womb. This limits
our ability to monitor normal growth of organs as well as how to evaluate the
effect of specific genes of interest on development over time. In vitro culture of
organoids and spheroids provide an alternative model to study genetic alterations
in tissue-specific progenitor cells.
Organoid and spheroid cultures have become more sophisticated and complex as
the field has grown. These methods enable long term culture of primary cells of
interest that mimic the in vivo system. Lung organoids have been made from
most regions of the adult lung [Rock et al., 2009, Vaughan et al., 2006, Peng et al.,
2015, Kim et al., 2005, Barkauskas et al., 2013]. Additionally, lung organoids have
also been produced from human foetal lung. These organoids derived from the
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early embryonic lung can self-renew and differentiate into both bronchiolar and
alveolar cell types [Nikolić et al., 2017].
Organoids cultures have proven to be immensely useful and reminiscent of the
organ in which they were derived, however culture of these mini-organs is often
time consuming, they are slow growing and require a 3D-Matrigel supported cul-
ture. Nichane et al. recently described a method for culturing mouse embryonic
lung epithelial cells. Their method enabled long term culture of a population of
Sox9+ lung progenitor cells, that lacked the self-organising structure of organoids
but provided a method for investigating early lung progenitor cells. They demon-
strated that these cells recapitulated the equivalent E12.5 lung cells and were
relatively transcriptionally stable over time. Additionally, they provided evidence
that they were able to differentiate the cultured Sox9+ cells into both the alveolar
and bronchiolar lineages. The Sox9+ cells were also used to repopulate the adult
lung after injury although at a very low success rate [Nichane et al., 2017]. Al-
though useful, the method described by Nichane et al. requires specific Sox9-GFP
expressing mice and cells must be sorted prior to plating. Here is described a
similar Sox9+ lung progenitor culture method that does not require cell sorting
and can be applied to wild-type mice or any genetically modified mouse models.
3.3 Results
3.3.1 Pneumosphere culture method
To be able to look for novel epigenetic regulators of early lung development it
was necessary to develop a method to grow early embryonic lung cells in vitro.
A published culture method for mammary gland progenitor cells [Sheridan et al.,
2015] provided a starting point Dr Caitlin Filby and Associate Professor Marie-
Liesse Asselin-Labat to develop a culture system for early lung progenitor cells,
called pneumospheres. A detailed protocol for the production of pneumospheres is
described in section 2.2.1. and is visually represented in Figure 3.1A. Briefly, E11.5
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lungs were isolated and pooled and single cell suspensions made. The cells were
plated on a regular tissue culture plate and supernatants, enriched for epithelial
cells, were harvested one-hour after plating. The cells were then plated on a
low-attachment plate where they formed spheres. Pneumospheres were split at
day 3, day 7 and final harvesting happened at day 10. From eight E11.5 lungs
an average of approximately 300,000 cells were dissociated to single cells before
mesenchymal depletion. After depletion this number approximately halves leaving
approximately 150,000 enriched-epithelial cells.
In culture the E11.5 epithelial-enriched cells form clusters of cells henceforth called
pneumospheres. Pneumospheres show a variety of sizes, and different cultures
show a difference in pneumosphere number at day 3, day 7 and day 10 (Figure
3.1B). H&E staining reveals pneumosphere are solid and composed of hundreds
of cells but without obvious signs of a self-organising structure and thus pneumo-
spheres are a spheroid culture not an organoid culture (Figure 3.1B insert). To
determine if pneumospheres were clonal we mixed two epithelial enriched E11.5
cells from different strains of mice and genotyped individual pneumospheres at day
3 and then after splitting the cells at day 7 and day 10. Figure 3.1C shows that
pneumospheres contain cells with both genotypes indicating that pneumospheres
are not derived from a single cell and aggregate together to form spheres.
Overall, pneumospheres are a relatively quick and easy way to culture E11.5 lung
epithelial cells. Pneumospheres are enriched for lung epithelial cells, and can be
grown for ten days in vitro.
3.3.2 Pneumospheres are highly proliferative and express
the lung stem cell marker Sox9
Immunohistochemical (IHC) analysis of pneumospheres harvested at day 3, day
7 and day 10 was performed to evaluate markers of proliferation, cell death and
progenitor cells (Figure 3.2; Figure 3.3). Pneumosphere sections were first stained
for the proliferation marker Ki67, which revealed that over the 10 days in culture
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Figure 3.1: Development of an early lung progenitor cell culture
assay
(A) Schematic of the pneumosphere culture process. E11.5 lungs are isolated and single cell
suspensions are made. Cells are plated in a regular tissue culture plate for 1 hour during which
time the mesenchymal cells will adhere to the bottom of the plate. Supernatant containing
epithelial enriched cells is harvested and cells are replated on low attachment plates. Cells are
grown for 10 days in culture and split at day 3, day 7 and day 10. (B) Representative brightfield
images of pneumospheres grown in 24-well low attachment plates. Scale bars represent 500 µM
(n=3). (B insert) Representative images of HE sections of pneumospheres. Scale bars represent
50 µM (n=3). (C) Representative images of PCR genotyping determine that pneumospheres
are not clonal. Individual pneumospheres were picked and genotyped and showed both and
genotypes (lanes 1 and 2) indicating they were not derived from a single colony as seen pneumo-
spheres derived from either ? (lanes 3-4) or 4 genotypes (5-6). (n=3 independent experiments,

















Figure 3.2: Pneumospheres are highly prolific by
immunohistochemistry
Representative images of pneumospheres at day 3, 7 and 10 stained by IHC. (A) Pneumospheres
stained for a marker of proliferation (Ki67). (B) Pneumospheres stained for a marker of cell
death (cleaved caspase 3). Scale bars represent 50 µM (n=3).
the pneumospheres remain highly proliferative (Figure 3.2A). At day 3 and day
7 all cells are Ki67+ however by day 10 there is evidence of non-proliferating,
Ki67- cells. To determine if the high proliferation rates associated with increased
cell death, the marker of apoptosis, cleaved caspase 3 (CC3) was examined in
pneumosphere sections (Figure 3.2B). Interestingly no evidence of CC3 staining
was observed at any of the pneumosphere harvest days.
Due to the high proliferation rates and lack of cell death, it was reasoned that
pneumospheres were likely composed of early lung progenitor cells. The E11.5
lung contains two progenitor cell types, Sox2+ progenitor cells, which will give
rise to the bronchiolar cells of the lung and Sox9+ progenitor cells, which will
give rise to all epithelial cell types including the Sox2+ progenitor cells and the
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Figure 3.3: Pneumospheres express the progenitor marker Sox9 by
immunohistochemistry
Representative images of pneumospheres at day 3, 7 and 10 stained by IHC. (A) Pneumospheres
stained for the proximal lung progenitor marker Sox2. (B) Pneumospheres stained for the distal
lung progenitor marker Sox9. Scale bars represent 50 µM (n=5).
IHC staining revealed no nuclear Sox2 positive cells at day 3, day 7 or day 10
(Figure 3.3A). By contrast, pneumospheres expressed high levels of Sox9 at all
three harvest time points (Figure 3.3B).
In conclusion these results show that pneumospheres are a highly proliferative
population of Sox9+ cells. They display minimal cell death and do not express
the bronchiolar progenitor marker Sox2.
3.3.3 Genome-wide expression analysis of pneumospheres
To further characterise the pneumospheres, sequencing of the RNA (RNAseq) by
next generation was performed on bulk pneumospheres populations harvested at
day 3, day 7 and day 10. RNAseq libraries were prepared using the Illumina TruSeq
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RNA kit for three independent experiments. Samples were barcoded, pooled and
sequenced in house with the Illumina Nextseq platform using 100 bp, single-end
reads. Data was analysed by Associate Professor Matthew Ritchie and Dr Charity
Law in R-studio following their previously published protocol by Law et al. [Law
et al., 2016]. Multidimensional scaling (MDS) plot reveals that samples clustered
together by harvest day rather than by experimental replicate. Additionally, there
was little variance between the replicates at each harvest day indicating a high
level of reproducibility (Figure 3.4A).
Pneumospheres from all harvest days expressed similar levels of embryonic lung
progenitor markers such as Nkx2.1, Sox9, Id2, Tgfβ, Bmp4 and Etv5 (Figure 3.4B)
[Morrisey and Hogan, 2010]. Consistent with the IHC results (Figure 3.3A), Sox2
is not expressed. As expected pneumospheres do not express or very lowly express
markers of differentiated lung cell types such as ciliated cells (Foxj1 ), basal cells
(Trp63 ), neuroendocrine cells (Ascl1 ), goblet cells (Spdef ) or AT2 cells (Sftpc)
(Figure 3.4C). Interestingly pneumospheres did express markers of AT1 cells in-
cluding Pdpn (T1α), Ager (RAGE), and Hopx. Examination of freshly isolated
EpCAM+ E11.5 cells also reveal that these transcripts are expressed during in the
E11.5 epithelium as well (Figure 3.4D).
Recently a similar Sox9+ progenitor assay was published by Nichane et al. [Nichane
et al., 2017]. In their method, E12.5 Sox9-GFP+, EpCAM+, Ptprc-, Pecam1-,
Ter119- cells were isolated by FACS sorting and plated in a 3D Matrigel-supported
culture. Nichane et al., also performed RNAseq analysis at passage 2 and passage
10 to robustly characterise their Sox9+ progenitor cells. By comparing the tran-
scriptome of their Sox9+ progenitor cell culture with adult lung epithelial cells
they identified a gene set of 1,226 genes that were enriched in their Sox9+ progen-
itor population [Nichane et al., 2017].
The Nichane et al. Sox9+ progenitor population was compared to our RNAseq
pneumosphere data and found that the Nichane et al. geneset tends to be highly
expressed in pneumospheres at day 3, day 7 and day 10 (Figure 3.5E). Using
barcode plots as seen in Figure 3.5 each black line represents one of the 1,226
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E11.5 epithelial cells
Figure 3.4: RNAseq analysis of pneumospheres
RNAseq was conducted on wildtype pneumospheres harvested at day 3, day 7 and day 10 in three
independent experiments. (A) Multidimentional scaling plot reveals the greatest level of variance
is determined by the day the pneumospheres were harvested and that replicate samples cluster
by harvest day. (B) Log counts per million (logCPM) over the three harvest days of genes that
are important in lung progenitor cells including: Nkx2.1, Sox9, Id2, Tgfb2, Bmp4 and Etv5. (C)
LogCPM over three harvest days in pneumospheres of genes that are expressed by adult lung
cell types including: Foxj1 (ciliated cells), Trp63 (basal cells), Ascl1 (neuroendocrine cells),
Spdef (goblet cells), Sftpc (AT2 cells). (D) LogCPM over three harvest days in pneumospheres
of genes that are expressed by mature AT1 cells including: Pdpn, Ager and Hopx. (E) LogCPM
in E11.5 EpCAM+ cells of genes that are expressed by mature AT1 cells including: Pdpn, Ager
and Hopx. (Expression is given as log of the normalised counts per million (CPM) for each gene.
Data represent mean ± SEM of 3 independent experiments)
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genes identified by Nichane et al. This is overlaid on top of our data, divided into
lowly expressed genes (blue) and highly expressed genes (pink). The above line
graph represents enrichment of the 1,226 genes based on the density of black lines.
In summary, pneumospheres are transcriptionally stable over time. They express
common embryonic lung progenitor markers such as Sox9 and Id2. No evidence of
differentiated cell types was observed transcriptionally and it was confirmed that
the Sox2 transcript is not expressed in pneumospheres. Additionally, it was found
that pneumospheres express the same set of upregulated progenitor cell markers
defined in a previous study using Sox9+ sorted cells.
3.3.4 Pneumospheres can potentially differentiate into
mature lung cell types
To determine if pneumospheres truly represented a population of lung progenitor
cells, pneumospheres were induced to differentiate in a transwell sphere-based as-
say in the presence of adult mesenchymal cells, previously shown to induce adult
lung progenitor cell differentiation [Barkauskas et al., 2013]. Epithelial-enriched
pneumosphere cells were mixed with FACS sorted adult lung mesenchymal cells
and plated with Matrigel in a transwell and grown for 16 days. Immunofluores-
cent staining of the colonies harvested revealed strong expression of Sox9 (Figure
3.6Aiii), indicating that cells had not lost their Sox9+ phenotype during the cul-
ture. Interestingly, expression of alveolar lineage markers, T1α (Figure 3.6Aii)
and ProSPC (Figure 3.6C) representing AT1 and AT2 cells respectively, were ob-
served. Colonies expressing Keratin 5 (Figure 3.6B), a marker of basal cells were
detected, indicating that pneumospheres also have the potential to differentiate
into airway basal cell lineage.
These experiments indicate that pneumospheres can be differentiated into both
alveolar and basal lineages. However, results presented are preliminary (two inde-
pendent experiments). Ongoing experience with the differentiation assay has re-








































































































































































Figure 3.5: Barcode blots of RNAseq analysis of pneumospheres
Barcode plots in which our data, represented by the coloured boxes (blue and pink) was com-
pared to a gene set list of genes enriched in Sox9 progenitor cells in culture method published
by Nichane:2017ih. Genes from set list are represented by black lines and enrichment is seen
in transcripts that are also enriched in our pneumosphere RNAseq. Line above barcode plot













Figure 3.6: Differentiation of pneumospheres into mature lung
lineages
Pneumospheres grown in a transwell differentiate into more mature lung cell types over time. (A)
Representative image of pneumosphere differentiation stained for lung progenitor marker Sox9
in yellow (Aiii) and the alveolar type 1 marker T1α in magenta (Aii). (Ai) DAPI is shown in
blue. (B) Representative image of pneumosphere differentiation stained for the basal cell marker
keratin 5 (K5) in magenta, DAPI is stained in blue. (C) Representative image of pneumosphere




are needed to confirm if pneumospheres have full differentiation capacity. Addi-
tionally, it will be necessary to perform other staining to confirm commitment to
lung lineages. Future stains will include markers for the bronchiolar lineage such
as Foxj1 for ciliated cells, CC10 for club cells and Trp63, Sox2 and Krt14 for basal
cells. Although ProSPC and T1α are common markers to identify the alveolar
lineage cells, it would be important to also stain for Sftpb and Aqp5 to further
confirm AT2 and AT1 cell differentiation.
3.3.5 Pneumospheres can be chemically and genetically
manipulated
Once we had confirmed we had a robust and reproducible culture method that was
enriched for early lung progenitor cells we next assessed the potential uses for these
cells. BGJ398 is a pan-FGFR inhibitor [Guagnano et al., 2012] currently in clinical
trial for the treatment of FGFR1-amplified breast and lung cancer [Weeden et al.,
2015, Nogova et al., 2017]. The Fgfs are critical during lung development, partic-
ularly in branching morphogenesis where Fgf10 located in the lung mesenchyme
at E11.5 signals to its receptor Fgfr1/2 in the epithelium to promote outgrowth
of Sox9+ distal progenitor cells [Park et al., 1998, Bellusci et al., 1996, De Moer-
looze et al., 2000]. Ex vivo E11.5 lungs can be cultured in an air-liquid interface
for 3-4 days, and constitute a robust assay to evaluate the effect of molecules of
interest on lung branching morphogenesis (section 2.3). To confirm the role of Fgf
signalling on branching morphogenesis, E11.5 lungs were cultured in an ex vivo
air-liquid interface culture and treated with increasing amounts of BGJ398. These
treated lungs showed severe branching defects characterised by a lack of proliferat-
ing epithelial cells (Ki67 staining) (Figure 3.7A). To assess if a similar abrogation
could be observed in pneumospheres, we treated pneumospheres with increasing
concentrations of BGJ398 in vitro. Confirming ex vivo results, treatment of pneu-
mospheres with the Fgfr inhibitor greatly reduced pneumosphere proliferation as










































































































Figure 3.7: Genetic and chemical manipulation pneumospheres
(A, B) Chemical inhibition of pneumospheres mimics the affect observed in ex vivo lung cultures.
(A) The Fibroblast Growth Factor Receptor inhibitor (FGFRi), BGJ398, inhibits branching mor-
phogenesis in ex vivo E11.5 lung cultures treated with increasing concentrations of BGJ398. Ex
vivo lungs are stained for the proliferation marker Ki67 (yellow), the epithelial marker E-cadherin
(magenta) and the nuclei are stained with DAPI (blue). Scale bars represent 200 µM. (Data
representative of n=3 experiments). (B) Cell viability assay shows the pneumosphere viability is
affected by increasing concentrations of BGJ398 (Data represents mean ± SEM of 3independent
experiments). (C, D) Gene knockdown effects competitive behaviour in pneumosphere assay.
(C) Loss of Trp53 gives a competitive advantage compared to cells infected with a non-silencing
shRNA (Data represents mean ± SEM of 7 independent experiments). (D) Loss of the lung
developmental factor Yy1 has a competitive disadvantage compared to cells infected with a non-
silencing shRNA (Data represents mean ± SEM of 3 independent experiments. Significance by
two-way ANOVA; ****p<0.0001; ***p<0.0002; *p<0.02).
no difference to the size or shape of pneumospheres was observed after treatment
with BGJ398.
We next evaluated whether pneumospheres could be transduced and genetically
manipulated using short-hairpin RNA (shRNA) knockdowns. Retroviral vectors
containing BFP and an shRNA were used to knockdown genes known to be im-
portant in proliferation and lung development. The addition of a fluorescent tag
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enabled us to track how knockdown of important genes affected pneumosphere
growth by representation of BFP over time.
Loss-of-function mutations in the tumour suppressor gene Trp53 leads to unchecked,
increased cell proliferation [Donehower et al., 1992]. Consistently, knockdown of
Trp53 in pneumospheres lead to a significant increase in BFP+, Trp53 knock-
down pneumospheres (Figure 3.7C). To further show that pneumospheres can
recapitulate known biological processes we assessed the effect of knockdown of the
transcription factor Yy1, which is an important factor in early lung development,
on pneumosphere growth. Knockout of Yy1 in a lung specific mouse model lead
to a disorganised fluid filled lung characterised by reduced epithelial proliferation
[Boucherat et al., 2015]. In concordance, knockdown of Yy1 in pneumospheres
lead to a significant reduction in BFP+, Yy1 knockdown pneumospheres over
time, confirmed using two different validated and published Yy1 hairpins (Figure
3.7D) [Majewski et al., 2010].
Overall, pneumospheres can be both genetically and chemically manipulated to
assess the role of signalling pathways or genes of interest in epithelial progenitor
cells. Pneumospheres recapitulate known in vivo responses and evidence provided
here shows that they are potentially a powerful tool for studying lung development.
3.3.6 Pneumospheres can be transformed
To further investigate the potential uses of pneumospheres we next determined
if the cells could be transformed. As mentioned in Figure 3.7C, loss of the tu-
mour suppressor Trp53 leads to an increase in Trp53 knockdown pneumospheres
cells. To determine Trp53 knockdown conveyed a prolonged survival advantage to
pneumosphere cells, we knocked down Trp53 and monitored cell growth over time.
We found that loss of Trp53 enabled pneumospheres to be grown indefinitely and



































































Figure 3.8: Transformation of cells in pneumospheres with oncogenic
genes
(A) Depletion of the tumour suppressor gene Trp53 by shRNA knockdown provides a competitive
advantage to cells grown in pneumospheres and passaged up to 10 times compared to cells infected
with a non-silencing shRNA (Data represents mean ± SEM of 3 independent experiments). (B)
Cell counts showing that pneumospheres cultures of Trp53 knockout cells transduced with the
oncogenic KrasG12V are more competitive over time than knockout cells that are transduced
or wildtype cells transduced with a virus to overexpress KrasG12V (n=1). (C) Kaplan-Meier
survival curve of NOD-SCID-IL2Rγ mice subcutaneously injected with Trp53−/−; KrasG12V
pneumospheres (n=6 mice per group).
KrasG12V is a common oncogene found in lung adenocarcinoma. Oncogene in-
duced senescence in vitro is a well-known phenomenon that occurs upon intro-
ducing a single oncogenic alteration in cells. It has been shown that KrasG12V
induced cell senescence is rescued by loss of Trp53 [Brady et al., 2011]. We also
observed that pneumospheres that expressed just KrasG12V senesced by passage
6 (Figure 3.8B). However, expression of KrasG12V in pneumospheres generated
from Trp53−/− embryos induced an increase in competitive behaviour in pneumo-
spheres for at least 11 passages, compared with the internal untransduced controls


















Figure 3.9: Trp53−/−; KrasG12V pneumospheres for tumours in NOD-
SCID-IL2Rγ mice
(A, B) Representative images of Trp53−/−; KrasG12V tumour sections stained with markers
of lung adenocarcinoma (Hmga2 and Nkx2.1) and (B) a lung squamous cell carcinoma marker
(Trp63). Scale bars represent 100 µm. Insert shows Isotype control. (n=6)
To determine if these Trp53−/−; KrasG12V pneumospheres had any oncogenic ca-
pacity, we injected them subcutaneously into the right flank of NOD-SCID-IL2Rγ
mice. These mice developed aggressive tumours and had to be sacrificed less than
40 days after injection (Figure 3.8, blue line), compared to the controls who were
transplanted with Trp53+/+; KrasG12V cells and did not develop tumours dur-
ing the 100-day experiment (Figure 3.8C, red line). When the harvested tumour
tissue was transplanted back into NOD-SCID-IL2Rγ mice, tumour latency was
even shorter than the first generation, however this could be due to the size of the
tumour pieces transplanted (Figure 3.8C green line).
IHC analysis of the Trp53−/−; KrasG12V pneumosphere tumours revealed a dense
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disorganised cellular structure and expression of lung carcinoma markers (Fig-
ure 3.9). Compared to spontaneous Trp53−/−; KrasG12V mouse lung tumours,
the pneumosphere derived tumours were highly disorganised and did not show
the histological features of adenocarcinomas. However, primary and transplanted
tumours expressed high levels of the adenocarcinoma-specific markers Nkx2.1,
Hmga2, as well as Trp63, a well-known marker of lung squamous cell carcinoma,
indicating the tumours derived from Trp53−/−; KrasG12V pneumospheres maybe
undifferentiated carcinomas.
In summary, pneumospheres can be transformed and offer a quick way to test for
oncogenic capacity of selected genes in lung cells. Although further testing would
be required in more accurate models, these experiments show the potential for
using both embryonic cells and in vitro culture methods for oncogenic studies.
3.4 Discussion
Presented in chapter 3 is a robust, reproducible and useful method for culturing
E11.5 Sox9+ lung progenitor cells that recapitulates the early developing lung
cells.
The pneumosphere culture system for E11.5 epithelial Sox9+ cells is an easy and
quick method for the analysis of early lung progenitors. Other culture methods
such as the culture of Sox9+-GFP sorted E12.5 described in [Nichane et al., 2017]
is a similar system but has significant barriers compared to our own pneumosphere
protocol. Firstly, the method published by Nichane et al., requires a specific mouse
model (Sox9-GFP) to enable sorting for Sox9+ progenitor cells. Our system en-
ables a much simpler, although cruder way to enrich for Sox9+ progenitor cells.
We have demonstrated that pneumospheres have high expression of Sox9 and re-
tain that expression through their time in culture similar to the protocol described
by Nichane et al.
Other methods to study the embryonic lung, such as culture of the E11.5 lung on
an air-liquid interface have proven useful but limited [Del Moral and Warburton,
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2010, Seth et al., 1993, Jaskoll et al., 1988] [Nikolić and Rawlins, 2017]. Due to
their size and 2D growth they are unsuitable for many downstream applications
such as genetic modifications. Additionally, they involve culture of the entire
embryonic organ and therefore contain a complex mix of cells. Pneumospheres
circumvent these shortcomings and enable culture of Sox9+ epithelial progenitors
in a free-floating culture that are amenable to many different manipulations.
More recently cultures from human foetal lungs have been achieved [Nikolić et al.,
2017, Miller et al., 2018]. Nikolic et al., were able to successfully create organoids
from microdissected human epithelial stalks and tips from 5 to 9 weeks post
conception. Grown in a Matrigel supported culture these organoids displayed
branched structures, retained expression of Sox2 and Sox9 and were able to be
differentiated [Nikolić et al., 2017]. In this system, the interaction between the
mesenchyme and the epithelium was preserved, likely participating in the self-
organisation of the cells in organoids. These results have revealed differences in
mouse and human cells and are an important tool in further our understanding of
normal lung development [Nikolić et al., 2017, Miller et al., 2018]. However, due
to the difficulty in obtaining human tissue these cultures are not always feasible
it is necessary to further develop techniques using the mouse providing further
support that pneumospheres are a useful and necessary technique.
The ability to differentiate pneumospheres towards a mature lung cell lineage en-
ables greater and more powerful downstream applications. Given the pluripotent
nature of the Sox9+ epithelial lung cells it should be possible to differentiate these
cells into all of the mature cell lineages. Defining how to differentiate pneumo-
spheres into specific mature cells will provide insight into the mechanisms and
factors controlling this process which will further our understanding of in vivo
lung development.
Moreover, the use of pneumospheres enables large scale drug and genetic screens to
look for factors that promote progenitor activity, initiate differentiation or regulate
differentiation. High throughput screens such as small molecule inhibitor screens or
genetic screens using hairpins or CRISPR/Cas9 systems in pneumospheres would
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enable researches to look for novel factors regulating early lung progenitor cells.
These studies would determine mechanisms that could be regulated to induce, for
example, alveolar cell differentiation in pre-mature infants.
Other systems such as the tracheosphere culture [Rock et al., 2009] and alveo-
larsphere culture [Barkauskas et al., 2013] require scaffolding materials such as
Matrigel and/or transwells to support cell growth [Barkauskas et al., 2017]. These
methods are more difficult to scale up than pneumospheres for such screening pur-
poses. The benefit of pneumospheres are their free-floating multi-well culture that
enables replicate testing easily. Additionally, organoid cultures and differentiation
protocols are notoriously difficult to handle, giving highly heterogenous results
[Huch et al., 2017]. Although improving, culture conditions for the generation of
various lung organoids are not fully defined and as a result, researchers can have
little control over the exact shape and cell types produced from these cultures and
many replicates are needed to ensure robust data [Clevers, 2016]. Pneumospheres
in their free-floating culture system however, have proven to be highly reproducible
and consistent throughout experimental replicates thus providing a robust starting
point.
The pneumosphere system has caveats as well, the first being that they are a
spheroid culture not an organoid culture. This meaning that they have no self-
organising structure reminiscent of the organ in which they were derived. However,
when we consider that the E11.5 lung epithelium is composed of only two cell
types, the Sox2+ cells and the Sox9+ cells perhaps this is not unexpected. The
pneumosphere assay is highly proliferative and does not upregulate or express, at
any time during culture, any markers of differentiation and as such only maintains
the proliferative cells available at E11.5, the Sox9+ cells. It is also well known that
the mesenchyme plays an important role in establishing the shape of the epithelium
at the early stages of lung development. Signalling from the mesenchyme will
be required to generate organoid cultures from the early embryonic progenitor
cells. The differentiation assay used in these experiments requires pneumospheres
to be mixed with adult mesenchymal cells to induce differentiation. It will be
interesting to investigate different differentiation protocols and media supplements
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to determine if a self-organising structure with differentiated cell types could be
achieved without the addition on mesenchymal cells.
Secondly pneumospheres in this study have only been cultured for up to day
10 for all downstream applications. We have demonstrated that pneumosphere
can remain in culture for a longer period of time but begin to down regulate
proliferation markers such as Ki67. Additionally, with knockdown or knockout
of Trp53 we are able to immortalise these cells and maintain them in culture
until at least passage 10 ( 30 days) however it is currently unknown what the
transcriptional profile or genetic stability is of these cells is after 10 passages.
Loss of Trp53 is known to cause genomic instability, so we predict we would
need to alter factors downstream of Trp53 to ensure genomic stability in such
long-term cultures. In this case it would also be necessary to test if late passage
immortalised pneumospheres could still differentiate, to determine if they still have
the full progenitor capacity.
Finally, although pneumospheres retain a high expression level of Sox9 and other
lung epithelial progenitor markers we also observed a high expression of alveolar
type 1 markers including T1α (Pdpn), Ager (RAGE) and Hopx (Figure 3.3D).
Interestingly, examination of freshly sorted E11.5 EpCAM+ cells also reveals high
expression of these AT1 markers. Although this was surprising, we failed to ac-
count for the fact that these are markers of mature cell types and had not consid-
ered that their expression in the embryo could be different from that of the adult
lung. For example, T1α is expressed in the foregut region and cardiac mesenchyme
of the developing embryo from E9.5. As development continues T1α expression is
maintained in the intestine, heart, lymphoid and central nervous system. Within
the lung specifically it regulates AT1 differentiation and is restricted to those cell
types in late stage embryo and the adult [Turley, 2012]. Therefore, it is not un-
reasonable to assume that within the pneumosphere culture and the E11.5 lung,
derived from the foregut that cells expressing T1α would still be present. Similar
expression patterns have been described for Ager [Serveaux-Dancer et al., 2019]
and Hopx [Mariotto et al., 2016]. Furthermore, there has been some suggestion
recently that specification into the alveolar lineages happens much earlier then
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previously thought ( E18.5). Frank et al. found evidence of a multipotent AT2
progenitor cell at E13.5 which upregulated Hopx by E15.5. It is possible that a
proportion of Sox9+ cells have already begun specifying to the alveolar lineage by
E11.5. However a much more through investigation into these cells is needed to
support this observation [Frank et al., 2019].
Overall pneumospheres are a useful tool for studying Sox9+ epithelial lung pro-
genitors. Their ease of production and use mean that they are comparable if not
preferable to other culture systems previously described. Pneumospheres are a
screening tool for discovery of functional pathways and a necessary step before in
vivo validation. They enable further investigation into novel genes involved in stem
and progenitor maintenance and differentiation. The potential to utilise pneumo-
spheres in drug discovery, disease modelling and possibly regeneration highlight
the many benefits of using pneumospheres in lung research.
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Screening for novel epigenetic
regulators of lung development in
early lung progenitor cells
4.1 Abstract
Through development of the pneumosphere cells we were able to perform an
shRNA screen for novel epigenetic regulators of lung development. Bioinformatic
analysis and an extensive literature review narrowed the almost 1000 hairpin list
to 22 hairpins (19 genes) of interest that went on for further validation. Validation
was a two-step process in which hairpins were assessed first for their knockdown ca-
pacity and secondly for their ability to recapitulate the effect observed in the screen
in a pneumosphere competition assay. We identified 8 hairpins that significantly
knocked down their target gene and of these 7 validated in a competition assay
conducted in pneumospheres. These hairpins targeted the genes Aurkb, Sae1,
Rnf20, Smc2, Hdac3 and Ruvbl1, representing six potential candidate epigenetic




A greater understanding of how our bodies, and the natural world work have
changed the way we conduct research. Genome sequencing has revolutionised
the way we examine and produce data. The ability to genetically modify, and
specifically cause gene-deletions has greatly enhanced our understanding of gene
function. It was first identified that RNA interference (RNAi) could be used to
disrupt gene function in 1998, when it was found that introducing double stranded
RNA (dsRNA) into either Drosophila embryos or Caenorhabditis elegans (C. el-
egans) that could interfere with gene function [Fire et al., 1998, Kennerdell and
Carthew, 1998]. This initial discovery has led to large-scale loss-of-function screens
and the identification of many important genes underlying biological functions.
Although lower organisms could be directly injected with dsRNA and some hu-
man cell lines demonstrated effective screening using chemically synthesised short
interfering RNA (siRNA), a significant number of mammalian cells were resis-
tant to the transfection methods used for introducing siRNAs [Abbas-Terki et al.,
2002]. Therefore, it was necessary to develop viruses which could carry expression
cassettes that encoded the siRNA. Researchers trialled using the siRNA inside a
more endogenous backbone, as a short hairpin RNA (shRNA). In this way the
virus could utilise the cell’s RNAi machinery to generate specific siRNAs within
the cell [Brummelkamp et al., 2002, Paddison et al., 2002]. Since then many li-
braries of shRNA-expressing retroviral or lentiviral vectors have been produced
allowing researchers to perform large-scale loss-of-function screens in a wide array
of mammalian cells. Some of the most successful shRNA libraries go one step
further and have the shRNA inside an endogenous microRNA, thereby taking ad-
vantage of the full RNAi cascade [Dickins et al., 2005]. shRNAs only produced
gene knockdown, but through the recent utilisation of CRISPR/Cas9 technology it
has also been possible to completely ablate gene function [Cong et al., 2013, Mali
et al., 2013]. In addition to large, knockout CRIPSR/Cas9 screens it has also
been possible to conduct gain-of-function screens utilising overexpression vectors
and the CRISPR activation technology [Schuster et al., 2019].
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Screening using pooled guide RNAs (gRNAs) or shRNAs permits simultaneous
targeting of a large number of genes under the assumption that only one gene
is disrupted per cell. In this way a transduced population of cells, under the
influence of selective pressure (such as time) will demonstrate either an enrichment
or depletion of cells harbouring specific gRNAs or shRNAs [Crotty and Pipkin,
2015]. Additionally, because each construct contains a single unique shRNA, they
are effectively barcoded and therefore identifiable through sequencing technologies
[Echeverri and Perrimon, 2006]. The desired outcome of a pooled screen is a change
in abundance of the barcode and thus hairpin, compared to a control population,
indicating that loss of a targeted gene of interest affects phenotype [Schaefer et al.,
2018]. The use of barcodes facilitates larger pools to be used and utilises next
generation sequencing technology to assay many samples simultaneously.
However, infection efficiency is a necessary consideration when undertaking pooled
hairpin screens. It is known that targeting several genes within a single cell can
weaken the individual silencing of each gene [Gonczy et al., 2000], and with a small
pool of genes, if two shRNAs repeatedly occurred together, it would be difficult to
discriminate which causes the phenotypic change. Therefore, infection efficiency,
the number of transduced cells and the number of hairpins are important factors
when designing a hairpin screen to ensure enough power is gained to confidently
draw conclusions from the results. Furthermore, validation of results on an indi-
vidual hairpin level is also necessary before robust conclusions can be made, in
part due to the high false positive rate for most pooled screens [Echeverri and
Perrimon, 2006]. Overall pooled hairpin screens offer an unbiased look at how
perturbations of a large number of genes-of-interest can affect a chosen phenotype
to gain further insight into such chosen systems. These large-scale analyses enable
rapid testing of multiple genes and make new discoveries more efficient.
Epigenetic control of lung development has not been extensively explored thus
far. Much of the research that has been conducted centres around early respi-
ratory disease. Large-scale genome and epigenome studies have aimed to detect
the differences in lung diseases such as asthma and bronchopulmonary dysplasia
(BDP) compared to healthy controls. However, these studies focus on disease and
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often focus on late stage developmental causes and epigenetic influences. The im-
pact of epigenetics on the early stages of lung development is still underexplored.
The epigenome controls activation and repression of gene expression in response
to developmental cues and environmental signals and can subsequently pass these
responses onto daughter cells to ensure normal biological functions. It is therefore
assumed that epigenetics will play an important role in all aspects of maintaining
homeostasis, response to injury and of particular interest to this study, develop-
ment. I reasoned that important epigenetic factors control the early stages of lung
development. In particular, epigenetic factors will in some way regulate the early
lung progenitor cells and affect their differentiation for the development of the
lung into a functioning gas-exchange organ. Therefore, the aim of this chapter
was to conduct an shRNA screen in pneumospheres, using a shRNA library tar-
geted against epigenetic regulators, to identify novel epigenetic regulators of lung
development.
A list of 1200 putative epigenetic regulator genes was curated by Dr Linden Gear-
ing, Associate Professor Marnie Blewitt and Dr Andrew Keniry in the hope to
identify novel epigenetic regulators of X-inactivation. Ten hairpins were designed
for each gene and at least six were cloned into BFP expressing retroviral vectors
[Keniry et al., 2016]. I decided to utilise this established library to identify novel
epigenetic regulators of lung development. A subset of the library was chosen,
targeted against 130 putative or known enzymatic epigenetic regulators, to use in
my screen.
4.3 Results
4.3.1 Epigenetic regulator screen in pneumospheres
The pooled hairpins used in this screen were designed by Dr Jarny Choi and cloned
by Dr Tracy Willson. The pool contains 130 putative epigenetic enzymatic factor
genes with approximately six to ten hairpins per gene and includes appropriate
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1 260 136 60 2.30x106 1.34x106 58.9% 790
2 226 80 65 3.96x106 1.63x106 86.1% 1403
3 291 116 116 5.93x106 3.09x106 ND ND
controls. A schematic of the retroviral vector containing hairpin design, based on
[Dickins et al., 2005], can be seen in Figure 4.1A. The vector contains promot-
ers, puromycin resistance gene, EBFP2 and the shRNA sits within the natural
microRNA30 (miRNA3) context.
Based on the literature it is recommended to have 5,000-10,000 integrants/hairpin
[Sheridan et al., 2015]. It was decided that only one integrant per cell would be de-
sirable, for simplicity, this means 5,000-10,000 transduced cells per shRNA. Thus,
this screen of 1059 hairpins would require approximately 5x106 transduced cells.
However, an average litter of C57BL/6 embryos will yield eight E11.5 embryonic
lungs which results in approximately 150,000 cells after mesenchymal depletion.
To obtain 5x106 embryonic lung cells would require 266 embryos per experiment.
To make the experiment more feasible it was calculated that a desired result could
be achieved with 1000 cells per hairpin which would result in a total of 1x106 cells
required per experiment (54 embryos). Additionally, it was reasoned that with
a pool of around 1000 shRNAs, the chance of co-incident transduction with the
same two shRNAs would be low. Therefore, to make the screen feasible a 50%
transduction efficiency and around 1000 transduced cells per shRNA was aimed
for. To ensure a sufficient number of E11.5 lungs was obtained on the same day,
in vitro fertilisation (IVF) was performed for all three replicate experiments. Ta-
ble 4.1 shows the success rate of the IVF and the number of cells obtained and
subsequently transduced with the pooled screen virus.
The embryos were dissected and E11.5 lung cells isolated as per the pneumosphere
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protocol. Cells were depleted for mesenchymal cells and enriched epithelial cells
were transduced with the pooled retrovirus. A schematic of the experimental
procedure can be seen in Figure 4.1B. At day 1 transduced cells were selected
with puromycin. At day 3 one third of the cells were taken and snap frozen for
DNA purification at the conclusion of the experiment. The remaining two thirds
were split as per the pneumosphere protocol. At day 7 one half of the remaining
cells were harvested for DNA and one half was re-plated. At day 10 all remaining
cells were collected for DNA. Infection efficiency for the three replicate screens
ranged from 50-80% BFP positive cells at day 1 before puromycin selection. This
produced between 700-1500 cells/hairpin over the three replicate screens.
DNA was extracted and proviral intergrants were amplified using primers that
recognised common regions of the shRNAs. Primers were tagged with unique bar-
codes to identify each of the different samples, and Illumina sequencing adaptors
for sequencing (Figure 4.1B). Pooled libraries from three independent experiments
were sequenced at the Australian Genome Research Facility (AGRF) on the Illu-
mina Hi-Seq platform using 100 bp, single-end reads.
4.3.2 Screen analysis
Associate Professor Matt Ritchie performed sequencing analysis of the shRNA
screen. The total number of reads was 162 million, however only 43% of those
mapped to both barcode and hairpin primer sequences, meaning we sequenced to
a depth of 3̃5,000 reads/hairpin/sample. This low mapping efficiency is common
due to PCR errors in shRNA amplification. The experimental design was a time
course, where changes over time were examined. A model was used in which
y=intercept + replicate + slope*time. This analysis produced a list of shRNAs
where the slope was used to indicate the hairpins that showed the greatest change
over time.
A workflow to determine which of the hairpins would go on to be validated can
be seen in Figure 4.2. From the analysis performed by Associate Professor Matt
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Figure 4.1: shRNA screen design in pneumospheres
(A) Retroviral vector layout illustrating promoters in black, ψ packaging signal, puromycin
resistance gene and internal ribosomal entry site in grey, EBFP2 in blue, and inverted coloured
arrows represent individual shRNAs within the mir30 cassette targeting 130 enzymatic epigenetic
modifiers. Figure based on Dickins et al. (2005) [Dickins et al., 2005]. (B) Schematic illustrating
the work flow for conducting the enzymatic epigenetic screen in pneumospheres. E11.5 epithelial-
enriched cells were infected with pooled retroviral library. At one day of culture they were
selected with puromycin. At day 3 one third of the cells were harvested and snap frozen for
DNA purification and remaining cells were split per the pneumosphere protocol. At day 7 half
of the remaining cells were harvested for DNA and the other half were split and replated. At
day 10 all cells were harvested for DNA extraction. DNA was extracted from harvested cells and
primers which anneal to common regions of the shRNAs (black) and a unique barcode (orange)
and Illumina sequencing adaptors (blue), were used to amplify the proviral integrants. Pooled
libraries were sequenced on the Illumina Hi-Seq platform using 100 bp, single-end reads.
133
Chapter 4
Statistical top table of hairpins that changed significantly over 
three time points
785 hairpins
Sorted hairpins by p value
Hairpins with p-value of <0.05
63 hairpins
Sorted hairpins by logFoldChange







Validate 22 hairpins by knockdown and competition assay
Figure 4.2: Pipeline for analysis of shRNA pneumosphere screen
hits
Workflow to determine which hairpins from the shRNA screen in pneumospheres needed further
investigation.
Ritchie we had a top table of hairpins ranked by p-value (appendix B). However,
although some of the hairpins had significant p-values they had very small log-
FoldChange (logFC), which would be very challenging to validate or study further.
Therefore, the list was filtered to include those shRNAs with a p-value of less than
0.05, and a logFC of greater than 0.2 (Figure 4.3A). This gave provided a list of
37 hairpins to further investigate, highlighted in green, orange and blue in Figure
4.3B.
To determine which of the 37 hairpins would go on to be further investigated re-
quired an extensive literature review. Any hairpins which targeted genes where
134
Chapter 4














































Figure 4.3: shRNA pneumosphere screen data, showing shRNAs
selected using logFC and p-value cut off criteria
(A) Volcano plot showing hairpins from the shRNA screen conducted in pneumospheres. X axis
is logFC of hairpins over time and y axis is p-value for each hairpin generated by a regression
analysis of the screen timecourse. (B) Volcano plot showing only hairpins which had a logFC of
greater than 0.2 and a p-value < 0.05 (represented by dotted lines). These hairpins represented
the candidates to be further validated. Colours represent outcome of further validation including
hairpins which require further in vivo characterisation (green), those which potentially need
further investigation (orange), and those which have been excluded from further investigation
(blue). Controls are highlighted in purple.
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knockout mice survived, as lung phenotypes would result in death after birth
due to respiratory failure were eliminated. This cut the list of hairpins to 28.
Using online resources including: Eurexpress [Diez-Roux et al., 2011], Mouse Ge-
nomic Informatics (MGI) website [Bult et al., 2019, Smith et al., 2019], LungMaps
[Ardini-Poleske et al., 2017] and Transcript expression in mouse lung development
of three strains [Beauchemin et al., 2016], two hairpins targeting genes which had
no expression in the developing lung between E10.5-E15.5 were also eliminated.
Finally, and importantly any hairpins targeting genes that had already been im-
plicated in lung development were eliminated. These were important because they
provided an unbiased internal control indicating that the screen was picking out
important regulators of early lung development. These hairpins included, two
hairpins against Hdac1 and one hairpin against Carm1 which both have known
roles in lung development [Wang et al., 2013, Ito et al., 2002, Ito et al., 2005]
[O’Brien et al., 2010]. After all the filtering and literature review, the total num-
ber of hairpins was 23, targeting 20 genes of interest. However, one hairpin was
eliminated during the validation process due a bacterial glycerol stock that would
not grow, preventing individual validation of the shRNA, resulting in 22 hairpins
targeting 19 genes of interest.
The expression of the top 19 genes of interest was examined in our previously
generated RNAseq data for pneumospheres harvested at day 3, day 7 and day 10
and E11.5 EpCAM+ epithelial lung cells. This was to ensure that all 19 genes
were expressed in E11.5 epithelial cells and expressed in pneumospheres over time.
Figure 4.4A shows expression of the top 19 genes identified from the screen in the
E11.5 epithelial lung cell RNAseq and in pneumosphere RNAseq. All 19 genes are
expressed at a high level in both E11.5 epithelial cells and in the pneumospheres
over time. In Figure 4.4B the top 19 genes are shown in different colours over the
three harvest days in the pneumosphere RNAseq. They do not appreciably change
expression over time indicating that the results from the screen are not skewed

















































Genes of interest over time in 
pneumospheres
A B
Figure 4.4: All 19 genes-of-interest are expressed in E11.5 lung
epithelial cells and pneumosphere cultures over time
(A) RNA expression of the 19 top genes from the screen in RNAseq data from E11.5 EpCAM+
epithelial cells and WT pneumospheres harvested at day 3, 7 and 10 show moderate to high
expression of all genes. (B) Expression of each of the 19 genes (each represented by a different
colour) does not change significantly over time in the pneumosphere culture. Expression is given
as log of the normalised counts per million (CPM) for each gene. Data represent mean ± SEM
of 3 independent experiments.
4.3.3 Validation of hairpins by knockdown
To validate the hairpins, we needed to confirm target gene knockdown by quantita-
tive reverse transcription PCR (qRT-PCR). It was determined that only hairpins
which significantly knocked down their gene of interest would be considered for
further analysis.
Overall, of the 22 hairpins, 14 of them did not significantly knockdown relative
to non-silencing control (Figure 4.5A). The remaining 8 hairpins all significantly
knocked down their target gene relative to non-silencing control (Figure 4.5B).


















































































































Figure 4.5: Knockdown validation of the top 22 hairpins in Mouse
Embryonic Fibroblasts (MEFs)
All experiments used Hmbs mRNA expression for normalisation. Expression of the targeted gene
in knockdown cells was compared to a non-silencing control. (A) 14 of the 22 hairpins did not
significantly knockdown their target gene when compared to a non-silencing control in MEFs.
(B) Eight of the 22 hairpins did significantly knockdown their target gene when compared to non-
silencing control. Data represent mean ± SEM of 2-10 independent experiments. Significance by




4.3.4 Validation of hairpins by competition assay
Further validation of hairpins required analysis by competition assay in pneumo-
spheres, to determine if the same effect was observed using individual hairpins as
was seen in the screen, and remove false positives which are common in pooled
screens. A schematic of the competition assay is described in Figure 4.6. Vec-
tors containing the hairpins also contain a BFP tag allowing the representation of
each hairpin over time to be assessed by flow cytometry. For example, if gene x
was knocked down and an increase in the percentage of BFP+ cells was seen over
time, this meant that loss of gene x lead to a competitive advantage over WT-
BFP- (non-infected) cells. This would suggest that gene x inhibits proliferation,
and/or induces cell differentiation or death. In contrast, when gene z was knocked
down and a decrease in the percentage of BFP+ cells was observed, this indicates
that gene z had a competitive disadvantage over WT-BFP- (non-infected) cells.
It could be concluded that gene z is important for proliferation and survival. Fi-
nally, if gene y was knocked down and no change in BFP expression over time was
seen, it would be concluded that gene y is not important in pneumospheres and
loss of gene y offered no competitive advantage or disadvantage over WT-BFP-
(non-infected) cells. Alternatively, the level of gene y knockdown was insufficient
to disrupt the pneumosphere competition assay (Figure 4.6).
In parallel with knockdown analysis, all 22 of our top hairpins from the screen were
assessed using the pneumosphere competition assay. First to assess if the hairpin
significantly competed in the pneumosphere system and secondly, if the readout
recapitulated what was observed in the screen. Figures 4.7 and 4.8 reveal the
results of all 22 individual hairpins in the competition assay. Eight of the hairpins
did not significantly change over time, meaning they did not read out and did
not recapitulate what we observed in the screen. These hairpins included: Elp3.7,
Kdm4a.6, Mettl8.2, Ehmt2.6, Kdm6a.2, Ash1l.2, Ehmt2.5 and Prdm5.3 (Figure
4.7A). There were five hairpins that displayed significantly different behaviour
compared to WT-BFP- cells when normalised to a non-silencing control (p≤0.02,
Figure 4.7B-E). These hairpins included, Kat5.2, Setd1a.6, Setd2.10, and Chd4.2
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Loss of gene Y
Loss of gene Z
BFP+ cells out 
compete WT 
cells
No change in 
BFP+ cells
WT cells out 
compete BFP+ 
cells
Gene X inhibits proliferation, 
induces cell differentiation or 
cell death
Gene Y is not important
(nonsilencing control)
Gene Z is important for prolif-
eration and survival
Figure 4.6: Schematic detailing the competition assay used for
validation of the hairpins from the enzymatic regulator screen in
pneumospheres
Hairpins are tagged with BFP which is monitored overtime to look for changes in the percentage
of cells expressing BFP. An increase in BFP indicates that loss of that gene provides a competitive
advantage compared to uninfected (WT) cells. A decrease in BFP indicates that loss of that
gene has a competitive disadvantage to uninfected (WT) cells.
and Chd4.3. However, these hairpins were eliminated as gene knockdown not
efficient, with more than 50% of normal transcript levels retained in the knockdown
cells (Figure 4.5B).
The hairpins, Aurkb.5, Sae1.4, Sae1.3, Rnf20.2, Rnf40.2, Smc2.5, Ruvbl1.8, Hdac3.8
and Prmt7.5 all demonstrated a highly significant read out in the competition as-
say (p<0.0001). However, only Aurkb.5, Sae1.4, Sae1.3, Rnf20.2, Smc2.5, Ruvl1.8
and Hdac3.8 also performed well in the knockdown assay in section 4.3.3, with each
hairpin knocking down their respective gene to less than 50% expression compared
to the non-silencing control. Therefore, Rnf40.2 and Prmt7.5 were eliminated from
further examination. It is also interesting to note that knockdown using Prmt7.5
conveyed a competitive advantage in three independent experiments however did
not recapitulate what was observed in the screen, a competitive disadvantage
(logFC -0.27). Overall, these 7 hairpins targeting 6 genes are potential novel reg-
ulators of early lung progenitor cells. Further investigation into their function in

























































































































































 Significance ≤ 0.02
A
Figure 4.7: Validation of the top 22 hairpins from the enzymatic
regulator screen in pneumospheres by competition assay
(A) Eight of the 22 hairpins did not significantly differ to controls in their behaviour in the
competition assay. (B-E) Five of the 22 hairpins had a significant (p<0.02) response in the
competition assay, displaying a decrease in BFP+ cells compared to WT (BFP-) cells. These
hairpins however did not knockdown their target gene. X-axis represents days in culture, y-
axis represents the proportion of BFP+ cells normalised to the non-silencing control. BFP+
cells represent cells transduced with individual shRNAs. Data represent mean ± SEM of 2-10









































































































































































































































Figure 4.8: Examination of the top 22 hairpins from the enzymatic
regulator screen in pneumospheres by competition assays
Nine of the 22 hairpins had a highly significantly altered behaviour compared with controls
(p<0.0001) in the competition assay. Of these, only seven hairpins (Aurkb.5 (A), Sae1.3 and
Sae1.4 (B), Rnf40.2 (D), Smx2.5 (E), Ruvbl1.8 (F) and Hdac3.8 (G)) also significantly depleted
the expression of their target gene. X-axis represents days in culture, y-axis represents the
proportion of BFP+ cells normalised to the non-silencing control. BFP+ cells represent cells
transduced with individual shRNAs. Data represent mean ± SEM of 3-10 independent experi-




Much of the knowledge that has been gained about the mechanisms regulating
developmental processes and cellular dynamics has been learned from functional
genetic screening. Hairpin screens have become a powerful tool in elucidating the
genetic regulators of biological processes. In this chapter I have demonstrated that
screening in pneumospheres can be used to find putative novel regulators of lung
development. Table 4.2 summarises the results of the screen.
Table 4.2: Summary of the shRNA screen in pneumospheres





1 Chd4.2 -1.43 × × ×
2 Aurkb.5 -1.35 P P P
3 Elp3.7 1.25 × × ×
4 Sae1.4 -1.07 P P P
5 Kat5.2 -0.95 × × ×
6 Rnf20.2 -0.64 P P P
7 Mettl8.2 -0.63 P × ×
8 Kdm4a.6 -0.41 × × ×
9 Setd2.10 -0.37 × P ×
10 Sae1.3 -0.35 P P P
11 Kdm6a.2 -0.35 × × ×
12 Ehmt2.5 -0.34 × × ×
13 Rnf40.2 -0.33 × P ×
14 Chd4.3 -0.33 × P ×
15 Smc2.5 -0.33 P P P
16 Setd1a.6 -0.32 × P ×
17 Hdac3.8 -0.31 P P P
18 Prmt7.5 -0.27 × P ×
19 Ash1l.2 -0.26 × × ×
20 Ruvbl1.8 -0.24 P P P
21 Ehmt2.6 -0.21 × × ×
22 Prdm5.3 -0.21 × × ×
The table includes the hairpin’s log fold change (logFC) and ranking based on the logFC and
p-value from the screen analysis. Ticks indicate if the hairpin caused significant knockdown
in column four and if the hairpin had a significant competitive effect in column five. Finally,
hairpins that were validated in both the knockdown and competition assay are summarised in
column six and represented in green. Hairpins in blue did not validate.
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Through three independent replicate screens conducted in pneumospheres, 923
hairpins targeting 130 genes were ranked based on the relative representation of
these hairpins over time. In this way I aimed to identify genes that conveyed a sur-
vival effect to epithelial lung progenitor cells that would further our understanding
of early lung development. Through bioinformatic analysis and an extensive lit-
erature review, a potential list of 22 candidate hairpins, targeting 19 genes was
established. Of the initial 22 hairpins that went through the validation process
only seven hairpins targeting six genes gave significant and strong readouts in
both knockdown experiments and in competition assay. The targeted genes were:
Aurkb, Sae1, Rnf20, Smc2, Hdac3 and Ruvbl1. These six genes warrant further
investigation in vivo into their role in lung development.
Reproducibility across studies is often difficult, mainly attributed to differences in
knockdown efficiencies and off-target effects. Therefore, it is necessary to ensure
multiple shRNAs per gene are included in pooled screens [Fellmann and Lowe,
2014]. At onset of the hairpin screen I endeavoured to only validate genes which
had at least two hairpins in the top table. However, upon screen analysis it was
realised that this criterion severely limited our potential candidates. There are
many reasons that screens can fail to identify shRNAs with real effects on the
assay, i.e. false negatives. One major reason in this case is likely the low cell
number and therefore number of integrants that were able to be analysed for
each shRNA in the pool. With lower integrant number there is a higher chance
of random dropout for each shRNA. Additionally, pooled screens require a PCR
amplification step prior to sequencing which can lead to a non-linear representation
of viral integrants and therefore create false positive or false negative results.
Of the top 22 hairpins targeting 19 genes, only three genes had two hairpins,
these included: Chd4 (Chd4.3, Chd4.2), Ehmt2 (Ehmt2.5, Ehmt2.6) and Sae1
(Sae1.3, Sae1.4). Only one of the two hairpins for Chd4 (Chd4.3), displayed any
knockdown efficiency, and Chd4.3 was only able to knockdown Chd4 expression
to 75% of normal expression. Although Chd4.3 did compete significantly in
the competition assay this result was more subtle than what was observed for
other hairpins. Given that the second hairpin targeting Chd4, Chd4.2 did not
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validate in either knockdown or competition assay, Chd4 was eliminated as a
gene of interest. Although both Ehmt2 hairpins demonstrated some knockdown
efficiency, both failed to show any significant change in the competition assay
and therefore Ehmt2 was eliminated as a gene of interest. Only the two hairpins
targeting Sae1, Sae1.3 and Sae1.4 showed robust knockdown and significant change
in the competition assay and was therefore listed as a potential candidate gene for
validation in vivo. Overall, although the screen was limited by a smaller starting
cell number, validation of the results of the screen indicate identification of real
candidates, further validated by the appearance of two genes in the top list that
had already been identified as regulators of lung development. However, genes
which only had one shRNA, Aurkb, Smc2, Rnf20, Hdac3, and Ruvbl1 will need
to be further validated with a second hairpin to ensure there were no off target
effects associated with the primary hairpin. Encouragingly, in a smaller pilot
screen conducted by Dr Laura Galvis prior to this screen, many of the same genes
were identified as potential candidates including Aurkb, Sae1 and Ruvbl1, all of
which had different hairpins identified to the ones identified in this current screen
(L. Galvis, Honours Thesis 2013).
Although I identified several genes-of-interest in this shRNA screen in pneumo-
spheres it would be interesting to perform a similar screen using the recently
developed CRISPR/Cas9 technologies. The relative ease of designing sgRNA,
commercially available screening libraries, the single editing event, and sensitivity
make CRISPR knockout screens very attractive [Schuster et al., 2019]. However,
there were significant downfalls that made a CRISPR/Cas9 screen unattractive in
pneumospheres such as, low cutting efficiency and off-target effects. Not all muta-
tions introduced by cutting at the sgRNA site will lead to a knockout and this can
lead to confounding results. Additionally, due to the nature of the DNA repair
process and the efficiency of targeting, frequently the outcome is a set of cells with
heterogeneous mutations across the two alleles in the cell and between the alleles
in different cells, despite all having the same sgRNA [Morgens et al., 2016]. Fi-
nally, the major limitation of a CRISPR knockout screen in relation to this study
is the extreme potency and fast effect. I wanted to assess how loss of a gene would
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affect lung progenitor cells over time. CRISPR/Cas9 knockout screens are geared
towards detection of genes that give a positive advantage when knocked out. This
may have meant that the current genes-of-interest identified in this screen would
not have been identified as only genes that conveyed a disadvantage when depleted
were found. Therefore, shRNA was deemed a more reliable way to assess what
were likely to be very important factors in lung development, as knockdown often
leaves cells alive and able to be studied. In the future, it would be beneficial to
use a CRISPR/Cas9 screen to complement the shRNA screen as these may reveal
genes that are less dose sensitive and require full knockout to reveal a result.
In the present study only a subset of the curated library produced by Dr Linden
Gearing, Associate Professor Marnie Blewitt and Dr Andrew Keniry was used.
Further shRNA screens using the remaining library may reveal additional genes-
of-interest. The extended library contains other family members and complex
partners of the current genes-of-interest. By using screens containing these addi-
tional genes it may be possible to further validate the current genes-of-interest,
as well as identify other candidate genes. Conducting the additional epigenetic
regulator screens in pneumospheres could broaden our understanding of the epige-
netic control of early lung progenitor cells. Little is known about how these very
early lung cells are regulated and it is very likely that there are many processes
underlying normal development that have yet to be elucidated.
Of note, this curated list of genes in the library was specifically aimed at identifying
genes that are involved in X inactivation and reactivation. It is possible that many
of the genes-of-interest that have been identified in this screen in lung progenitor
cells are genes that are of global importance to all cells. As the current epigenetic
library is repurposed in other systems, it will be interesting to note whether similar
genes are identified as those identified in our screen. Similar hits would indicate
that genes identified in this screen are of global importance and might require fur-
ther investigation in other tissues or processes. However, to identify genes specific
to lung development, additional screens could be undertaken specifically targeting
putative lung regulator genes. It has been demonstrated that pneumospheres are
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a powerful tool for investigating the Sox9+ lung progenitor cells and could be used
to identify further genes of interest.
In conclusion, I have identified new genes that are potentially involved in the
regulation of Sox9+ epithelial progenitors in the E11.5 lung. These genes have
never been associated with lung development before and their characterisation in
lung development could result in a further understanding of normal lung processes.
Further investigation could provide insight into proliferation, differentiation and
maintenance of the progenitor cells that will enhance our understanding of disease
and development of better treatments. These six candidate genes uncovered from
the shRNA screen in pneumospheres reveal that we still have much to learn about
how the lung is regulated, develops and is maintained. Screening in primary cells
remains a powerful and necessary approach to identifying important genes and
gene networks regulating biological processes.
147
Chapter 5
Aurkb is a novel regulator of early
lung development
5.1 Abstract
Lung development is a complex process that is still not well understood. Presented
here is an investigation into the role of a novel regulator of lung development, Au-
rkb. Aurkb is involved in the cell cycle and is often overexpressed in cancer.
Through a shRNA screen in early lung progenitor cells (pneumospheres), Aurkb
was identified as a candidate gene-of-interest in the regulator of Sox9+ epithelial
lung cells. Aurkb is highly expressed throughout all stages of lung development.
Genetic deletion or chemical inhibition of Aurkb in pneumospheres showed an
accumulation of cells in the G2/M cycle of cell division and treatment with an
Aurkb specific inhibitor preventing branching morphogenesis in an E11.5 ex vivo
assay. Conditional knockout of Aurkb in lung epithelium from E9.5 resulted in a
complete lack of lung tissue at birth. Lightsheet microscopy analysis of the devel-
oping E11.5 lung revealed a stunted epithelium and no branching morphogenesis.
Further investigation into the exact role of Aurkb in lung development is neces-
sary. Overall, Aurkb is a novel regulator of early lung development that informs




At the conclusion of the screen (Chapter 4) we had six candidate genes that could
be involved in lung development based on their effect in pneumospheres. It was
therefore necessary to evaluate each candidate and choose a gene that would most
likely play an important role in early lung progenitor cells and lung development
to follow up in detail. To narrow down this choice, two main criteria were chosen
for determining the main gene of interest for an in-depth study. The first was
based on a literature review to select a gene likely to have an effect on early lung
epithelial progenitor cells based on its known mechanisms of action and role in
other organs. Secondly, an attractive gene candidate would have technical and
experimental resources available, such as inhibitors and mouse models to facilitate
our investigation. Of the six genes, Aurkb, Sae1, Rnf20, Smc2, Hdac3 and Ruvbl1,
Aurkb seemed the most attractive candidate gene to follow up on within the time
frame available.
Aurkb is a highly conserved serine/threonine kinase and belongs to the Aurora
kinase family which includes Aurka, Aurkb and Aurkc [Goldenson and Crispino,
2015]. All three family members play important roles during the cell cycle, but
despite their high sequence similarity they have distinct functions and localisations
during cell division. Aurkb and Aurkc do have functional overlap but are expressed
in different tissues and at times, with Aurkc expression restricted to the testis and
pre-implantation embryo [Kimura et al., 1998].
A detailed mechanism of action of Aurkb is presented in section 1.7. In brief,
Aurkb is recruited to the chromosomes at the onset of the G2/M transition. At
prometaphase Aurkb is restricted to the centromeres of the chromosomes where
it forms the catalytic subunit of the chromosomal passenger complex (CPC),
with inner centromere protein (INCENP), Borealin and Survivin [Goldenson and
Crispino, 2015]. The CPC regulates kinetochore-microtubule attachments to en-
sure correct separation of the two sister chromatids. Aurkb lowers the binding
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affinity of the kinetochores to the microtubules, delaying the onset of anaphase
until all the correct attachments are made [Krenn and Musacchio, 2015].
Thus far Aurkb has only been studied in pre-implantation embryos [Fernández-
Miranda et al., 2011]. Deletion of Aurkb in zygotes resulted in normal development
until just after implantation after which the embryos died [Fernández-Miranda
et al., 2011]. To date, no other reports have been made about the role of Aurkb
during embryogenesis. Given the multiple and important roles in the cell cycle it
seems likely that Aurkb would play an important role in the highly proliferating
tissues throughout development. The early stages of lung development are marked
by signification proliferation and outgrowth and therefore Aurkb seems a likely
candidate gene playing an important role in this process.
Although little is known about Aurkb’s role in development much of the knowledge
we do have is due to its important role in disease, specifically cancer. Aurkb
overexpression is detected in many primary tumours such as non-small cell lung
cancer and breast cancer, and is associated with multinucleation and polyploidy of
cancerous cells [Schwartz et al., 2013, Nguyen et al., 2009, Vischioni et al., 2006,
Liao et al., 2018]. Due to its frequent overexpression in many cancers there have
been significant efforts to develop inhibitors of Aurkb. The compound AZD1152,
also known as basasertib, is a highly specific Aurkb inhibitor that is frequently
used in laboratory experiments [Yang et al., 2007, de Groot CO et al., 2015].
AZD1152 has been shown to disrupt cell cycle progression, to delay cells in G2
and to inhibit phosphorylation of H3S10 and H3S28.
Given the importance of Aurkb in the cell cycle and disease, many laboratory
tools have been developed to study this kinase including: overexpression vectors,
antibodies, inhibitors and a floxed mouse model. Aurkb was therefore selected for




5.3.1 Aurkb is highly expressed during lung development
Based on the pneumosphere and E11.5 EpCAM+ epithelial cell RNA expression
data sets I knew that Aurkb was highly expressed in the E11.5 epithelium and
throughout the pneumosphere culture period (Figure 4.4). I therefore looked at
Aurkb expression during other stages of lung development, first using an online
resource by Beauchemin et al., in which they generated genome wide expression
data during murine lung development from E9.5 to P56 [Beauchemin et al., 2016].
It was found that Aurkb was expressed at a high level from the earliest stages
of lung development, E9.5, until the saccular stage of lung development around
E17.5 (Figure 5.1A). After this stage expression of Aurkb decreased until just after
birth when there was another wave of upregulation of its expression until P9 when
expression decreased again and stabilised for the remaining time tested. It was
found that this expression pattern of Aurkb closely mimicked the expression of
the proliferation marker Ki67, through lung development (Figure 5.1B). Given
the role of Aurkb in proliferation and mitosis it makes sense that the expression
patterns of these two genes would be very similar.
To further confirm Aurkb expression at the protein level during lung development
and to examine the cell types in which it is expressed, immunohistochemistry
(IHC) staining for Aurkb at E11.5-E18.5, P0.5, P7, P28 and adult lung was per-
formed (Figure 5.2A). Similar to what was observed in the Beauchemin et al.
data, Aurkb was highly expressed throughout the embryonic, pseudoglandular,
and canalicular stages of lung development. Expression appeared to decrease some-
what during the saccular stage of lung development but was very strong at P0.5
just after birth as was seen in Figure 5.1A. Additionally Lightsheet microscopy
was undertaken to examine Aurkb expression in wholemount E11.5 lungs (Figure









































































































Figure 5.1: Aurkb transcript is expressed throughout lung
development and mimics expression profile of the proliferation marker
Ki67
Transcriptional profile of Aurkb (A) and Ki67 (B) throughout lung development (E9.5-P56)
from [Beauchemin et al., 2016]. Aurkb expression is high from E9.5-E16.5, and decreases until
birth. The expression increases after birth until P5 and then slowly decreases and plateaus.
Expression of Aurkb closely mimics the expression pattern of Ki67. Colours represent stages
of lung development including: embryonic (orange), pseudoglandular (blue), canalicular (teal),
saccular (olive), and alveolar (pink). (Data represents mean ± SEM of 3-4 replicates)
observed in the distal epithelium consistent with proliferation and outgrowth of
the developing lung.
Given the high sequence similarity of the three Aurora kinase proteins, expression
of Aurka and Aurkc in the Beauchemin et al. data was also examined. As to be
expected given the role of Aurka in the cell cycle, Aurka is expressed in a similar
pattern to both Aurkb and Ki67 (Figure 5.3A), suggesting Aurka may play a
role in lung development. However, it has been extensively shown that Aurkb
and Aurka play mutually exclusive roles and Aurka cannot rescue the phenotype
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E11.5 E12.5 E13.5 E14.5
E15.5 E16.5 E17.5 E18.5
P0.5 P7 P28 Adult
A
B Ecad Aurkb Merge
Figure 5.2: Aurkb protein is expressed throughout lung
development in both epithelial and mesenchymal cells
(A) Immunohistochemistry staining for Aurkb on embryonic and post-natal lung sections from
E11.5-E18.5, P0.5, P7, P28 and adult. Aurkb staining can be seen in cuboidal epithelial cells as
well as in surrounding mesenchymal cells. (B) Lightsheet analysis of an E11.5 lung stained for
E-cadherin (magenta) and Aurkb (yellow). Aurkb is expressed in both within the epithelium as









































































































Figure 5.3: Aurka and Aurkc transcript expression throughout lung
development
Transcriptional profile of Aurka and Aurkc throughout lung development (E9.5-P56) from [Beau-
chemin et al., 2016]. (A) Aurka expression mimics expression of Aurkb. (B) Aurkc is lowly
expressed throughout lung development and into adult life. Colours represent stages of lung
development including: embryonic (orange), pseudoglandular (blue), canalicular (teal), saccular
(olive), and alveolar (pink). (Data represents mean ± SEM of 3-4 replicates)
associated with loss of Aurkb [Goldenson and Crispino, 2015, Fu et al., 2009, Hans
et al., 2009]. Therefore it is anticipated that knockdown or knockout of Aurkb
during lung development would not be compensated by Aurka.
Aurkc is thought to play similar roles to Aurkb but only during the very earliest
stages of embryogenesis and in the testis of adult mice. A very low level of Aurkc
expression is observed throughout lung development indicating that Aurkc is un-
likely to play a role in lung morphogenesis (Figure 5.3B). Overall, Aurkb is highly
expressed throughout lung development particularly at the early embryonic and
pseudoglandular stages that were analysed in the pneumosphere assay.
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5.3.2 Loss of Aurkb affects cell cycle progression
Given the potent effect the hairpin against Aurkb, Aurkb.5, had in both the screen
and in the competition assay (Figure 4.8A) we tested knockdown efficiency in
pneumospheres as previous expression knockdown studies had been conducted in
MEFs. Knockdown efficiency in MEFs was just below 50% of normal expression
(Figure 4.5B) however in pneumospheres this effect was much stronger with Au-
rkb.5 knocking down Aurkb expression to approximately 20% of normal expression
(Figure 5.4A).
In addition to the potent hairpin targeting Aurkb, the effect of the Aurkb spe-
cific inhibitor AZD1152 on pneumosphere cell proliferation was also evaluated.
Pneumospheres were treated with AZD1152 at different concentrations then cell
proliferation was measured by MTS assay. Increasing concentrations of AZD1152
caused a significant reduction in the percentage of viable cells with an IC50 of 148
nM (Figure 5.4B).
Given Aurkb’s important role during mitosis we wanted to determine if any effect
on the cell cycle could be observed after Aurkb depletion or inhibition. Pneumo-
spheres were transduced with Aurkb.5 at a ratio 50% infected cells to non-infected
cells to internally control the experiment. At day 3, cells were treated with bro-
modeoxyuridine (BrDU). After two hours BrDU incorporation and DNA content
was measured to assess the proportion of cells in G0/G1, S-phase and G2/M phases
of the cell cycle. In normal uninfected cells, the proportion of cells in G0/G1 was
70% (+/-3%), 25% (+/-2%) in S-phase, while the remaining 2% (+/-1%) of cells
were in G2/M (Figure 5.4Ci). Similar proportions of cells in each of the cell cycle
phases was observed in non-silencing transduced cells (Figure 5.4Ciii). However,
upon knockdown of Aurkb, we saw an increase in the number of cells in G2/M,
rising to about 27% (+/-5%) of total cells (Figure 5.4Cii). Similarly, an accu-
mulation of cells in G2/M when pneumospheres were treated with AZD1152 was
also observed (Figure 5.4D). As the concentration of AZD1152 was increased, the
proportion of cells in G2/M also increased although this was also accompanied by




































































































































Pneumospheres treated with AZD1152
BAurkb.5 knockdown Pneumospheres treated with 
AZD1152
shRNA AZD1152
BFP- BFP+ DMSO 400nM
Figure 5.4: Knockdown by shRNA or chemical inhibition of Aurkb
in pneumospheres leads to decreased proliferation and accumulation
of cells in G2/M
(A) Knockdown validation of Aurkb.5 shRNA in pneumospheres and MEFs compared to non-
silencing control. Knockdown of Aurkb using the same shRNA is much stronger in pneumospheres
than in MEFs. (B) MTS proliferation assay of pneumospheres treated with the Aurkb inhibitor
AZD1152 for 3 days. (C-D) BrDU incorporation and 7-AAD staining analysis show an accumu-
lation of cells in G2/M 3 days after knockdown or inhibition of Aurkb in pneumospheres. (C)
FACS plots comparing uninfected BFP- (Ci) and transduced Aurkb.5 BFP+ cells (Cii). (Ciii)
Quantification of cells in different phases of the cell cycle after transduction with non-silencing
shRNA or Aurkb.5 shRNA. (D) A similar effect can be seen when using the Aurkb inhibitor
AZD1152 (Dii) compared to the DMSO control (Di). (Diii) Bar plot showing quantification
of cells in the different phases of the cell cycle after treatment with increasing concentrations
of AZD1152. (Data represents mean ± SEM of 3 independent experiments. Significance by
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Smc2.5 Ruvbl1.8
BFP- BFP+ BFP- BFP+
Figure 5.5: The shRNA screen was not selecting for genes that are
involved in the cell cycle as confirmed by examining two other hits
from the screen, Smc2.5 and Ruvbl1.8
No significant change was observed in the percentage of cells in each of the cell cycle stages
for either hairpin. (A) BrDU analysis of pneumospheres transduced with Smc2.5. FACS plots
comparing uninfected BFP- (Ai) and transduced Smc2.5 BFP+ cells (Aii). (Aiii) Quantification
of three independent replicate experiments compared to a non-silencing control to confirm effect
is not bias due to hairpin infection. (B) A similar effect can be seen when pneumospheres were
transduced with Ruvbl1.8 (Biii) Quantification of three independent replicate experiments is
seen. (Data represent mean ± SEM of 3 independent experiments. Significance by two-way
ANOVA; ****p<0.0001, ***p<0.001, **p<0.01)
Due to the highly proliferative nature of the pneumosphere assay I wanted to
assess if the hairpin screen pulled out candidate genes that were only targeting
proliferation and the cell cycle. Two other candidates, Ruvbl1.9 and Smc2.5 were
also tested in the BrDU incorporation assay. No change in the cell cycle was seen
when Ruvbl1 or Smc2 were knocked down in pneumospheres (Figure 5.5A & B).
This indicated that the screen did not only target genes that were involved in
proliferation and thus may be lung development specific targets.
Utilising AZD1152 the effect of inhibition of Aurkb on branching morphogenesis
was assessed. E11.5 lungs were treated with 500 nM and 1 µM of AZD1152 and
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imaged after three days in culture (Figure 5.6). Lungs that had been treated
with AZD1152 failed to branch compared to the DMSO control lungs. Treated
lungs showed no evidence of any epithelial growth although lungs did not have
the shrunken tissue look typical of this assay when the drug is toxic to the cells.
Immunofluorescence staining for the epithelial marker E-cadherin and the prolif-
eration maker Ki67 show that there are some proliferating epithelial cells in the
treated lungs (Figure 5.6A). However, if these cells are progressing through the
cell cycle or stuck in S-phase/mitosis can not be determined. Examination of the
apoptosis marker cleaved caspase 3 (CC3) revealed there was cell death in the
surrounding mesenchyme as well as within the E-cadherin+ epithelial cells (Fig-
ure 5.6B). Overall, the appearence of Ki67+;E-cadherin+ epithelial cells supports
the BrDU incorporation assay (Figure 5.4) and suggests cells are stuck in the cell
cycle rather preventing branching morphogenesis.
In concordance with the role of Aurkb in the cell cycle, inhibition of Aurkb disrupts
lung epithelial cell proliferation. Treatment of pneumospheres with the hairpin
against Aurkb or when treated with AZD1152 lead to an accumulation of cells
in G2/M. Additionally, inhibition of Aurkb in a branching morphogenesis assay
prevented any branching of the epithelium ex vivo.
5.3.3 Lung epithelial specific deletion of Aurkb disrupts
lung development
Given the important role Aurkb appeared to be playing in early lung epithelial
progenitor cells it was decided to import the Aurkbflox mice and induce an early
lung epithelial specific deletion of Aurkb using the Shh-Cre mice [Harfe et al., 2004],
herein referred to as AurkbcKO. Shh is expressed in the ventral foregut endoderm
at E9.5 and expression of Cre driven from this locus causes excision of exons 2-6
in the Aurkb gene. Shh-Cre is a common mouse model used to explore early lung
epithelial cells and has been shown to exhibit few off target effects and specific lung
expression. Experimental AurkbcKO embryos were obtained by crossing a male


























































Figure 5.6: Inhibition of Aurkb affects lung branching
morphogenesis
(A,B) Treatment of ex vivo E11.5 lungs with AZD1152 for 3 days blocking branching mor-
phogenesis. (A) Immunofluorescence staining for the proliferation marker Ki67 (yellow) show
that cells are still proliferating including within the epithelium (stained with E-cadherin, ma-
genta) despite no branching morphogenesis occurring. (B) Immunofluorescence staining for the
apoptotic marker Cleaved Caspase 3 (CC3) (green) show that both epithelial and mesenchymal
cells are dying (stained with E-cadherin, magenta). Representative images for 3 independent
experiments. Scale bars represent 200 µM (Z stack) and 50 µM (optical section).
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Phenotype Mutant Heterozygous Wildtype Wildtype
No of embryos 75 65 55 52
Ratio 30% 26% 22% 21%
No of female 
embryos 22 (19%) 7 (6%) 14 (12%) 12 (10%)
No of male 
embryos 16 (14%) 14 (12%) 18 (16%) 12 (10%)
genotyped and found present at expected Mendelian ratios before birth (Table 5.1).
Additionally, sexing genotyping was undertaken for the first 115 offspring. Overall
there was an even split between female and male embryos (48% female vs. 52%
male) (Table 5.1). Furthermore, no differences in phenotype was observed between
heterozygous mice and wildtype mice and therefore both genotypes were used as
littermate controls. In three experimental litters collected after birth, mutant mice
did not survive after birth and died from respiratory difficulties. These mutant
mice were noticeably smaller than their littermate controls, appearing to have a
shortened anterior-posterior axis (Figure 5.7A). It was also observed that mutant
mice had hypomorphic tails, which were both shorter and thinner than littermate
controls (Figure 5.7A & B). It was possible to detect these phenotypic details as
early as E13.5 (Figure 5.7B).
To further investigate why mutant mice died at birth from respiratory distress, I
initially tried dissecting out the lungs of E18.5 embryos. However, no lung tissue
was found at this time point. Therefore, to obtain more structural information
on the E18.5 AurkbcKO we performed wholemount MicroCT imaging following
the STABILITY protocol [Wong et al., 2013, Hsu et al., 2016]. Imaging of the
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E18.5 AurkbWT embryo revealed normal lung structure which were reconstructed
in 3D in Figure 5.7C. In contrast, imaging of the AurkbcKO embryo revealed an
absence of lung tissue (Figure 5.7D). A large cavity where the lungs should have
been is observed and the atrium of the heart has expanded to fill the cavity. A
computational rendering of the AurkbWT and AurkbcKO E18.5 embryos can be
seen in Figure 5.7E in which the embryo has been cleared and only the lungs
highlighted. As seen in Figure 5.7D, no lung is observed in the mutant embryo.
Additional planes of view have been included in appendix C. In addition to the lack
of lung tissue, there appeared to be some disruption to the gastro-intestinal organs
(appendix C) and further investigation into this phenotype will be necessary.
Given that dissection of any lung tissue was proving to be difficult, histological
sections of whole embryos were examined at E16.5, E13.5 and E11.5 (Figure 5.8).
Similar to what was observed at E18.5, no evidence of any lung structure or of the
trachea at E16.5 (Figure 5.8B) or at E13.5 (Figure 5.8D, F) in AurkbcKO embryos.
Heart formation appeared to be normal however the large cavity left by absence
of the lungs did cause some structural disturbances to the heart as observed at
E18.5 by MicroCT. Additionally, little or no evidence of any lung tissue at E11.5
was seen (Figure 5.8H). There was some evidence to suggest some tracheal tissue
(Figure 5.8J blue) however this tissue was significantly smaller than littermate
controls.
Wholemount E11.5 embryos appeared similar to littermate controls and the short-
ened anterior-posterior axis and hypomorphic tails were less recognisable at this
early stage. Upon dissection of the E11.5 embryos it was possible to isolate lung
tissue (Figure 5.9A). AurkbcKO lungs at E11.5 had two primary buds (Figure 5.9A
1-3) but no evidence of any secondary branches compared to littermate controls
(Figure 5.9A 4-10). However, this phenotype differed between litters with some
E11.5 AurkbcKO displaying no primary branch points and only a rudimentary tra-
chea, which may explain why no lung was found in the 9 E16.5-E18.5 AurkbcKO
whole embryos dissected.











Figure 5.7: Phenotypic analysis of AurkbcKO reveal developmental
defects and lung malformations
(A) AurkbcKO mice are born but die shortly after birth due to respiratory distress. AurkbcKO
mice have a shorted anterior-posterior body axis and a hypomorphic tail compared to AurkbWT
controls. (B) Shortened body axis and hypomorphic tail can be observed as early as E13.5
(hindlimbs removed for photo). (C-E) MicroCT imaging of E18.5 Shh-Cre; Aurkb embryos.
(C) AurkbWT embryo where lungs have been rendered in yellow to show positioning and normal
appearance. (D) In comparison AurkbcKO embryo show large empty cavities (*) and no evidence
of any lung tissue at E18.5. Atrium of heart (arrow) has expanded to fill the empty body
cavity. (E) Computer reconstruction of AurkbWT and AurkbcKO embryos in which the lung is

































Figure 5.8: H&E sections of Shh-Cre; Aurkb embryos at different
time points reveal no lung tissue at E16.5 or E13.5
(A-B) Transverse sections of Shh-Cre; Aurkb E16.5 embryos highlight complete lack of lung tissue
in AurkbcKO (B) compared to AurkbWT (A) controls. (C-D) Sagittal sections and transverse (E-
F) of Shh-Cre; Aurkb E13.5 embryos reveal no lung tissue. (G-H) Sagittal sections and transverse
(I-J) of Shh-Cre; Aurkb E11.5 embryos reveal some evidence of tracheal tissue (blue). In all
images lungs in control samples are circled in blue and oesophagus is circled in red. AurkbcKO
samples at all age groups have developed an oesophagus but no lung tissue. Representative
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Figure 5.9: AurkbcKO E11.5 lungs have two primary lung buds but
show no evidence of secondary branch structure
(A) Representative image of E11.5 Shh-Cre; Aurkb litter. AurkbcKO lungs (1-3) are smaller
than littermate control lungs (4-10) and show no evidence of any secondary branches. (B) Lung
branching morphogenesis assay reveals that AurkbcKO E11.5 lungs have no capacity to branch
compared to littermate controls. Representative image of n=5 AurkbcKO E11.5 lungs.
branches, lung branching morphogenesis was examined ex vivo. AurkbcKO lungs
had no capacity to branch or to grow in this assay compared to littermate control
lungs (Figure 5.9B). In contrast to the wildtype E11.5 lungs treated with AZD1152
(Figure 5.6) these lungs failed to thrive and were dead by day 2. It was not pos-
sible to perform any further analysis of the lungs by immunofluorescence as the
tissue failed to adhere to the membrane and quickly disintegrated.
Phenotypically, deletion of Aurkb in early lung epithelium leads to a complete
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lack of lung tissue by E13.5. AurkbcKO mice are born but have a shorted anterior-
posterior axis and a hypomorphic tail and die shortly after birth due to respiratory
distress. A lung development phenotype can be observed as early as E11.5, where
the lungs fail to grow further than the trachea and primary lung buds. This
rudimentary organ fails to grow in a lung branching morphogenesis assay.
5.3.4 Loss of Aurkb in lung epithelial cells prevents
epithelial growth
Due to the fragility of the E11.5 AurkbcKO lung it was decided to conduct Light-
sheet microscopy to gain further insights into the structure of the mutant lung.
Although confocal microscopy would have been more powerful method of assessing
the epithelial cells in the mutant lung, several attempts were made unsuccessfully
and lightsheet analysis proved to be gentler on the delicate tissue. Aurkb is re-
sponsible for phosphorylation of H3S28 during mitosis. Therefore, H3S28ph was
used as a marker for Aurkb activity. From expression analysis (5.3.1) it was
known that Aurkb was expressed in the distal epithelium and surrounding mes-
enchyme. AurkbWT lungs stained for H3S28ph appeared to have positive cells in
the same region as Nkx2.1 positive cells, however further confocal microscopy will
be needed to confirm co-localisation. It was also observed that there was H3S28ph
staining in the surrounding mesenchyme (Figure 5.10A). Interestingly significant
H3S28ph staining was detected in mutant samples (Figure 5.10B). Positive stain-
ing appeared to be mostly restricted to the surrounding mesenchyme but further
analysis will be needed to determine if epithelial H3S28ph expression is also present
in the epithelium.
Interestingly, all of the AurkbcKO samples that were analysed (n=7) appeared to
have a bifurcation point as seen in the AurkbcKO in Figure 5.8A. Samples that only
had a trachea were unable to be analysed by Lightsheet due to the fragility of the
tissue. Of the 7 AurkbcKO embryos examined, 4 were stained for Nkx2.1 revealing
the presence of a rudimentary epithelium (Figure 5.10B). Initial bifurcation was


















Figure 5.10: Lightsheet analysis of E11.5 AurkbcKO lungs reveal
deformed primary epithelial branches and high H3S28ph staining
(A) AurkbWT E11.5 lungs stained with epithelial marker Nkx2.1 (magenta) and the Aurkb phos-
phorylation mark H3S28ph (cyan). (B) AurkbcKO E11.5 lungs stained with epithelial marker
Nkx2.1 (magenta) reveal severe disruption to primary epithelial branch outgrowth. H3S28ph
staining in the mutant can be seen in the surrounding mesenchyme similar to the pattern ob-
served in the WT littermate control. Scale bars represent 200 µM. Representative image of
n=4-7 E11.5 lungs per genotype.
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lungs were stained (n=3) for the epithelial cell junction marker E-cadherin (Figure
5.11) the trachea was seen but primary lung bud outgrowth was non-existent in
contrast with the initial bifurcation event observed in Nkx2.1+ mutant epithelium.
Elongation and branching are driven by Sox9+ cells present at the tip of the
branches. To determine if Sox9+ progenitor cells were affected by loss of Aurkb,
E11.5 lungs were stained for Sox9 (Figure 5.11; video in appendix D). Control
lungs showed two primary epithelial lung branches with several secondary branches
(Figure 5.11A; video in appendix D) with the distal tip cells expressing Sox9. In
contrast, the mutant lungs displayed no evidence of co-localised expression of Sox9
and E-cadherin (Figure 5.11B; video in appendix D). Additionally a population
of Sox9+ cells was observed around the E-cadherin cells at the proximal end of
the lung in both the control and mutant lungs which correspond to the tracheal
cartilage progenitor cells. However there appears to be no difference in staining
pattern between control and mutants.
Of the seven E11.5 AurkbcKO lungs analysed by Lightsheet microscopy, all were
observed to have two primary lung buds under brightfield imaging. However, fur-
ther analysis revealed that this is only due to outgrowth of the mesenchyme not
of the epithelium. It is known that the outgrowth of the lung requires reciprocal
signalling from the epithelium and mesenchyme. In AurkbcKO lungs, the mes-
enchyme appears to start to grow out but is unable to develop further without
normal growth signals from the epithelium.
5.4 Discussion
Presented here is the early investigation into the role of Aurkb on early lung
epithelial progenitor cells in lung development. I have shown that Aurkb is highly
expressed throughout lung development and genetic deletion or chemical inhibition
of Aurkb in early lung epithelial cells prevents outgrowth and stalls cells in G2/M.

















Figure 5.11: Lightsheet analysis of E11.5 AurkbcKO lungs show severe
epithelial deformities and aberrant Sox9 staining
(A-B) AurkbWT and AurkbcKO E1.5 lungs stained with the lung progenitor marker Sox9 (yel-
low) and the epithelial marker, E-cadherin (magenta). Wildtype samples show normal E-cadherin
staining revealing secondary branches and Sox9 staining is restricted to the distal tips of branch
points. AurkbcKO samples reveal restricted E-cadherin-expressing cells and no evidence of pri-
mary branches. Unidentified Sox9+ staining is also observed surround the E-cadherin+ cells.
DAPI stained nuclei reveals the mesenchyme has grown out in the primary lung bud shape de-
spite no epithelial outgrowth. Scale bars represent 150 µM (A) and 100 µM (B). Representative
image of n=4-7 E11.5 lungs per genotype.
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tissue characterised by a lack of lung epithelial outgrowth from the earliest stages
of lung development.
This is still the beginning of the characterisation of the role Aurkb has in lung
development and there is still much that is not well understood.
Further Lightsheet analysis is needed to understand the phenotype caused by dele-
tion of Aurkb in the lung epithelium from E9.5. Firstly, it would be beneficial to
understand why the phenotypes look so different when Nkx2.1 staining is used
compared to E-cadherin staining. It is possible that these differences are due to
inter-litter differences as the E-cadherin samples were all from one litter. How-
ever, the Nkx2.1 staining was consistent and seen over 3 different litters. Further
samples are needed for E-cadherin analysis. It would also be beneficial to stain
AurkbcKO lungs for both Nkx2.1 and E-cadherin in the same sample to internally
control for any observable differences.
While it was clearly observed that the epithelium failed to grow from E11.5, it
would be useful to image the lung from earlier time points including E10.5 and E9.5
to identify exactly when the phenotype is emerging. Shh is expressed in the foregut
endoderm from E9.5 but formation and separation of the oesophagus and trachea
in mutants suggest that the effects due to loss of Aurkb are not occurring until after
the separation of the two tubes post E10. Given the very short-half-life of Aurkb,
less than minute [Beardmore et al., 2004, Murata-Hori and Wang, 2002, Ahonen
et al., 2009] and the presence of rapidly dividing cells at this time point it seems
unlikely that a delay in deletion of the protein is responsible for the onset of the
phenotype. Interestingly, Shh has been found to be an important regulator of
oesophageal outgrowth however there were no defects associated with oesophageal
and stomach formation seen [Morrisey and Rustgi, 2018]. This observation is
important because it indicates that Aurkb could be playing a lung-specific role.
More intriguingly, Shh is very important in the development of the neural tube
and digits [Riddle et al., 1993, Litingtung and Chiang, 2000] however no defects in
these tissues were observed in any of the AurkbcKO embryos analysed. However,
the shortened body axis and hypomorphic tail do indicate secondary effects in
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non-lung tissues due to Shh-Cre mediated deletion of Aurkb. It will be necessary
to investigate these phenotypes further first by evaluating potential skeletal defects
through wholemount skeletal preparations and vertebrate counting.
As well, the variety of epithelial outgrowth phenotypes observed, such as no tra-
cheal forking to some development of primary buds, indicate that there may be
some variation in deletion time and recombination efficiency. It is possible that
some cells escape the deletion of Aurkb and are able to promote outgrowth. It is
also possible that many of these cells that have grown out have an Aurkb deletion
but have been able to progress through one to two rounds of cell division. It has
been shown that Aurkb does not always cause cell cycle arrest and cell death.
Some cells will progress through the cell cycle but display severe defects such as
chromosome abnormalities and multinucleation [Fernández-Miranda et al., 2011].
High resolution imaging will help in resolving this query. Confocal microscopy or
two-photon imaging of the developing lung, at places where outgrowth should oc-
cur will allow visualisation of cells with multinucleation. However, it is clear that
although some of the cells may escape immediate arrest after deletion of Aurkb,
those that do continue through the cell cycle are unable to rescue the phenotype
as we see no evidence of lung outgrowth past the initial formation of the primary
lung buds.
Due to the complete lack of lung tissue past E13.5 and the frailty of lung tissue
at E11.5 using the AurkbcKO model, alternative methods to study the role of
Aurkb in early lung progenitors must be sought. Recently we have imported a
Sox9-CreER mouse to circumvent these issues. This Cre recombinase mouse is
driven from the Sox9 promoter and Cre is only expressed upon administration of
tamoxifen [Soeda et al., 2010, Chang et al., 2013] which will enable deletion of
Aurkb in Sox9 expressing cells at specific time-points during development. Using
this mouse model it will be possible to answer some crucial remaining questions
about the role of Aurkb in Sox9+ progenitor cells at different time points.
Firstly, it would be interesting to identify if loss of Aurkb at E11.5, would prevent
further outgrowth of the lung similar to the early E9.5 deletion observed using
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the Shh-Cre model. Assuming that Aurkb is having the same effect on Sox9+
progenitor cells that was observed when Aurkb was inhibited in pneumospheres in
vitro (Figure 5.4), the cells will not progress through the cell cycle, stalling lung
growth. However, at E11.5 secondary and tertiary branches have already been
established and downregulation of Sox9 has started to occur in the stalk regions.
These experiments address whether the lung could overcome loss of Aurkb in
Sox9+ cells by promoting outgrowth of stalk cells. Additionally, the initial pool
of lung progenitor cells at E9.5 when the deletion of Aurkb is initiated using the
Shh-Cre is much smaller, so it is possible that at E11.5 this much larger pool of
progenitor cells will be able to overcome deletion of Aurkb and continue outgrowth.
Whether these cells would have chromosomal defects remains to be seen.
Using the Sox9-CreER model it is possible to determine if loss of Aurkb at the
canalicular stage of lung development would prevent further maturation of the
alveolar cells. Sox9+ cells will give rise to both AT1 and AT2 cells and is expressed
until E16.5 [Ustiyan et al., 2016]. Therefore, would loss of Aurkb from E16.5 in
these cells prevent differentiation into the alveolar lineage and therefore prevent
maturation of the lung? As differentiation still requires the cell to proliferate to
reach its final cell fate, it seems plausible that a phenotype would be observed.
However, it will be interesting to determine if the defects are more severe in the
AT2 cells, the progenitor cell of the alveolar region, or if there can be differentiation
of the two alveolar cell types at all.
In a similar vein, would deletion of Aurkb in late alveologenesis disrupt further
maturation of the alveoli? Just after birth there is a significant increase in the
number of proliferating cells as the lungs must grow rapidly once exposed to oxy-
gen, time during which expression of Aurkb peaks again (Figure 5.1). Therefore,
loss of Aurkb in AT1 or AT2 type cells may prevent growth of these cells and dis-
rupt alveologenesis. To address this question, the SPC-CreER mouse model where
Cre expression is driven by the SPC promoter in AT2 cells will be used. AT2 cells
are the progenitor cell of the alveolar region [Barkauskas et al., 2013, Rock and
Hogan, 2011, Desai et al., 2014] so it will be feasible to monitor how loss of Aurkb
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in AT2 cells affects production of both AT2 and AT1 cells. Furthermore, if a dis-
ruption of alveologenesis is observed, it would be interesting to investigate whether
this phenotype recapitulates lung disease characterised by immature alveoli. If so,
this could not only offer a novel model for studying diseases related to defective
alveoli but a model to test new therapies.
A further line of enquiry centres around the adult lung and whether deletion
of Aurkb in adult lung progenitor cells affects lung repair after injury. Upon
injury the lung must be able to repair itself rapidly and does so through many
regional specific progenitor cells [Hogan et al., 2014]. As one of the hallmarks of
a stem/progenitor cells is the ability to self-renew, would loss of Aurkb render the
lung stem/progenitor cells of the adult lung unable to self-renew and therefore
repopulate the lung after injury? To address this question, several mouse models
are available in the laboratory to delete Aurkb in different lung progenitor cells
including, the SPC-CreER model specific to AT2 cells and the CC10-CreER in
which Cre expression is driven by the CC10 promoter expressed in Club cells,
the progenitor cell for most of the bronchiolar lineages [Giangreco et al., 2002,
Giangreco et al., 2009, Hong et al., 2001, Rawlins et al., 2009a].
Due to the various and numerous roles Aurkb has during mitosis it will be chal-
lenging to determine in vivo the specific mechanisms by which Aurkb loss in early
lung progenitor cells leads to a failure of lung growth. However, using multiple
mouse models, it will be possible to determine exactly when Aurkb is important
during lung development. Additionally, further mechanistic exploration into the
role of Aurkb in early lung progenitor cells using in vitro cultures such as the pneu-
mosphere system is accomplishable. Using shRNAs, inhibitors and the Aurkbflox
mouse, or CRISPR/Cas9 technologies pneumospheres could be used to tease apart
which of Aurkb roles are having the greatest effect on the early lung progenitor
cells. To investigate the role of Aurkb and other members of the CPC complex
in lung progenitor cells we can delete/activate factors in the CPC complex and
observe if that mimics or rescues the Aurkb mutant phenotype.
Overall, I have shown that Aurkb plays an important role in lung development.
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Inhibition or loss of Aurkb in early lung progenitor cells prevents proliferation
and lung growth. Through the use of pneumospheres we have discovered a novel
regulator of early lung development that will facilitate further investigation and




This thesis is a thorough investigation into early lung development. A graphical
summary of this thesis can be seen in Figure 6.1. We have developed a technique
that allows for long term culture of early lung epithelial progenitor cells that
recapitulate the E11.5 lung. Using pneumospheres we conducted a shRNA screen
looking for novel regulators of lung development and identified several genes-of-
interest. Investigation into one of these candidate genes, Aurora kinase B, revealed
an important role for this gene in outgrowth of the epithelium from E9.5. While
further investigation is still required to identify the exact mechanism of action of
Aurkb in lung development, this research has provided essential insight into early
lung growth and epithelial proliferation.
The importance of studying development is highlighted through population statis-
tics, approximately 3% of live births have major developmental defects, and up to
70% of neonatal mortality can be attributed to a birth defect [Centers for Disease
Control and Prevention (CDC), 2008]. The causes are sometimes known, such as
an inherited gene mutation or exposure to toxins, as highlighted by altered lung
function due to maternal tobacco use. More specifically, the study of lung devel-
opment remains an important field of research as lung disease accounts for over
4 million deaths globally per year [Ferkol and Schraufnagel, 2014]. Respiratory
diseases, including developmental lung defects disproportionately affect children
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Figure 6.1: Graphical summary of thesis
Development of an E11.5 epithelial lung progenitor culture system, pneumospheres has enabled a
targeted hairpin screen to be performed to identify novel regulators of early lung progenitor cells.
The screen identified several candidate genes including Aurora Kinase B. Loss of Aurkb in a lung
specific mouse model, ShhCre caused severe lung defects including complete lack of epithelial
lung branching. This model has provided insights into how the embryonic lung develops and the
processes controlling normal formation.
with approximately 48 per 1000 children under the age of 5 dying from a lung
related affliction [Zar and Ferkol, 2014]. Therefore, it is important to study de-
velopment not only to understand the processes regulating normal and abnormal
development and treat disease, but to provide evidence to policy makers to regu-
late environmental exposure to drugs and pollutants that pose significant threat
to our healthy and normal development. Additionally, through the identification
of gene networks and pathways regulating organ development, we obtain a greater
understanding of how those genes participate in adult tissue homeostasis, health
and disease. It is through the discovery and elucidation of gene function that
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we can discover targeted genes for disease treatment. For example, regulation of
normal development is controlled by the epigenetic factors which ensures differen-
tiation of stems cells into complex organs. In cancer, many of the same epigenetic
factors that regulate development are due to a malfunction in epigenetic machin-
ery [Bellacosa, 2013]. Therefore, an understanding of normal epigenetic control
may also help us understand disease.
Pneumospheres have proven to be a powerful tool to investigate early lung progen-
itor cells. Through these results we have demonstrated pneumospheres as a useful
method to investigate Sox9+ progenitor cells of the developing lung and further
our understanding of how these cells are regulated, maintained and differentiated.
In vitro techniques are a necessary and primary step in any scientific investigation.
It is not always possible to investigate a hypothesis on lung developmental biology
in vivo and therefore a robust and reliable in vitro method to study lung cells is
important. Pneumospheres recapitulate the E11.5 epithelial progenitor and have
been shown to be highly reproducible. Although there are many uses for pneu-
mospheres one of their greatest assets is their use in screening. The E11.5 lung
does not yield many cells, and is therefore a difficult tissue to interrogate com-
plex scientific questions. A method that amplifies E11.5 lung cells is valuable and
provides a necessary first stepping stone to enable large scale analysis that can be
further validated in vivo.
Screening provides a faster, non-biased way to identify potential genes of interest.
Sequencing has become much more ubiquitous and new technologies are emerging
every day that allow researchers to screen for RNA, DNA, proteins, metabolic
pathways, methylation, and many others, in formats that include bulk popula-
tions, isolated specific populations and single cells. Scientists are generating huge
amounts of data simply by looking at the difference between different cell pop-
ulations or treatments. For example a number of studies have been published
recently in which researchers have aimed to find lung development genes that
are also involved in lung cancer later in life [Zhang et al., 2015, Zhang et al.,
2016, Feng et al., 2014, Li et al., 2018b, Powers and Mu, 2014, Nadkarni et al.,
2015, Mirzadeh Azad et al., 2015, Arima et al., 2014, Kopantzev et al., 2008, Liu
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et al., 2013b, Cortese et al., 2008]. Studies like these are important as they can
reveal important developmental networks involved in cancer progression and can
identify new biomarkers for the characterisation of cancer. These sequencing com-
parisons are generating large lists of genes-of-interest. To validate these genes
individually is still a mammoth task. However, by curating a library of shRNAs
or gRNAs against genes-of-interest identified in these studies and screening for a
desired phenotype in cells of interest, a much smaller list of candidate genes can
be identified. Pneumospheres offer an ideal way to screen for genes that regulate
early lung progenitor cells, genes that affect proliferation and differentiation and
based on our own studies using Trp53−/−; KrasG12V pneumospheres, a way to
test for potential oncogenic factors. We propose that our system may be useful
for many others in screening their own genes of interest.
There are a number of commercially produced whole genome screening libraries
available. Therefore, it would be possible to screen the entire genome in pneumo-
spheres to look for further lung-specific genes-of-interest. Additionally, users are
curating their own CRISPR gene subset libraries by ordering gRNA oligos and
shotgun cloning into their chosen viral backbones. This method is both cheap and
fast however pools can be quite variable in the representation between gRNAs.
In this way it is possible to create targeted screening libraries directed against
specific genes of interest. As in our study, we utilised a shRNA library origi-
nally designed to identify regulators of X-inactivation. Although not intended for
discovery of novel regulators of early lung development we were able to identify
several candidate genes providing robust evidence that screening is a valuable tool
for identification of novel regulatory genes.
We have also demonstrated that pneumospheres have the potential to differentiate
into mature lung cells. Therefore, it would be possible to conduct a screen to look
for regulators of differentiation using the differentiating pneumospheres. In our
case, it would be interesting to conduct the same shRNA screen as was performed
in normal pneumospheres, in differentiating pneumospheres, to determine if there
were genes that were the same or different between maintenance of early lung
progenitor cells and differentiating progenitor cells. Furthermore, discovery of any
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factors that promote progenitor differentiation into a specific cell type would not
only benefit our knowledge about lung development but offer potential therapeutic
opportunities. For example, if loss of a specific gene causes an increase in the
number of AT1 cells to develop, then at least in theory pharmacological depletion
or inhibition of such a factor could help premature babies who suffer from a lack
of AT1 development.
Further proof of principle for the power of screening in pneumospheres is provided
through our identification of Aurkb as a novel regulator of early lung epithelial
cells. Knockout of Aurkb in vivo in epithelial cells early in lung ontogeny revealed
an important role for Aurkb in regulating epithelial outgrowth. Although, further
investigation into the exact role Aurkb plays during lung development is needed,
it is clear that it is contributing significantly to the maintenance and formation of
the lung.
Intriguingly, based on the known roles of Aurkb in mitosis, our screen identified a
gene of fundamental importance to dividing cells. Interestingly, the effect of Shh-
Cre driven Aurkb deletion was less dramatic or absent in other Shh expressing
tissues, potentially suggesting that mitosis is less necessary in those developing
tissues. As noted in Chapter 5, we have identified a shortened anterior-posterior
body axis in the Shh-Cre; Aurkb deleted embryos. However we saw no evidence
of a failure to close the neural tube or to pattern the digits correctly, tissues that
are also regulated by Shh at earlier (Notochord E7.5 [Briscoe and Ericson, 2001])
and later (digits, E10.5 [Harfe et al., 2004]) time points than the lung (E9.5). The
lack of deformities in these tissues suggests that they do not require Aurkb and
mitosis at this developmental time, in comparison to the lung, which still does.
Given this observation, it raises the question: how essential is mitosis in different
tissues at different times during development? Along a similar vein, a recent study
found that apoptosis was not required for almost all facets of normal development.
Programmed cell death had long believed to be essential for shaping tissues during
organogenesis but when researchers knocked out the apoptotic proteins Bak, Bax
and Bok they found that they obtained adult mice that had developed without
any cell death capability [Ke et al., 2018]. Although proliferation does have an
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important role in development, it is not beyond the realm of possibility that long
held assumptions about the role of proliferation in embryogenesis could be rede-
fined. It would be interesting to test the proliferation requirement of other tissues
during development at different times, using the Aurkb knockout mouse model to
determine if Aurkb/mitosis is always crucial for development of other tissues.
Our studies on Aurkb in lung development have contributed to our understanding
of the regulatory mechanisms governing lung growth and development. Through
these studies we further our understanding of how normal morphogenesis occurs
to further understand how disease develops due to mis-regulation of these genes.
Overall, pneumospheres provide a reliable and robust method to study early lung
progenitor cells. These cells are amenable to manipulation and recapitulate the
in vivo response. We have demonstrated that large-scale screening is possible and
we have identified several candidate genes that we believe could play important
roles in lung development. We have provided further evidence on the power of
screening in pneumospheres by validation in vivo of one candidate gene, Aurkb.
Loss of Aurkb dramatically affected lung growth and development. Our research
contributes to the greater understanding of normal lung development and our dis-
coveries have the potential to facilitate further research utilising the pneumosphere
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Combined view with rendered lung:
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Shh−Cre+/+; Aurkbfl/+ Lightsheet images of E11.5 lung showing Sox9 (yellow),
Ecadherin (magenta), DAPI (blue):
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Shh−CreKi/+; Aurkbfl/fl Lightsheet images of E11.5 lung showing Sox9 (yellow),
Ecadherin (magenta), DAPI (blue):
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